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ABSTRACT 
 
Infectious diseases such as pneumonia still pose a major global health concern. Currently, 
the world is facing widespread emergence of acquired bacterial resistance to antibiotics 
which constitute one of the chief causes of infectious diseases. The accumulation of 
different antibiotic resistance mechanisms within the same strains has induced the 
appearance of the so called “superbugs”, or “multiple-drug resistant bacteria”. Due to 
antibiotic resistance, attention is currently being drawn towards biologically active 
components isolated from plant species commonly used as herbal medicine, as they may 
offer a new source of antibacterial, antifungal and antiviral activities. This is the basis of this 
study. 
 
In this study four medicinal plants namely, Cassia abbreviata, Geranium incanum, 
Pelargonium hortorum and Tecoma capensis were investigated for their antimicrobial 
potential. In vitro antimicrobial activity using agar disc diffusion method, agar dilution 
method and broth microdilution plate determination of minimum inhibitory concentration 
(MIC), were carried out against ATCC (American Type Culture Collection) strains and clinical 
isolates known to cause pneumonia. Aqueous, methanol and acetone extracts from the 
selected plants were thus tested against strains of Streptococcus pneumoniae, Haemophilus 
influenzae, Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, 
Acinetobacter baumannii, Escherichia coli and Candida albicans. The plants exhibited 
pronounced antimicrobial activity and were more active against Gram-positive bacteria 
than Gram-negative bacteria. 
 
During agar disc diffusion method, the highest inhibition zone was demonstrated by the 
acetone extract of P. hortorum (IZ=22mm and AI=0.73) against the reference strain of S. 
pneumoniae (ATCC 49619). The range of zones of inhibition in diameter across strains of S. 
pneumoniae and H. influenzae was 7mm to 22mm with activity index range of 0.23 to 0.74. 
The lowest MIC produced by medicinal plants in the study during agar disc diffusion 
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method against S. pneumoniae and H. influenzae strains, was 2.5mg/ml. In broth 
microdilution plate assay, the lowest MIC demonstrated by C. abbreviata, T. capensis and P. 
hortorum extracts on tested bacteria was 0.031mg/ml and that of G. incanum was 
0.063mg/ml. Candida albicans strains were only inhibited at 20mg/ml by the study plants. 
The highest activity among the individual extracts was shown by P. hortorum methanol 
extract which inhibited 71% of the studied bacteria. T. capensis methanol extract was the 
least and inhibited only 17% of the tested bacteria.  The strains of Klebsiella pneumoniae 
showed the highest resistance to medicinal plants employed in this study.  
 
Traditional preparation of selected medicinal plants did not show any significant 
antimicrobial activity. Bioactive analysis of compounds on study plants was carried out 
using standard methods which revealed the presence of anthraquinones, flavonoids, 
phytosterol, saponins, tannins and triterpenoids. Comparison of the inhibitory effect of the 
plant extracts against some broad spectrum antibiotics revealed that the tested medicinal 
plants showed greater antimicrobial activity than standard antibiotics. However, there was 
no correlation between the antibiotic susceptibility patterns of the bacteria and the effects 
of the plants, signifying that plants probably function through different mechanisms. 
Bioautographic findings on thin-layer chromatography plate, exhibited clear zones of 
inhibition of bacterial growth with the Rf value range of 0.09 to 0.94. Anti-mutagenic 
activity was assayed by the Ames mutagenicity test in the plate-incorporation method using 
histidine mutants of S. typhimurium strains TA 100. The selected plant extracts at 2.5mg/ml 
and 5mg/ml did not induce mutagenesis in the absence of liver-metabolizing enzymes.  
 
The study results indicated that the selected plants are capable of inhibiting the growth of 
the studied pathogenic microorganisms to a varied degree. The leaves of G. incanum, P. 
hortorum, T. capensis as well as the stem bark of C. abbreviata could be novel sources of 
antimicrobial agents that might have broad spectrum activity. The anti-mutagenic 
properties of the studied medicinal plants may also provide additional health supplemental 
value to the other claimed therapeutic properties of the plants. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 BACKGROUND INFORMATION 
 
Medicinal plants play a crucial role in traditional medicine practised all over the world due 
to their low cost, ease of access and familial phenomenon. During the past decade, the 
traditional system of medicine has become enormously vital as it is considered to be safe, 
with long lasting effects. In many low and middle income countries (LMICs) a large part of 
the population depends on herbal therapy. Phytomedicines have maintained popularity for 
historical and cultural reasons and have attracted attention as an alternative or 
complementary therapy (Arrowsmith, 2009; Liu, 2011; Jindal, Kumar & Singh, 2012).  
 
To this effect, nature has been a source of medicinal agents for many millenia and an 
impressive number of modern drugs have been manufactured from natural sources. 
Medicinal plants are therefore of profound importance to the health of individuals in 
various communities. Thus, about 80% of the world’s population especially from low and 
middle income countries rely on traditional medicine for their primary health care. Plants 
have for a long time formed the basis of sophisticated traditional medicine systems and 
repeatedly provide excellent leads for new drug developments  (Diederichs, 2006; Akintobi, 
Agunbiade, Okonko & Ojo, 2011; Rai, Cordell, Martinez, Marinoff & Rastrelli, 2012).  
 
The significance of botanicals in the evolution of medicines remains unchallenged 
irrespective of the decline in the application of plants as herbal remedies after the 
emergence of antibiotics in 1900. Revival of interest in plant derived drugs is mainly due to 
the current widespread belief that “Green Medicine” is safe, cheap and more reliable than 
costly synthetic drugs with a variety of adverse side effects, thereby making natural 
therepeutics an attractive option compared to synthetic pharmeceuticals (Jindal et al., 
2012, p. 270). Some of the adverse side effects exhibited by synthetic drugs include 
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hypersensitivity, immune-suppression and allergic reactions (Sadeghian, Hassanshahian, 
Sadeghian & Jamali, 2012, p. 465). 
 
In this context, numerous plants have been screened for anti-infective properties, as the 
probability of identifying diverse chemistries have been implicated to serve as leads for the 
new anti-infective drugs, as well as for the discovery of novel antimicrobial 
chemotherapeutic agents (Sharma, Meena & Meena, 2012).  Thus, many researchers have 
embarked on the investigation of natural products and plant extracts as sources of new 
bioactive molecules. This suggests that antimicrobial research is aimed at moving towards 
the discovery and development of novel antibacterial and antifungal agents (Jindal et al., 
2012). Hence in the present investigation, the antimicrobial potential of Geranium incanum, 
Tecoma capensis, Cassia abbreviata and Pelargonium hortorum plants have been evaluated 
against common bacterial and fungal pathogens that cause pneumonia in humans. 
 
Currently, there are many infectious diseases which constitute one of the major setbacks 
that modern medicine has faced over the last three decades (Pendota, Grierson & Afolayan, 
2009). Thus infectious diseases are still a paramount medical concern, accounting for 41% 
of the global disease burden measured in terms of Disability-Adjusted Life Years (DALYS), 
close to all noninfectious diseases (43%) and far more than injuries (16%) (Noumedem, 
Mihasan, Lacmata, Stefan, Kuiate & Kuete, 2013, p. 1). Pneumonia is one of the most 
common infectious diseases with a high mortality rate and is caused by bacteria such as 
Streptococcus pneumoniae and Haemophilus influenzae (Pallant & Steenkamp, 2008, p. 
864). Vong et al. (2013, p. 2) deduced that pneumonia and other acute lower respiratory 
infections were the third leading cause of death worldwide and the first in low-income 
countries. 
 
The prevalence of drug-resistance S. pneumoniae worldwide has increased, leading to the 
establishment of risk factors for β-lactam resistance which include: age over 65 or under 
five, β-lactam treatment within the previous three months, alcoholism, medical 
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comorbidities and immunosuppressive disease or treatment  (Esperatti & Marti, 2010, p. 
84). In South Africa, it was first documented in 1977 that multiple antibiotic resistant strains 
of S. pneumoniae were being isolated in pathology laboratories. These strains spread 
throughout the western world, such that many of S. pneumoniae isolated in Europe and 
America are now resistant to penicillin (Jensen, Wright & Robison, 1997, p. 220). In 
addition, the degree of S. pneumoniae macrolide resistance has risen substantially in many 
parts of the world, contributing to an elevated risk of macrolide treatment failure  
(Esperatti & Marti, 2010, p. 84). 
 
Infectious diseases are therefore deemed to be the leading cause of death worldwide. 
Concurrently, the clinical efficacy of various current antibiotics are being threatened by the 
emergence of multiple-drug resistant pathogens. A large proportion of antibiotics is 
accounted for pneumonia and other respiratory tract infections. Pneumonia is caused by a 
diverse group of pathogens and resistance to antibiotics such as the β-lactams, macrolides, 
vancomycin and fluoroquinolones have been observed (Pallant & Steenkamp, 2008, p. 860). 
Hence, increasing failure of chemotherapeutics and antibiotic resistance exhibited by 
pathogenic microbial infectious agents such as methicillin-resistant Staphylococcus aureus 
(MRSA) is a major cause for concern. This has led to the screening of sundry medicinal 
plants for their potential antimicrobial activities  (Pallant & Steenkamp, 2008; Sunita, Jha, 
Pattanayak & Mishra, 2012).  
 
Traditionally, plants have been utilized as a source of medicine in virtually all cultures. The 
use of herbal plants has intensified during the last decade and is currently gaining 
popularity. Such plants have continued to be used for primary healthcare, not only in low 
and middle income contries but also in countries where conventional medicine is 
predominant in the national healthcare system. The screening of plant extracts for 
antimicrobial activity has asserted that higher plants represent a potential source of novel 
antibiotic prototype (Pendota et al., 2009). Thus plants, especially medicinal herbs, 
constitute the groundwork of traditional pharmacopeias and have produced many current 
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pharmaceutical drugs of vital importance, for example, taxol from Taxus brevifolia, 
vinblastin and vincristine from Catharanthus roseus, and huperzine A from Huperzia serrata 
(Liu, 2011, p. 81).  
 
Even though there are at least 250, 000 species of higher plants available throughout the 
world, only about 20% of them have been subjected to pharmacological or biological 
investigation (Liu, 2011; Rahmatullah et al., 2011; Balaabirami & Patharajan, 2012). 
Surprisingly, South Africa has the richest temperate flora in the world with up to 19,581 
indigenous species. A minimum of 11,700 species are endemic to South Africa and about 
3,000 species are employed as medicines with approximately 350 species forming the most 
commonly traded and used medicinal plants (Nielsen, Kuete, Jager, Mayer & Lall, 2012). In 
view of this, it is evident that there is a need for the search and development of new 
antimicrobial substances by screening these traditionally used plants. Hence the existence 
of this study (Pallant & Steenkamp, 2008). 
 
1.2 STATEMENT OF THE PROBLEM 
 
The lungs are constantly exposed to microorganisms and are common portals for infection 
by viruses, bacteria, fungi, protozoa and other infecting agents (Van Woerden, Gregory, 
Brown, Marchesi, Hoogendoorn & Matthews, 2013, p. 1). The body host defenses are 
required to prevent microorganisms from entering the lungs and to remove them from the 
lungs. When the body’s defense mechanism is disrupted, pathogenic organisms may reach 
the alveoli. The combined effects of microorganism multiplication and host response, 
determine the clinical condition known as pneumonia  (Esperatti & Marti, 2010, p. 80). In 
adults the incidence of pneumonia differs among countries, from 1.6 to 11 per 1000 adults. 
Incidence is higher in the elderly and more rife in men than in women, with this difference 
increasing with age. In the United States of America, pneumonia is rated the sixth leading 
cause of death and age-adjusted mortality attributable to this disease is on the rise  (Jensen 
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at al., 1997; Esperatti & Marti, 2010). In children, it is the leading cause of mortality 
worldwide. More than two million children under five years of age die from pneumonia 
each year, accounting for almost one in five, under five deaths worldwide. Thus pneumonia 
kills more children than any other illness, more than AIDS, malaria and measles combined. 
Yet, little attention is paid to this disease (United Nations Children’s Fund [UNICEF] / World 
Health Organization [WHO], 2006, p. 4; Esperatti & Marti, 2010, p. 85). 
 
1.3 AIM OF THE STUDY 
 
The purpose of this study is to determine specific biological activities of selected medicinal 
plants in order to reveal that they contain antimicrobial compounds with diverse chemical 
structure and novel mechanism of activities against particular infectious agents that cause 
pneumonia. 
 
1.4 OBJECTIVES 
 
    To screen the different plant extracts for in vitro antibacterial and antifungal 
activities. 
    To determine the minimum inhibitory concentration of the selected plants. 
    To test the plant extracts for any mutagenic effects.  
    To phytochemical screen active compounds found in the plant extracts that have 
antimicrobial activity. 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 PNEUMONIA 
 
Our bodies are intermittently exposed to other highly infectious bacteria and viruses, 
besides those that are normally found on the skin, in the mouth, the respiratory 
passageways, the intestinal tract, the lining membranes of the eyes and even the urinary 
tract. These extremely infectious bacteria and viruses may cause acute lethal diseases such 
as pneumonia (Guyton & Hall, 2006). Stegman and Branger (2005) define pneumonia as 
inflammation of the lung parenchyma characterized by consolidation of the affected part, 
the alveolar air spaces being filled with exudates, inflammatory cells and fibrin. When the 
fluid filling the lungs is pus, the condition is termed empyema (Bauman, 2012). Empyema is 
therefore described as a purulent effusion when pus occurs in the pleural cavity. Not only in 
pneumonia can empyema appear but also with tuberculosis, infection of haemothorax, 
rupture of an abscess through the diaphragm, or could be secondary to bronchial 
obstruction by a tumour or foreign body (Cheesbrough, 2006; Billinger, 2012). According to 
Kumble (2006), the World Health Organization (WHO) estimates pneumonia as the most 
causative agent of death among infectious diseases worldwide (see Figure 2.1 on page 7). 
Such an elevated mortality rate by pneumonia is common among children, the elderly and 
other vulnerable patient groups (Melo-Cristino, Santos, Silva-Costa, Friaes, Pinho & 
Ramirez, 2010). 
 
Pneumonia is basically a severe form of acute lower respiratory tract infection that 
specifically affects the lungs (UNICEF/WHO, 2006). The respiratory tract is the most 
common site of infections in humans. This is because it is persistently exposed to a wide 
variety of potential pathogens from the environment during breathing and from hand 
contact with the nose and mouth. The organisms encountered include viruses, bacteria and 
airborne fungi (Nath & Revanker, 2006).   
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Figure 2.1: Percentage of deaths due to infectious diseases worldwide 
                          (Compiled from Kumble, 2006) 
 
2.1.1 An overview of the respiratory system 
The respiratory system brings oxygen into the lungs and takes carbon dioxide out of the 
lungs. It also plays a role in regulating blood pH whereby removal of CO2 causes the pH to 
rise and helps prevent acidosis (Guyton & Hall, 2006). 
 
The respiratory tract is divided into two sections. The upper respiratory tract consists of the 
nasal cavities, pharynx, glottis and larynx whereas the lower respiratory tract consists of the 
trachea, bronchi, bronchioles and the lungs (Mader, 2004; Bauman, 2012). The two lungs 
are enclosed within the thoracic cage, formed from the ribs, sternum and vertebral column, 
with the dome-shaped diaphragm separating the thoracic cavity from the abdominal cavity. 
The diaphragm is the chief muscle of inspiration because it enlarges the thoracic cavity 
vertically as the domes move inferiorly and flatten. The left lung has two lobes, the right 
three (Ward & Linden, 2008; Kelley & Petersen, 2013). The lungs are composed of 
thousands of tubes (bronchi) that subdivide into smaller airways (bronchioles), which end in 
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small sacs (alveoli). The alveoli contain capillaries where oxygen is added to the blood and 
carbon dioxide is removed (UNICEF/WHO, 2006). Figure 2.2 shows a simple diagram of the 
upper and lower respiratory tract system. 
 
 
Figure 2.2: Upper and lower respiratory system 
                                               (Taken from Bauman, 2012) 
 
2.1.2 Classification of pneumonia 
Physicians classify pneumonia according to the affected region of the lungs or the organism 
causing the disease; for example, lobar pneumonia which affects entire lobes of the lung, 
mycoplasmal pneumonia is caused by the bacterium Mycoplasma. Nosocomial pneumonia 
or hospital acquired pneumonia (HAP) is acquired after more than 48 hours in a health care 
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setting denoting that there is no evidence that the infection was present or incubating at 
the time of hospital admission. HAP is a common illness among the elderly and 
immunosuppressed patients (Esperatti & Marti, 2010; Bauman, 2012). Community-acquired 
pneumonia (CAP) occurs within 48 hours of hospital admission in normal hosts who have 
not been hospitalized for more than 14 days or who have not been inhabited in a long-term 
care facility for 14 days prior to the onset of symptoms, and is described as the most 
common cause of death among infectious diseases (Nath & Revanker, 2006; Hawboldt, 
2009; Ward, Ward & Leach, 2010; Borovac, Pejcic, Petkovic, Dordevic, Dordevic, Stankovic 
& Rancic, 2011). Hawboldt (2009) stated that CAP continues to be the leading cause of 
morbidity and mortality especially in the adult population with the highest rate occuring in 
people older than 65 years. Khawaja, Zubairi, Durrani and Zafar (2013) further described 
CAP as a commonly encountered disease of which one third is Severe Community Acquired 
Pneumonia (SCAP) that can be potentially fatal. Aspiration pneumonia is due to inhalation 
of food, fluid or infected material from the mouth or pharynx and the subsequent bacterial 
colonisation of the lungs (Howle, Nott & Baguley, 2011; Reid, Roberts, MacDuff, Callander & 
Ramsden, 2011). Table 2.1 on page 10 outlines classification of pneumonia. 
 
According to Reid et al. (2011), pneumonia is categorized into three major pathological 
classes namely: bronchopneumonia, lobar pneumonia and miscellaneous pneumonia. The 
three paramount pathological classes of pneumonia will be discussed in this section. 
 
2.1.3 Bronchopneumonia 
Bronchopneumonia is primarily an inflammation spreading from terminal bronchioles to 
their related alveoli and is more of patchy consolidation (Mims, Dockrell, Goering, Roitt, 
Wakelin & Zuckerman, 2004; Reid et al., 2011). The lesions are initially focal engrossed in 
one or more lobules and appear firstly red, then grey and show a central bronchiole 
containing pus (Reid, Roberts, Callander & Ramsden, 2005). Bronchopneumonia is the 
commonest form and is caused by different species of bacteria such as Streptococcus 
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pneumoniae, Haemophilus influenzae, Staphylococcus aureus and coliforms like Escherichia 
coli (Cheesbrough, 2006). This type of pneumonia may affect people of all ages but is 
specifically common in four circumstances namely: as a terminal event in a chronic 
debilitating disease, in infancy, in old age and as a manifestation of secondary infection in 
viral conditions such as influenza and measles (Reid et al., 2011).  
 
  Table 2.1: Classification of Pneumonia 
Classes of Pneumonia 
Classified according to anatomical, basis of aetiology and clinical place of origin 
 
1. Clinical a. Primary i. Community acquired 
ii. Hospital acquired 
b. Secondary i. Immunocompromised patients 
ii. Aspiration pneumonia 
2. Aetiological Infecting agent 
a. Typical 
pneumonias    
 
 
 
 
 
b. Atypical 
pneumonias                   
S. pneumoniae, H.  influenzae, K. 
pneumonia, S. aureus, P. aeruginosa, 
other enteric Gram-negative bacilli, L. 
pneumophilia, Influenza A virus, P. jiroveci, 
A. israelii, N.  asteroids, Cytomegalovirus, 
A. fumigatus, C. albicans, M.  A vium-
intracellulare and many others. 
 
Mycoplasma spp and Chlamydia spp. 
 
3. Anatomical 
 
a. Lobar 
b. Segmental 
c. Subsegmental 
d. Bronchopneumonia 
(Compiled from Cheesbrough, 2006; Underwood & Cross, 2009; Kumar & Clark, 2011; Reid 
et al., 2011; Billinger, 2012; Slack, 2012). 
 
 2.1.4 Lobar pneumonia 
Lobar pneumonia is a condition when a complete lobe or even two lobes of a lung are 
affected and the most striking changes occur in the alveoli. This type of pneumonia is 
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usually seen in adults aged 20-50 years with males predominating and is caused by 
Streptococcus pneumoniae. Klebsiella pneumoniae may sporadically cause pneumonia in 
the debilatated elderly, diabetics and alcoholics (Underwood & Cross, 2009; Reid et al., 
2011). The pneumococci may spread from the lungs into the pleural cavity or pericardium 
and cause abscesses in these areas. The infection in the pleural space is very painfull and is 
known as pleurisy (Jensen et al., 1997; Bauman, 2012). Pathologically, lobar pneumonia 
undergoes four sequential merging phases and in all, the alveoli in the lobe are uniformly 
affected (Reid et al., 2005). Table 2.2 show four pathological phases involved in lobar 
pneumonia.  
 
      Table 2.2: Sequential merging phases of Lobar Pneumonia 
  Activity Phase 1 Phase 2 Phase 3 Phase 4 
Time 1-2 days 2-4 days 4-8 days 8-10 days 
Gross 
appearance 
Lungs are 
dark red and 
wet 
Lungs are 
solid, RED 
and dry 
Lungs are solid 
and GREY (due 
to high 
concentration 
of neutrophils) 
Resolution 
begins 
dramatically 
and 
restoration 
of the lung to 
normal is 
rapid 
Microscopic 
appearance 
Congestion 
and fluid 
exudates 
Fibrin 
strands and 
numerous 
red cells 
Numerous 
neutrophils 
and dense 
fibrin strands 
 
 (Compiled from Reid et al., 2005; Reid et al., 2011) 
 
2.1.5 Miscellaneous pneumonias 
These type of pneumonias are due to opportunistic infections observed in therapeutically 
immunosuppressed patients and in AIDS (Acquired immunodeficiency syndrome) cases. The 
12 
 
aetiologic agents may include: viruses (e.g., Cytomegalovirus), bacteria (e.g., 
Mycobacterium avium intracellulare), or fungi (e.g., Candida albicans)  (Reid et al., 2005). 
The other predisposing factors leading to miscellaneous pneumonias may include physical 
injury to the respiratory tract which could result from inhaling toxic or irritating substances 
such as anesthetic gases; prolonged immobilization in bed; alcoholism; increasing in age; 
heart or lung disease; kidney failure; diabetes; asplenia and immuno deficiency diseases 
such as Hodgkin’s disease and sickle cell anemia  (Jensen et al., 1997; Kilian, 2007; Zagaria, 
2009). 
 
2.1.6 Causes of pneumonia  
Pneumonia may be caused by Gram-positive bacteria or Gram-negative bacteria, 
mycoplasmas, viruses, fungi or protozoa (see Table 2.3 on page 13). Bacterial pneumonias 
are more serious and more common in adults. Some of the organisms that are among the 
commonest causes of typical pneumonia and were incorporated in this study include: 
Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Pseudomonas 
aeruginosa, Klebsiella pneumoniae, Acinetobacter species, Escherichia coli and Candida 
albicans  (Cheesbrough, 2006; Nath & Revanker, 2006; Bauman, 2012; Mansour & Bendary, 
2012). The means of transmission is endogenous since common bacterial pathogens 
causing pneumonia are already present in the respiratory tract. For example, in 
pneumococcal pneumonia, the higher carrier rates are more common in young children 
particularly during winter months and in places where people are living in crowded 
conditions (Jensen et al., 1997; Kilian, 2007; Wistreich, 2007). Pathogens may also be 
spread through contaminated air droplets or may result from blood-borne infections 
(UNICEF/WHO, 2006). 
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     Table 2.3: Microorganisms and pathological insults that cause pneumonia 
Bacterial infections Atypical infections Fungal infections 
Streptococcus pneumoniae 
Haemophilus influenzae 
Klebsiella pneumoniae 
Staphylococcus aureus 
Pseudomonas aeruginosa 
Acinetobacter baumannii 
Gram-negative, e.g., E. coli 
Mycoplasma pneumoniae 
Legionella pneumophilia 
Coxiella burnetii 
Chlamydia psittaci 
Aspergillus 
Histoplasmosis 
Candida 
Nocardia 
 
Viral infections Protozoal infections Other causes 
Influenzae 
Coxsackie 
Adenovirus 
Respiratory syncytial 
Cytomegalovirus 
Pneumocystis carinii 
Toxoplasmosis 
Amoebiasis 
Paragonimiasis 
Aspiration 
Lipoid pneumonia 
Bronchiectasis 
Cystic fibrosis 
Radiation 
      (Compiled from Rello, 2007; Ward et al., 2010) 
 
2.1.7 Diagnosis, signs and symptoms of pneumonia 
Signs and symptoms of classical pneumonia begin with rapid onset of shaking chills and a 
fever of between 38.8˚C and 41.4˚C (Jensen et al., 1997; Wistreich, 2007). Severe chest 
pains are often present. A patient may also experience congestion, cough which may  result 
in tachypnoea and tachycardia, and possibly nausea and vomiting  (Nath & Revanker, 2006; 
Ward et al., 2010; Walters, 2011; Bauman, 2012). Blood frequently enters the lungs, 
causing coughed up sputum to be rust coloured (Jensen et al., 1997; Underwood & Cross, 
2009; Bauman, 2012). According to UNICEF/WHO (2006), children may experience 
headaches, loss of appetite and may develop wheezing. Young infants may suffer 
convulsions, unconsciousness, hypothermia, lethargy and feeding problems. Mental status 
changes with no other recognized cause, in adults of 70 years old or older.   
 
In the laboratory, neutrophils are present in the patient’s sputum smear (Bauman, 2012). 
Blood analysis may show leukopenia (<4,000 white blood cell count per microlitre 
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[WBC/µL]) or leukocytosis (>12,000 WBC/ µL). In radiology two or more serial chest 
radiographs with at least one of the following: new or progressive and persistent infiltrate, 
consolidation, or cavitation. In patients with no underlying pulmonary or cardiac disease, 
one definitive radiograph is acceptable  (Chen et al., 2011; Mansour & Bendary, 2012). 
Laboratory diagnosis also includes examining samples for culture, microscopy (Gram stain), 
serology and direct immunofluorescence tests (Elliott, Worthington, Husam & Gill, 2007). 
Other laboratory based tests include biochemistries such as CRP (C-reactive protein), urea 
and electrolytes, liver function tests and pulse oxymetry  (Borovac et al., 2011). Historically, 
laboratories conducted quellung reaction in which the presence of pneumococci with 
anticapsular antibodies cause pneumococcal capsules to swell (Bauman, 2012). Figure 2.3  
describes common signs and symptoms of pneumonia particularly CAP and the frequency 
with which they may occur. 
 
 
        
Figure 2.3: Percentage frequency of signs and symptoms of pneumonia 
                         (Compiled from Hawboldt, 2009) 
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2.1.8 Pathogenesis, prevention and treatment of pneumonia 
In order to undestand the pathogenicity of pneumonia, the genesis of pneumonia caused 
by bacterium Streptococcus pneumoniae will be discussed. In pneumonia, most 
hospitalization for this disease occurs due to pneumococcal pathogenicity (Bauman, 2012). 
According to Jensen et al. (1997), pneumococcal pneumonia is a potential threat to every 
hospital patient or person with a compromised host defence mechanism.  
 
Virulent strains of pneumococci secrete an attachment molecule, which is a poorly defined 
protein that mediates binding of the bacterium to epithelial cells of the pharynx. Virulent 
serotypes also possess a prominent  polysaccharide capsule that plays a vital role in the 
pathogenesis of pneumococal diseases by inhibiting complement deposition and also 
retarding the rate of phagocytosis where type specific opsonic antibody is absent  (Jensen 
et al., 1997; Kilian, 2007; Abbas & Lichtman, 2011; Bauman, 2012). To date, 94 capsular 
types, or serotypes have been expressed (Gillespie & Bamford, 2012; van der Linden, 
Reinert, Kern & Imohl, 2013). Strains without capsules are avirulent because alveolar 
macrophages clear them from the lungs. S. pneumoniae inserts into its cell wall, a chemical 
known as phosphorylcholine which binds to receptors on cells in the lungs thereby 
stimulating endocytosis of the bacterium. Pneumococci also secrete a cytoplasmic protein 
called pneumolysin which binds to cholesterol in host cell membranes, producing 
transmembrane or oligometric pores that result in the lysis of the cells  (Rodgers, Thornton, 
Barker, McDaniel, Sacks, Swiatlo & McDaniel, 2003; Bauman, 2012). Pneumolysin also 
suppresses the digestion of phagocytized bacteria by interfering with the action of 
lysosomes inside phagocytes (Davis, Nakamura & Weiser, 2011; Bauman, 2012). In addition, 
Pneumolysin inhibits lymphocyte proliferation and immunoglobulin synthesis (Kilian, 2007). 
Thus with the above mentioned factors, pneumococci is able to live in and subsequently kill 
lung cells. 
 
When the defence mechanisms of a host become suppressed, the pneumococci are able to 
multiply and establish a focus of infection. As the bacteria multiply, they damage the lining 
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of the alveoli inducing the infiltration of erythrocytes, leukocytes, and blood plasma into 
the lung. This fluid fills the alveoli in one or both lungs, reducing the lung’s ability to transfer 
oxygen to the blood and causing breathing difficulties (UNICEF/WHO, 2006; Bauman, 2012). 
When this edematous fluid fills the infected lung lobe causing areas of consolidation, the 
condition is termed lobar pneumonia. Conversely, when pneumococci spread from the 
lungs into the pleural cavity or pericardium and cause abscesses in those areas, the 
infection is termed pleurisy. Pleurisy is worsened by deep inspiration and coughing (Jensen 
et al., 1997; Ward et al., 2010; Bauman, 2012). Leukocytes attack the bacteria, in the 
process secreting inflammatory and fever-producing chemicals, which add to the 
manifestations of the disease. However, the body fights back by mitigating migration of 
bacteria throughout the lungs by binding the microbes with the active sites of secretory 
immunoglobulin A (IgA). The rest of the antibody molecule then binds to mucus, enabling 
mucus-enveloped bacteria to be swept from the air passage ways by the action of cilia. 
Pneumococci counteracts this defense by secreting secretory IgA protease, which destroys 
IgA thereby enabling these pathogens to evade the protective functions of the principal 
immunoglobulin isotype of the upper respiratory tract (Greenwood, Slack, Peutherer & 
Barer, 2007; Bauman, 2012). IgA is the major immunoglobulin in secretions such as saliva, 
milk and tears, and it is largely represented in the mucosal epithelia of the respiratory, 
genital and intestinal tracts  (Nairn & Helbert, 2007). 
 
Treatment of pneumonia is antibiotic therapy which depends on the causative agent 
indentified in sputum or other lower respiratory tract specimens (Elliott et al., 2007). In the 
case of pneumococcal pneumonia, penicillin has long been the drug of choice although 
about a third of pneumococcal isolates are now penicillin resistant. Cephalosporin, 
erythromycin and chloramphenicol are effective alternative treatments. The Centers for 
Disease Control and Prevention (CDC) recommend Pneumonia Conjugate Vaccine (PCV) 
against pneumococcus adiministered at 2, 4, 6, and 12-15 months of age and for all adults 
over age 65 (Bauman, 2012). However, according to Compcare Wellness Medical Scheme 
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(2012), adults of any age who have a depressed immune system or have a chronic illness 
such as asthma, cardiomyopathy, diabetes, HIV and so forth are also eligible for the 
pneumonia vaccine. In addition to this group, smokers over the age of 19 also qualify for 
vaccination because smoking has been discovered to be the strongest risk factor for 
invasive pneumococcal disease in immunocompetent nonelderly adults. Currently, there 
are two vaccines against pneumococcal infections: the polysaccharide vaccine, containing 
23 serotypes also known as Pneumovax 23; and the conjugate vaccines such as Prevenar, 
Synflorix and Prevenar 13  (Kayser, Bienz, Eckert & Zinkernagel, 2005; Dobay et al., 2010; 
Esperatti & Marti, 2010; Compcare Wellness Medical Scheme, 2012). In order to prevent or 
minimise the development of pneumonia in compromised hospital patients, good nursing 
and medical management practices must be employed (Jensen et al., 1997). 
 
2.2 TRADITIONAL HERBAL REMEDIES  
 
Wong (2009) and  Bhat, Kumar and Bussmann (2013) stated that many people regard plant-
based remedies as natural, cheap and produce less harmful effects to the body than 
pharmaceutical drugs.  They are able to ease both everyday and chronic health problems 
that orthodox medicine finds difficult to treat. 
 
2.2.1 Overview on herbal remedies 
Herbal remedies are regarded as one of the oldest forms of health care known to humans. 
Prior to the development of modern medicine, traditional systems of medicine which have 
evolved over the centuries within various communities, are still maintained as a great 
traditional knowledge base in herbal medicines (Mukherjee & Wahile, 2006). According to 
the World Health Organization (WHO), traditional medicine refers to health practices, 
approaches, knowledge and beliefs incorporating plant, animal and mineral-based 
medicines, spiritual therapies, manual techniques and exercises, applied singularly or in 
combination to treat, diagnose and prevent illnesses or to maintain well-being. If the 
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material being used is of plant origin, then it is referred to as traditional herbal medicine 
(Kalimuthu, Rajesh, Kannan, Balamurugan & Chandrasekar, 2010, p. 2779; Liu, 2011, p. 1).  
 
Natural products play important roles in drug development in the pharmaceutical industry, 
such that over 50% of all modern clinical drugs are of natural product origin  (Wong, 2009; 
Akintobi et al., 2011). The diversity of natural molecules still surpass those from synthetic 
compounds, and this ensures that natural products such as plants will continue to be 
important for drug discovery (Carpinella & Rai, 2009). In this regard, many of the 
pharmaceutical drugs in use are directly or indirectly derived from plants which implies that 
at least some plants contain compounds with pharmacological activity which can be 
harnessed as medicinal agents  (Pengelly, 2004). For this reason, medicinal plants present 
future prospects (Van Wyk, Van Oudtshoorn & Gericke, 2009).  
 
Different kinds of traditional medicines are widely applied in Asia, Africa and Latin America 
for people’s health care needs. Herbal medicine in low and middle income nations has a 
long and uninterrupted history of use (Koduru, Grierson & Afolayan, 2007; Liu, 2011). 
Traditional medicine has maintained its popularity in most regions of the developing world 
largely due to economical conditions (high cost of Western pharmaceuticals) and 
availability of limited health services (Marzouk, Marzouk, Decor, Edziri, Haloui, Fenina & 
Aouni, 2009; Liu, 2011; Rivera, Cedillo, Hernandez, Castillo, Sanchez & Castaneda, 2012). In 
addition, spritual and cultural practices have also contributed to the utility of herbal 
medicine in low and middle income countries (Koduru et al., 2007). The practice of using 
herbal medicine is also rapidily spreading in industrialized countries, where adaptations of 
traditional medicines are often termed “complementary” or “alternative.” In the United 
States of America, the National Institutes of Health (NIH) use the name complementary and 
alternative medicine (CAM) to cover health systems, practices and products that are not 
considered part of conventional medicine (Liu, 2011). Among the various complementary 
therapies, perhaps medical herbalism can be made to fit the orthodox model most easily. 
Few people would disagree with this proposition, however, there are many who persist in 
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referring to herbal medicines (along with other CAM) as unproven and therefore of little or 
no clinical value. The public and in particular those in the medical field are demanding 
herbalists and other complementary therapists to provide scientific evidence for the 
efficacy and safety of their practices (Pengelly, 2004). This is the reason this study was 
conducted, in order to scientifically prove some of the medicinal herbs used in the Eastern 
Cape Province of South Africa to treat infectious diseases such as pneumonia. 
 
Worldwide, among all the different traditional medicine systems applied, traditional 
Chinese medicine (TCM) is currently the most popular, followed by Indian (Ayurveda) 
medicine (Liu, 2011). In South Africa there are about 200 000 indigenous traditional healers 
and up to 60% of South Africans consult these healers, apart from using modern biomedical 
services (Van Wyk et al., 2009). Although allopathic medicine is the mainstream medicine in 
western countries, the use of traditional medicine, including herbal therapies, is growing 
worldwide. This is because modern drugs have demonstrated a lot of adverse side effects 
or inefficiency. People have begun to increase their faith in the use of herbal medicine. 
According to WHO as presented in Figure 2.4, about 80% of the population in Africa uses 
traditional medicine for primary health care; 30-50% of herbal preparation in China account 
for medicinal consumption; over 50% in Europe, North America and other industrialized 
regions use complementary or alternative medicine at least once; 90% of people in 
Germany have used natural remedies at some point in their lives (Liu, 2011). This 
demonstrates how traditional medicines play important roles in most of the traditional 
medicine systems across the globe. An overall report by WHO states that 80% of the 
world’s population, mostly from low and middle income countries, use plant-based 
remedies to meet their primary healthcare needs (Barnes, Anderson & Phillipson, 2007; 
Bhat et al., 2013). Furthermore while largely unrecognised, it is estimated that 25% of all 
prescribed medicines contain some ingredient(s) derived from plants (Diederichs, 2006, p. 
3). 
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Figure 2.4: WHO data on worldwide use of traditional medicine 
                                (Compiled from Liu, 2011) 
 
2.2.2 History of phytotherapy 
The application of wild plants as medication, elixirs, love potions and remedies is as old as 
humankind itself. Notably many years ago, prior to the written word, someone somewhere 
– out of lucid curiosity or need – chewed a leaf, sniffed some scrapings of bark or nibbled a 
bulb and experienced relief, enchantment or euphoria. They passed on their experiences to 
other people (Pepler, Botha & Laurian, 2009, p. 7). Thus through trial and error, early tribes 
accumulated useful amounts of knowledge on how to relieve pain and sickness through 
various forms. One of the methods, as already hinted in this passage was the gigantic 
intellectual leap for people to use their surroundings in nature, as a potential way to 
promote healing. In this way, they managed to discover plants that were detrimental or 
toxic to human consumption and others that were non-effective (Lewis & Elvin-Lewis, 2003; 
Heyman, Hussein, Meyer & Lall, 2009; Rai et al., 2012). Bremness (1988) documented that 
herbal medicine was almost universally a feminine vocation in pre-scientific cultures 
because women of child bearing state assumed the task of collecting and administering 
herbs to their young ones, thereby restricting their mobility. In order to sustain the ability, 
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efficiency and effectiveness of phytotherapy, herbal knowledge was handed down from 
mother to daughter or father to son (Bremness, 1988; Hostettmann, Marston, Maillard & 
Hamburger, 1995; Arrowsmith, 2009). For example in South Africa, the informal oral-
tradition medical systems of the Khoi-San people, the Nguni and the Sotho speaking people 
have not yet been systematised, and are passed on from one generation to next. These 
medical systems and their herbal, animal and mineral materia medica have ancient origins 
which may date back to palaeolithic times (Van Wyk et al., 2009, p. 10). 
 
Sundry accounts on plant utilization for treatment of diseases have been recorded in 
history since 4 000 BC  (Duarte & Figueira, 2009, p. 124). According to Schneider (2002), a 
number of prehistoric sites have revealed the presence of huge quantities of seeds, plants 
that were processed and utensils used to crush them. As early as 3100 BCE, the first 
Sumerian writings tell of the cultivation and use of herbs. These were the Tables of Aleppo, 
clay tablets that recorded several recipes based on plants still widely used today such as 
cedar, juniper and lavender, as well as the distillation techniques used to extract the 
essential oils. The Egyptians were highly qualified in the art of using plants, which is 
evidenced by the Ebers Papyrus (1500BC) which contains 811 prescriptions and 700 drugs  
(Duarte & Figueira, 2009). Historically, China is renowned for the use of healing plants. The 
first Chinese text on medicinal plants (500 BC) mentions names, dosage and indications of 
plants used for the treatment of diseases, which are still used in contemporary Chinese 
medicine. Examples of such plants include Ginseng (Panax spp.), Ephedra spp., Cassia spp 
and Rheum palmatum L. Some of these plants are sources for pharmaceutical industries 
(Schneider, 2002;  Duarte & Figueira, 2009). Traditional medicinal techniques in China 
specifically embody herbal medicine, acupuncture and moxa counterirritants. Shen Nong, 
father of Chinese medicine and who lived about 2000 BC, compiled the first great herbal list 
of 365 drugs and their properties  (Lewis & Elvin-Lewis, 2003).  The Bible also speaks of 
balsam, bitter herbs, manna and rue. The Old Testament has a detailed recipe for holy oil 
(Ex. 30, 22-25) that calls for precious spices and refers to the Queen of Sheba who brought 
back to Salomon, large quantities of myrrh from the region of Aromata. Myrrh was utilized 
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during religious ceremonies and for sterilizing homes and wounds  (Schneider, 2002; Pepler 
et al., 2009).  
 
According to Pepler et al. (2009), in South Africa in 1813, Carl Peter Thunberg completed his 
great field study packed with descriptions of herbs for Flora capensis. However, Anders 
Sparrman, William Paterson and Francois Le Vaillant described medicinal plants long before 
Carl Peter Thunberg. Today, a healthy relationship exists between traditional herbalists, 
western homeopathy and oriental influences from Ayurvedic treatments. In the past, 
prayer and prescription went hand in hand. Although not all sacred herbs may have had 
pharmacological value, over millennia a vast bank of plant knowledge increased, 
interwoven with faith and superstition. Scientists who have drawn on this knowledge, apply 
it in the laboratory in order to develop important drugs from medicinal plants. 
Pharmaceutical companies are currently carefully examining “primitive” indigenous 
remedies (Arrowsmith, 2009; Pepler et al., 2009). These companies invest vast resources of 
time and money in developing natural products, extracted from medicinal plants to 
manufacture more cost effective remedies which are affordable to the public (Jindal et al., 
2012, p. 270). It is therefore of profound significance to study the practices of indigenous 
populations before they are lost, either through human indifference or our relentless ability 
to alter and demolish vegetation around us  (Lewis & Elvin-Lewis, 2003). 
 
2.3 IMPORTANCE OF MEDICINAL PLANTS 
 
Plants contribute to the survival of the human race as a source of food and oxygen and 
provide climate stability on earth. Plants, in addition provide a basis for a large proportion 
of medical remedies, with up to 50% of the world’s top proprietary drugs originally derived 
from natural sources (Schneider, 2002; Wong, 2009). The use of herbal medicines for the 
treatment of diseases was first documented several thousand years ago. Various studies on 
herbal medicines have been encompassed under several different names such as plant 
medicine, phytomedicine, pharmacognosy and natural products. Natural products typically 
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refer to products processed or derived from living organisms, including plants, animals, 
insects, microorganisms and marine organisms (Liu, 2011). According to Wong (2009), 
traditional plant-based remedies have provided modern Western medicine with some of its 
most important drugs, and are still studied by pharmaceutical companies, offering tip-offs 
that may lead to new breakthroughs. Data from WHO estimate that 25% of modern 
medicines are derived from plant based compounds that were first used traditionally and 
many others are synthetic analogues built on prototype compounds isolated from plants 
species (Liu, 2011; Satdive, Chimata, Namdeo & Fulzele, 2012; Bhat et al., 2013). Well-
known examples of plant-derived medicines include atropine, morphine, quinine, 
ephedrine, warfarin, aspirin, digoxin, vincristine, taxol, codeine, reserpine, tubocurarine, 
cocaine and hyoscine (Pepler et al., 2009; Van Wyk et al., 2009; Wong, 2009; Rahmatullah 
et al., 2010; Liu, 2011). In South Africa, a huge part of day-to-day medicine is still derived 
from plants and large quantities of plants or their extracts are sold in the informal and 
commercial sectors of the economy (Diederichs, 2006; Van Wyk et al., 2009).  
  
The use of plants for medicinal purposes is an integral part of South African cultural life and 
it is unlikely that this will change in the years to come. It is estimated that 27 million South 
Africans use herbal medicine from more than 1020 plants in comparison to 150 animal 
species (Koduru et al., 2007). However, Heyman et al. (2009) record an estimation of 20 000 
plant species that are used for medicinal purposes in South Africa. On the other hand, 
Pepler et al. (2009) noted that about 70% of the people in South Africa rely on plants for 
primary health care. There is also an increasing number of people who depend on these 
plants for their livelihood. South Africa’s contribution to world medicine includes Cape 
aloes (Aloe ferox), buchu (Agathosma betulina) and devil’s claw (Harpagophytum 
procumbens), but local equivalents exist for many famous remedies used elsewhere (Van 
Wyk et al., 2009).  
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2.3.1 Some remedial activities of plants 
Plants have contributed immensely in terms of remedial action and its impact on health. A 
few examples have been illustrated in this discussion. Plants have demonstrated remedial 
properties in the fight against cancer. Many lives have been saved or extended by the use 
of the antineoplastic agents of microorganisms and the alkaloids vincristine and vinblastine 
of the Madagascaran periwinkle. The use of these compounds in combination, for treating 
extremely complicated diseases such as Hodgkin’s disease, acute lymphoblastic leukemia, 
Burkitt’s lymphoma and gestational choriocarcinoma have clearly shown eminent 
achievement in the use of plant products  (Schneider, 2002; Lewis & Elvin-Lewis, 2003). 
Other plants contain active ingredients of various types of curares (the famous dart and 
arrow poisons of South America) which do have an anesthetic activity making the surgical 
process more effective (Lewis & Elvin-Lewis, 2003; Van Wyk et al., 2009). Many plant 
products affect the nervous system for example, willow and poplar bear aspirin-like 
compounds which relieve fever and pain. Opium alkaloids also relieve pain and morphine is 
considered the all-important analgesic in conventional medicine. Plants play an important 
role in relieving people even from the world’s greatest killer, heart disease. Without 
foxglove, or other plant-produced cardiotonic compounds, congestive heart failure 
followed by death would inevitably occur for many, but not quickly for most (Lewis & Elvin-
Lewis, 2003). 
 
Plants have had great impact in recent years in the area of producing the basic steroidal 
compounds for efficient development of human sex hormones. These products are 
available cheaply for oral contraception and for treating menopause, improper 
menstruation, premenstrual tension and testicular deficiency. Interestingly, plants and their 
products are also commonly used to treat respiratory tract conditions such as pneumonia. 
Many plants, some which were used in this study have multiple respiratory uses and some 
appear as panaceas  (Lewis & Elvin-Lewis, 2003). 
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2.3.2 Methods of herbal administration and dosage preparation 
According to Pooley (1998), ethnobotany is referred to as the study of interactions of 
people and plants including the influence of plants on human culture.  It is a distinct branch 
of natural science involving many disciplines. Diederichs (2006) observed that important 
economic, social and health opportunities are supplied by natural plants to rural 
communities, businesses and national economics. The parts of the plant which are usually 
used for medicine include: roots, bulbs, rhizomes, tubers, bark, leaves, stems, flowers, fruit 
and seeds, gums, exudates and nectar (Van Wyk et al., 2009; Umer, Tekewe & Kebede, 
2013). Thus, it is of immense signifinace to preserve the beauty and vast wealth of wild 
plants when harvesting and processing them for medicinal purposes. The rule is to harvest 
only as much as that which will be used and not to take more than half the leaves, fruit or 
stems of any plant. Enough should be left for wildlife to eat and to ensure future plant 
generation (Schneider, 2002; Wong, 2009). Even trade in plants has to be well regulated in 
order to avoid depletion of species which may lead to erosion of genetic diversity and the 
degradation or loss of ecosystems (Diederichs, 2006). 
 
The method of herbal medicine preparation is crucial because it involves the amount of 
fresh or dry plant material to be used. It also requires the addition of appropriate volumes 
of solvents such as water or alcohol, and additional activities such as boiling for a specified 
period of time, or partial burning to achieve a desired colour. Instructions on how to 
prepare and take the remedy are either written on the label or conveyed orally by the 
healer. In case of toxic plants, the remedy is professionally prepared and standardised. The 
dosages are adjusted after an appraisal of the physical and general condition of the patient. 
Side effects and contra-indications are well known to an experienced healer. Various types 
of dosages exist and these include enemas, extracts, infusions (or herbal teas), inhalations, 
linctuses, decoction, liniments, lotions, mixtures, nasal drops, ointments, tinctures, syrups 
and snuffs (Schneider, 2002; Arrowsmith, 2009; Van Wyk et al., 2009). Plant medicine may 
be administered into a patient in various ways. The most common ones include oral, 
sublingual, rectal, topical, nasal, smoking, steaming and bathing (Van Wyk et al., 2009). 
26 
 
2.3.3 Harmful effects of plants 
Green plants are essential for all animal life on earth since they convert solar energy into 
organic carbon compounds which in turn are used to produce essential food. Should 
photosynthetic activity of green plants cease, so would the lives of animals and hence the 
need to preserve plant life (Miller, 1973; Jothy et al., 2012). Due to fear of side effects from 
Western medicine, more and more people every year turn to herbal or natural medicine 
because it is considered to be generally effective and safe.  The term, “natural” may sound 
good, but it does not necessarily mean safe. Many people mistakenly believe that all herbal 
medicines are generally safe and free from toxicity. However, this  notion is dangerously 
misleading and is far from the truth because plants do have injurious effects. Even though 
many plants have been successfully screened for various biological activities, some plants 
have proven very toxic for example, tobacco and belladonna contain poisonous alkaloids 
(Aronson, 2009; Liu, 2011; Tchacondo et al., 2012).  
 
Many plants cause serious illness and death when ingested even though these numbers are 
minimal. Plants may injure us by causing severe changes in our cells which can lead to 
inheritable mutations, abnormal foetuses, and aberrations of the blood. Several herbal 
medicines pose serious problems for surgical patients, for example through an increased 
bleeding tendency. Another major concern is that people may suffer from allergic diseases 
such as hay fever, asthma and dermatitis  (Lewis & Elvin-Lewis, 2003; Aronson, 2009). It is 
therefore necessary that information regarding the risks associated with the use of herbal 
products is systematically collected and analysed in order to protect public health (Barnes 
et al., 2007). 
 
There is limited toxicological data available on medicinal plants because not many herbal 
products have been investigated  (Liu, 2011). However, a considerable body of information 
exists though it overlaps between herbs used for medicinal purposes and those for 
cosmetic or culinary purposes. Some culinary herbs contain potentially toxic constituents. 
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The safest way of using  culinary herbs is by limiting the amount of constituent permitted in 
a food product, to a concentration not considered to represent a health hazard. For 
example, the volatile oil of a parsley tree causes abortifacient activity, hepatotoxic and liver 
damage if excessively ingested exceeding normal dietary consumption over a long period of 
time  (Barnes et al.,  2007).  
 
Interestingly, most herbal practitioners know herbal safety very well. In China about two 
thousand years ago, traditional Chinese herbs were divided into three categories based on 
clinical experiences in order to denote their toxicity. Herbs were grouped as follows: herbs 
with no toxicity, minor toxicity and heavy toxicity. Herbs with no toxicity are less likely to 
induce side effects if taken in the recommended dose range, are thus safe in nature and are 
most often used, for example, licorice and goji berry. Herbs with minor toxicity may induce 
mild side effects, especially if overdosed or applied with long tenure, for example, apricot 
seeds and ginkgo nut, causing mild breathing difficulties, abnormal heartbeat, or dizziness. 
On the other hand, herbs with heavy toxicity may easily cause serious toxic effects, 
especially if improperly applied, for example, unprocessed croton fruits and monkshood, 
causing coma, nausia, and numbness of mouth and limbs (Liu, 2011).  
 
In summary, herbal adverse effects include allergic, cardiac, hepatic, hormonal, irritant, 
purgative and a range of toxicities. Herbs are safe if applied according to syndrome 
differentiation and within the recommended dosage for an appropriate length of time 
(Lewis & Elvin-Lewis, 2003; Barnes et al., 2007; Liu, 2011). This calls for greater public 
awareness that adverse reactions can occur and such reactions should be reported. This 
also highlights the need for healthcare professionals to take a detailed medical history 
including use of herbal products and to be aware that patients may be reluctant to provide 
information (Barnes et al., 2007). That is why mutagenic effect of medicinal plants utilised 
in this study was tested. 
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2.3.4 Bioactive compounds in herbal medicines 
Currently, natural plant-based products are becoming increasingly popular  (Van Wyk et al., 
2009). Surprisingly in nature, all living organisms produce numerous chemical compounds 
that are referred to as natural products (Barnes et al., 2007). In plants, the chemicals can be 
divided into two major categories namely: primary metabolites and secondary metabolites 
based on the range of molecular weight, distributions in species, and biological roles in 
plants  (Hussain et al., 2011; Liu,  2011, p.81). Primary metabolites (mol wt > 2000 amu) are 
common to all life forms and are exemplified by carbohydrates, proteins, fats, nucleic acids, 
vitamins and mineral nutrients. They provide nutrients, and thus are deemed essential for 
growth and survival (Barnes et al., 2007). On the other hand, secondary metabolites such as 
phenols and alkaloids are small organic compounds (mol wt < 2000 amu) that are 
synthesized frequently by a particular species, usually possessing significant biological 
activity (Pengelly, 2004; Liu, 2011). Since secondary metabolites can be taxonomically 
unique to specific species or genera, they do not play any role in the plants’ primary 
metabolic requirements, but rather they increase their overall ability to survive and 
overcome local challenges by allowing them to interact with their environment (Kennedy & 
Wightman, 2011; Umer et al.,  2013). 
 
The biosynthetic pathways in plants are universal and are responsible for the occurence of 
both primary and secondary metabolites. Secondary metabolites are derived from primary 
metabolites. The most common pathways derived from Pengelly (2004) are: 
   Pentose → glycosides, polysaccharides 
   Shikimic acid → phenols, tannins, aromatic alkaloids 
   Acetate – malonate → phenols, alkaloids 
   Mevalonic acid → terpenes, steroids, alkaloids 
 
Liu (2011, p. 81) deduced that a number of secondary metabolites in plants serve as 
chemical messengers and defensive chemicals, and play important biological and ecological 
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roles. Most of these compounds serve primarily to repel grazing animals or destructive 
pathogens  (Pengelly, 2004). To this effect, several functions of secondary metabolites are 
relatively straightforward; for example, they play a host of general, protective roles (e.g., as 
antioxidant, free radical scavenging, UV light absorbing and antiproliferative agents) and 
defend the plant against microorganisms such as bacteria, fungi and viruses. They also 
manage inter-plant relationships, acting as allelopathic defenders of the plant’s growing 
space against competitor plants (Kennedy & Wightman, 2011). 
 
Around the globe, there are at least 121 chemical substances of known structure that are 
still extracted from plants and are useful as drugs (Hossain & Nagooru, 2011). According to 
Liu (2011), there is growing interest in the study of plant secondary metabolites as they 
represent a tremendous library of potentially useful leading compounds for new drug 
development. Currently, chemical substances derived from the plants remain the basis for a 
large proportion of commercial medications for the treatment of cardiac disease, 
hypertension, pain, asthma and other problems (Hossain & Nagooru, 2011). These 
phytomedicines are sold as extracts or powders in which the concentration of the active 
ingredient is standardized to ensure safety and efficacy (Van Wyk et al., 2009).  
 
There are many groups or families of phytochemicals which assist the human body in 
several ways. Chemical constituents are non-nutritive plant bioactive chemicals that have 
protective or disease preventive properties. They either act directly or indirectly in order to 
prevent or treat disease and maintain health (Van Wyk et al., 2009; Hossain & Nagooru, 
2011). Plants produce these bioactive chemicals to protect themselves but recent research 
demonstrates that many chemical constituents can protect humans against diseases. There 
are so many groups of bioactive chemicals in fruits, vegetables and herbs and each works 
differently (Hossain & Nagooru, 2011). Some of the major types of bioactive ingredients 
present in plants include: sugar and gums, glycosides and aglycones, amino acids, lectines, 
glycoproteins, flavonoids, tannins, quinones, coumarins, terpenoids and steroids, and 
alkaloids (Lewis & Elvin-Lewis, 2003; Pengelly, 2004; Raaman, 2006; Van Wyk et al., 2009; 
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Liu, 2011). Some compounds and their antimicrobial activities will be briefly discussed as 
follows: 
 
2.3.4.1 Alkaloids  
All alkaloids are alkaline, nitrogen-containing substances with a nitrogen atom (N) as a 
member of the heterocyclic ring system (Barnes et al., 2007; Van Wyk et al., 2009). 
Alkaloids are famous for their manifold pharmacological activities. Many modern drugs are 
manufactured from naturally occurring alkaloids or their synthetic analogs (Liu, 2011, p. 
82). Alkaloids may be classified by their chemical skeleta into the following major classes: 
pyrrolidine (e.g., occur in betonicine from white horehound); pyridine (e.g., gentianine from 
gentian); piperidine (e.g., occur in plants such as pelletierine); pyrrolizidine common in 
Senecio; and many more (Barnes et al., 2007; Van Wyk et al., 2009). Various remarkable 
activities from alkaloids include antibacterial (e.g., berberine), anti-malaria (e.g., quinine), 
analgesia (e.g., morphine), anesthesia (e.g., cocaine), anticancer (e.g., vincrinstine), cardiant 
(e.g., dl-demethylcoclaurine), antihypertention (e.g., resepine), cholinomimeric action (e.g., 
galatamine), relieving cough (e.g., codeine), spasmolysis (e.g., atropine), vasodilatation 
(e.g., vincamine), anti-arhythmia (e.g., quinidine), and anti-asthma (e.g., ephedrine) (Liu, 
2011, p. 82). 
 
2.3.4.2 Flavonoids 
Flavonoids are polyphenolic compounds that are found almost universally as water-soluble 
pigments in plants (Van Wyk et al., 2009). Flavonoids are biosynthesised from a 
phenylpropane unit (C6–C3), derived via shikimic acid and phenylalanine, and a C6 unit 
from three molecules of malonyl–CoA. The five main types of flavonoids include chalcones, 
flavonones, flavones, flavonols and anthocyanins (Barnes et al., 2007). Flavonoids provide 
several medicinal properties such as antioxidant, antibacterial, antiviral, antiallergic, 
antiplatelet, anti-inflamatory, and antitumor activities (Van Wyk et al., 2009; Liu, 2011). 
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They are ubiquitous in photosynthesising cells and are usually found in fruits, vegetables, 
nuts, seeds, stems, flowers, tea, wine, propolis and honey (Jindal et al., 2012, p. 270). 
 
2.3.4.3 Coumarins 
Coumarins are also phenolic compounds with a particular ring structure. Umckalin from 
Pelargonium sidoides or furanocoumarins are simple coumarins which have a furan ring 
attached to the first ring of their basic structure. Xanthotoxin is an example of this type of 
coumarin (Van Wyk et al., 2009). Coumarins have multi-biological effects such as anti-HIV, 
antitumor, antihypertension, anti-arrhythmia, anti-inflammation, anti-osteoporosis, pain 
relief, prevention of asthma and antisepsis. They are also widely used as anticoagulants for 
the treatment of excessive or undesirable blood clotting due to their competitive binding to 
vitamin K reductase and vitamin K epoxide reductase, which are essential for blood 
coagulation (Liu, 2011, p. 91). 
 
2.3.4.4 Tannins 
Tannins occur as two major types – the hydrolysable tannins and the non-hydrolysable 
(condensed) tannins (Barnes et al., 2007). Hydrolysable tannins are compounds which 
consist of one or more sugars bonded to phenolic acid molecules. The phenolic acids are 
either gallic acid or ellagic acids. Geranium species contains hydrolysable tannin. On the 
other hand, condensed tannins or proanthocyanidins are made up of two or more flavonoid 
units which decompose into anthocyanidins when treated with acids at high temperature. 
Cola tannins are examples of proanthocyanidins (Barnes et al., 2007; Van Wyk et al., 2009). 
Pharamaceutically, tannins have antiseptic effects and are usually used to cure intestinal 
disorders such as diarrhoea and dysentery (Faparusi, Bello-Ankinosho, Oyede, Adewole, 
Bankole & Ali, 2012). 
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2.3.4.5 Terpenoids and steroids 
Terpenoids and steroids are compounds which are formed by the linking together of a 
number of five carbon units, often called isoprene units (Liu, 2011, p. 97). There are various 
classes of terpenoids. The monoterpenoids contain two isopentane units and are 
constituents of many volatile oils such as menthol in Mentha longifolia. Sesquiterpenes 
have three isopentane units such as zingiberene in Zingiber officinale (Barnes et al., 2007; 
Van Wyk et al., 2009). Triterpenoids have six isopentane units such as madecassic acid in 
Cantella asiatica. Some secondary modifications occur in steroids such that the number of 
isoprene units are not immediately obvious. They all have a steroid skeleton which is clearly 
observed in diogenin in Dioscorea dregeana and typhasterol in Typha capensis. Both 
triterpenoids and steroids are usually found in plants in the form of saponins (Van Wyk et 
al., 2009). In general, terpenoids based on the number of carbon atoms in the manner of 
isoprene are classified into hemiterpenoids (C5), monoterpenoids (C10), sesquiterpenoids 
(C15), diterpenoids (C20), sesterterpenoids (C25), triterpernoids (C30), tetraterpenoids (C40), 
and polyterpenoids [C5n] (Liu, 2011, p. 98). Pharmaceutically, sesquiterpenoids exhibit a 
wide range of bilogical activities and many of them have shown to have highly significant 
antimycobacterial effects  (Okunade & Elvin-Lewis, 2009, p. 427). 
 
In order to study herbal medicine, the key bioactive chemical components should first be 
known. Only after the biological compounds in medicinal plants are correctly extracted, 
isolated, and identified can biochemical, biological, or pharmacological studies be 
performed scientifically (Liu, 2011). In this study, bioactive chemicals of selected plants 
were analysed using standard qualitative methods and thin layer chromatography. 
 
     2.3.5 Selected plants 
 A number of studies have been undertaken around the world to screen various plants for 
antimicrobial activity. However, only about 20% of plants in the world have been 
pharmacologically or biologically tested  (Marzouk, Marzouk, Decor, Edziri, Haloui, Fenina, 
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& Aouni, 2009), hence the reason why some selected plants were investigated in this study. 
The following plants, namely: Geranium incanum, Cassia abbreviata, Tecoma capensis and 
Pelargonium hortorum were investigated in this study. Pepler et al. (2009) documented that 
it was only in a laboratory where the medicinal powers of plants could be separated from 
their perceived magic. 
 
2.3.5.1 Geranium incanum 
 
 
Figure 2.5: Geranium incanum leaves 
 
This plant belongs to the family, Geraniaceae, which includes other Geranium species such 
as Geranium canescens and Geranium robertianum (Amabeoku, 2009). The common names 
include: vrouebossie, bergtee, amarabossie (Afrikaans); ngope-sethsoha, tlako (Sotho). G. 
incanum is an attractive, sprawling perennial shrublet with finely divided, silvery leaves. The 
flowers of this plant are white, pale pink, violet or magenta in colour and are borne on long, 
slender stalks subsequently yielding elongated fruit resembling a stork’s bill  (Van Wyk et 
al., 2009; Mohlakoana, 2010). The plant species is widely distributed in the Western and 
Eastern Cape Provinces of South Africa. G. incanum can grow up to 0.2-1m in height and 
grows at an altitude of 10-610m above sea level (Amabeoku, 2009). The leaves are parts of 
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the plant oftenly used for therapy purposes in treating various ailments (Van Wyk et al., 
2009).  
 
Medicinally, the leaves are useful as a tea substitute in treating bladder infections, venereal 
diseases and menstruation-related conditions (Van Wyk et al., 2009). On the other hand, G. 
canescens has been used for colic, diarrhoea, fever and bronchitis. In Europe and America, 
G. robertianum (Robert herb) is traditionally used to treat diarrhoea  (Amabeoku, 2009). 
Active ingredients contained in the leaves of Geranium species include tannins 
(polyphenols) and several flavonoids but nothing much is known about their chemistry (Van 
Wyk et al., 2009). In the present study, the plant was investigated for antibacterial and 
anticandidal activities on particular pneumonic pathogens. 
 
2.3.5.2 Cassia abbreviata Oliv. 
 
 
Figure 2.6: Cassia abbreviata Oliv 
                                                           (Taken from Le Roux, 2008) 
 
Cassia abbreviata Oliv. is part of the family called Fabaceae and its subfamily is known as 
Caesalpinioideae [Bauhinia subfamily]  (Foden & Potter, 2005; Le Roux, 2008). Other related 
Fabaceae plants of medicinal interests include Senna species such as Senna italica and 
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Senna petersiana  (Van Wyk et al.,  2009). The common names for C. abbreviata include: 
Long-tail Cassia (English); Sjambok Pod (English); Wild Senna (English); Sambokpeul 
(Afrikaans); Boontjieboom (Afrikaans); Muboma (Venda) and Mulambivhu [Venda]  
(Raimondo et al., 2009). 
 
C. abbreviata is a small to medium-sized deciduous tree which grows up to 7m in  height. Its 
slender to medium-broad trunk is covered in bark that spans from dark brown to grey and 
black. The bark is often deeply furrowed in old trees (Le Roux, 2008).  The leaves of this 
plant are compound, with four to six pairs of oblong leaflets and appear slightly drooping, 
bright green when young and fade to a darker green when older. Its flowers are deep 
yellow to yellowish-white often with slightly sickle-shaped pods. The flowers are clustered 
at the ends of the branches and can be seen mainly from August to October (Le Roux, 2008; 
van Wyk et al.,  2009). 
 
The genus Cassia, comprising of about 600 species widely distributed worldwide is well 
known for its diverse biological and pharmacological properties (Jothy et al., 2012). One 
such plant, Cassia abbreviata was employed in this study. C. abbreviata is distributed in the 
northern and eastern parts of South Africa especially in places such as the Limpompo 
province and Mpumalanga. It is also indigenous in Swaziland, throughout Southern Africa, 
through east Africa and up to Somalia (Le Roux, 2008; Van Wyk et al., 2009). 
 
Medicinally, C. abbreviata roots are used for treating fever, diarrhoea, gonorrhoea, 
abdominal pain and constipation. Powedered bark is sprinkled on ulcers. Regarding 
pharmacological effects, the roots of C. abbreviata are known to have diuretic, diaphoretic, 
cardiotonic and aphrodisiac properties (Van Wyk et al., 2009). Phytochemical screening 
done in other studies on Cassia species revealed the presence of alkaloids, tannins, 
saponins, anthraquinones, anthocyanosides, phenolic flavonoids, flavonoids, 
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carbohydrates, proteins, cardiac glycosides and phlobatannins  (Veerachari & Bopaiah, 
2012). In this study, the stem bark of C. abbreviata was investigated. 
 
2.3.5.3 Tecoma capensis (Thunb.) Spach 
Tecoma capensis (Thunb.) Spach formerly known as Tecomaria capensis is a plant that 
belongs to the family of Bignoniaceae. This plant is also known as Cape honeysuckle 
(English), Malangula (Swazi), and Umsilingi (Xhosa)  (Mutshinyalo, 2008). 
 
 
Figure 2.7: Tecoma capensis (Thunb.) Spach leaves and flowers 
 
The plant is a fast growing, scrambling shrub which may grow up to 2-3m high and spread 
more than 2.5m. T. capensis is an evergreen plant in warm climate areas but loses its leaves 
in colder areas. Its oval leaflets are pinnately compound, with blunt teeth. Flowering time 
for this shrub is very erratic. The plant flowers all year round. The flowers vary from red, 
deep orange, yellow to salmon and are tubular! They are bird: pollinated thereby attracting 
nectar-feeding birds particulary sunbirds  (Jothi, Ravichandiran, Babu & Suba, 2011; Saini, 
Singhal, Srivastava, Sachdeva & Singh, 2011; Jothi, Nithya, Lakshmi, Chand & Babu, 2012a). 
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T. capensis is an ornamental garden plant usually used for screening and decorative 
purposes. The part of the plant used for medicine include leaves, flowers and bark. The 
powdered bark of T. capensis is traditionally used as medicine to relieve pain and 
sleeplessness (Mutshinyalo, 2008; Al-Hussaini & Mahasneh, 2009; Saini et al., 2011;  Saini, 
Singhal & Srivastava, 2012). On the other hand, the leaves and flowers of the plant are 
traditionally used to treat pneumonia, enteritis, diarhoea and tonic (Al-Hussaini & 
Mahasneh, 2009).  According to Jothi, Ravichandiran, Venkatesh and Suba, (2012b) and 
Saini et al. (2011), T. capensis is among the list of African plants evaluated for in vitro 
antiplasmodial activity against Plasmodium falciparum. This shrub is widely cultivated and is 
commonly found throughout Northern Province, Mpumalanga, Swaziland, KwaZulu-Natal, 
Cape coast and Mozambique (Mutshinyalo, 2008). 
 
According to the investigation carried out by Saini et al. (2011), the methanolic leaf extract 
of T. capensis revealed the presence of flavonoids, flavones, phenolic compound, tannins, 
coumarins, volatile oils, fixed oil and fats, steroids, saponins and glycosides. 
 
2.3.5.4 Pelargonium  hortorum 
Pelargonium hortorum is a member of the geranium family. This plant is also known as  
Garden Geranium, Malva or Malvon (Bailey, 2013).  Pelargoniums may be tiny and delicate 
or tall and robust, as well as varying considerably in their habits, foliage and flowers. P. 
hortorum also commonly called “zonal pelargoniums” are perennial and vary in height from 
15cm to 1m. The plants produce variegated leaves, usually with horseshoe markings; 
flowers in shades of red, pink and white. Their flowers contain heads densely packed with 
single, semi-double or double blooms 1-2cm across. The flowers can bloom for most 
months of the year (Pienaar, 1987; Godbold-Simpson, 1993). 
 
Pelargoniums are ornamental plants and P. hortorum is the most widely grown for potted 
and bedding plants (Christopher, 1958; Bailey, 2013). It is stated that pelargoniums are 
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native to Southern Africa and fall into three main groups: Zonal, Regal and Ivy-Leaf 
Pelargoniums. Although commonly referred to as “geraniums”, they are quite distinct from 
the genus Geranium (Prance & Nesbitt, 2005). 
 
 
Figure 2.8: Pelargonium hortorum plant 
                                                     (picture taken by Kondwani Chikafa) 
 
The garden geranium (Pelargonium x hortorum) is an interspecific hybrid of unknown 
parentage, although many believe it to have been developed in cultivation more than 250 
years ago (Grazzin et al., 1997). Hence, zonal cultivars (P. x hortorum Bailey; section 
Ciconium) are mostly hybrids, derived from Pelargonium zonale and Pelargonium inquinans, 
whereas “ivy-leaved” cultivars were derived from crossing among various subspecies of 
Pelargonium peltatum Horn, section Dibrachya. These cultivated varieties are either diploid 
with a total of 18 chromosomes, or tetraploid with 36 chromosomes (Becher et al., 2000). 
 
Pelargonium species contribute significantly to the health care of a large proportion of the 
population in the southern African region. Thus, Pelargonium species are widely used in 
areas of southern Africa by Sotho, Xhosa, Khoi-San and Zulu traditional healers for its 
curative and palliative effects in the treatment of diarrhoea, dysentery, fever, respiratory 
tract infections, liver complaints, wounds, gastroenteritis, haemorrhage, kidney and 
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bladder disorders (Watt & Breyer-Brandwijk, 1962; Saraswathi, Venkatesh, Baburao, Hilal & 
Rani, 2011). 
 
Literature reveals several Pelargoniums that have shown antimicrobial activity against 
bacterial and fungal pathogens. Antibacterial effects of Pelargonium sidoides, Pelargonium 
reniforme, Pelargonium betulinum, Pelargonium capitatum, Pelargonium cucullatum and 
many more have been demonstrated in literature (Lawrence, 2001; Brown, 2006; Brendler 
& Van Wyk, 2008; Van Wyk et al., 2009; Kolodziej, 2011; Saraswathi et al., 2011; Maree & 
Viljoen, 2012). In traditional medicine, roots of Pelargoniums have been used for a number 
of ailments; both the rhizome and herb have been used for different purposes since ancient 
times to treat malaria, inflammation, abdominal and uterine disorders. They have been 
used in decoction to wash patients suffering from fever and also have been directly chewed 
or powdered and mixed with food. Thus the root extracts have shown to have antibacterial, 
antifungal and antitubercular activity which may justify its use by the people of South Africa 
in the treatment of coughs and tuberculosis (Watt & Breyer-Brandwijk, 1962; Koch & Biber, 
2007; Saraswathi et al., 2011). 
 
The active ingredients present in the tubers of Pelargonium species include tannins, 
coumarins, phenolic acids, monoterpenes, sesquiterpenes, cinnamic acids, flavones, 
flavonoids and flavonols derivatives (Karamanoli, Bouligaraki, Constantinidou & Lindow, 
2011; Kolodziej, 2011; Saraswathi et al., 2011).  Although a number of studies have been 
conducted on Pelargonium species, there is little data on the antimicrobial investigation of 
P. hortorum. The leaves of P. hortorum and not the roots were investigated in this study for 
antimicrobial activities. 
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2.3 ANTIMICROBIAL RESISTANCE 
 
Chen et al. (2011) reported that over recent decades, resistance to penicillin (a drug for 
treating pneumonia) and other antibiotics have increased dramatically worldwide. The 
world appears to be moving towards what might be expressed as the “post-antibiotic era”. 
This is because antimicrobial resistance is increasing worldwide and pathogenic 
microorganisms which are resistant to all available antimicrobial agents, are increasingly 
reported in various newspapers and other media. On the other hand, discovery and 
approval of new antimicrobial drug classes have decreased significantly over the past fifty 
years (Schultsz & Geerlings, 2012). 
 
The World Health Organization (WHO) describes Antimicrobial Resistance (AMR) as the 
expression of the ability of microbes to resist the actions of naturally occuring or 
synthetically produced compounds inimical to their survival (Sreekala, Kaswan, Nehra & 
Singh, 2012). AMR is a health concern related to both human and non-human antimicrobial 
usage. Feed animals are administered antibiotics to be cured from infections and 
additionally to improve metabolism and reduce dietary requirements by stimulating the 
growth of microbes that produce vitamins and amino acids (Rosenblatt-Farrel, 2009). 
Recently, there is a realization that even antimicrobial drugs used in the treatment of feed 
animals have the potential to create a unique residue — increased number of 
microorganisms that are resistant to antimicrobial drug treatment. It may include the 
potential for the animal antimicrobial drug to diminish the susceptibility of microorganisms 
to human antimicrobial drugs as well as any human medical use of the drug, and affect the 
relationship to other human antimicrobial drugs, and the ability of the animal drug to alter 
the susceptibility of relevant microorganism to important human antimicrobial drugs 
(Amabile-Cuevas, 2006; Sharma, Bhardwaj & Gupta, 2011, p. 209).  
In the medical world, some of the resistant pathogens are well recognized in their 
alphabetical soup as MRSA (Methicillin-resistant Staphylococcus aureus), VRSA 
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(Vancomycin-resistant Staphylococcus aureus), VISA (Vancomycin-intermediate 
Staphylococcus aureus), VRE (Vancomycin-resistant enterococci), MDR-TB (Multiple-drug-
resistant tuberculosis), and XDR-TB (Extensively-drug-resistant tuberculosis). Hence, the 
problem of drug resistance has drawn the attention of WHO, ECDC (European Centre for 
Disease Prevention and Control) and CDC (Centers for Disease Control and Prevention), 
which monitor and report the spreading of drug-resistant pathogens in the world (Bauman, 
2012; Wozniak, Tiuryn & Wong, 2012). This indicates that the issue of antimicrobial 
resistance is of grave importance and consequently represents a critical health threat to our 
world (Bauman, 2011). 
 
Antibiotic use promotes the development of antibiotic-resistant pathogens. Every time 
antibotics are utilised, susceptible pathogens are killed giving room to resistant germs to 
multiply and overgrow. This is why Cheesbrough (2006) and Rahimi et al. (2012) deduced 
that the substantial increase of antimicrobial resistance which is presently making it difficult 
to treat some infectious diseases such as pneumonia, is due to the extensive use and 
misuse of antimicrobial drugs which favours the emergence and survival of various resistant 
strains of microorganisms. For instance, more than one tonne of antibiotics are consumed 
in some European countries per day which has resulted in the rise and spread of a vast 
amount of antibiotic resistance determinants among bacterial populations. Hence the 
emergence of this critical public health problem (Duarte & Figueira, 2009). 
 
AMR is known to occur among protozoa, viruses, fungi and bacteria (Lubick, 2011; Bauman, 
2012). Resistance to antibiotics is leading to increased pressure on research scientists and 
microbiologists for technical innovation garnered from the armamentarium of science. 
Reflection of advances in antimicrobial therapy in routine daily life demand recognition of 
microbial aetiologies that now respond to therapeutic intervention (Sharma et al., 2011). In 
this discussion the main focus will be on bacterial resistance. Before expounding on AMR, 
an elucidation on how antibiotics work will be discussed first. 
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 2.4.1 Antimicrobial agents 
Antimicrobial agents are naturally occurring antibiotics, synthetic derivatives of naturally 
occurring antibiotics (semi-synthetic antibiotics) and chemical antimicrobial compounds 
(chemotherapeutic agents) that suppress the growth of or destroy microorganisms 
including bacteria, fungi, viruses, protozoa and helminths (Cheesbrough, 2006; Billinger, 
2012; Greenwood, Barer, Slack & Irving, 2012; Kumar, Kumar & Hindumathy, 2012). 
Antimicrobial substances that are too toxic to be used other than in topical therapy or for 
environmental decontamination, are referred to as antiseptics or disinfectants (Greenwood 
& Irving, 2012). 
 
Generally, however, the term “antibiotic” is used to describe antimicrobial agents (usually 
antibacterial) that can be used to treat infection. Antibiotics are therefore defined as 
natural metabolic products of fungi, actinomycetes and bacteria that kill or inhibit the 
growth of microorganisms. Antibiotics that directly kill bacteria are termed bactericidal. 
Penicillins and aminoglycosides are examples of these bactericidal agents. Antibiotics that 
hamper bacteria ability to grow and reproduce are bacteriostatic, exemplified by the drug 
chloramphenicol (Mims et al., 2004; Cheesbrough, 2006). Antibacterial agents that are 
lethal to spores are called sporicidal agents (Stegman & Branger, 2005). Antibiotics could be 
further categorized into broad spectrum implying those antibacterials with activity against a 
wide range of Gram-positive and Gram-negative organisms. They include some β-lactam 
antibiotics and the tetracyclines, aminoglycosides, sulphonamides and chloramphenicol. 
Other antibiotics include narrow spectrum antibiotics, which are those with activity against 
one or a few types of bacteria for example, vancomycin which is used against staphylococci 
and enterococci (Cheesbrough, 2006). 
 
Jensen et al. (1997), Gillespie and Bamford (2012) and Greenwood and Irving (2012) 
pointed out that when antimicrobial chemotherapeutic agents selectively interfere with the 
growth of microorganisms and do not significantly interfere with the functions of the cells 
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of the infected animal host, the phenomenon is termed selective toxicity. Such 
chemotherapeutic agents include insulin, anticancer drugs and drugs for treating infections 
(Bauman, 2012). Diseases caused by bacteria are more prone to chemotherapeutic agents 
than those which are caused by fungi, protozoa or viruses. This is because bacteria are 
prokaryotic cells and posses some structures and metabolic processes that distinctly differ 
from those of the eukaryotic cells of the animal host (Mims et al., 2004). The difference in 
cellular activities has made it possible to develop chemicals that particularly interfere with 
prokaryotic cell functions but not with eukaryotic cell functions. On the other hand, it has 
been difficult to develop chemicals that selectively inhibit a given type of eukaryotic cell 
such as a fungus without subsequently interfering with the activities of the animal host cell  
(Jensen et al., 1997). Likewise, antiviral agents have been even more difficult to uncover 
because viruses are not alive for they lack the metabolic apparatus to reproduce outside 
their host cells. They are pieces of DNA or RNA and hence they use their host cell functions 
to carry out their replication activities (Voet & Voet, 2011). In addition many antiviral 
agents have serious side-effects for instance, those used to treat HIV infection 
(Cheesbrough, 2006). This explains why there are fewer antiviral and antifungal agents. 
 
2.4.2 How do antibiotics work? 
Antibiotics stop or interfere with a number of everyday cellular processes that bacteria rely 
on for growth and survival through a variety of mechanisms. In order for the drug to be able 
to inhibit or kill the microbe, the drug must be able to cross the cell’s wall, then cross the 
cytoplasmic membrane to enter the cell and bind to its target molecule (Bauman, 2012). 
Mims et al. (2004) outline the five major target sites for antimicrobial action which include 
cell wall synthesis, protein synthesis, nucleic acid synthesis, metabolic pathways and cell 
membrane functions. Various classes of antibiotics and a few antifungal agents have been 
illustrated in this section in relation to their antimicrobial action on pathogens. An outline 
of antibiotic classes and their targets are shown in Table 2.4. 
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     Table 2.4: Antibiotics and their targets 
Antibiotic Target 
β – lactams Cell wall synthesis 
Glycopeptides Cell wall synthesis 
Bacitracin Cell wall synthesis 
Cephalosporins Cell wall synthesis 
Quinolones DNA replication and repair 
Aminoglycosides Protein synthesis 
Tetracyclines Protein synthesis 
Macrolides Proteins synthesis 
Choramphenicol Protein synthesis 
Lincomycin and clindamycin Protein synthesis 
Sulphonamides and trimethoprim Folic acid pathway 
Metronidazole and tinidazole DNA synthesis 
Lipopeptides Cell membrane 
     (Compiled from Jensen et al., 1997; Mims et al., 2004; Bauman, 2012; Billinger, 2012)  
 
2.4.2.1 Basic mechanisms of action of microbial agents 
Penicillins, cephalosporins, carbapenems and vancomycin kill bacteria by crippling or 
inhibiting the synthesis of bacterial cell wall that protects the cell from the external 
environment (Rosenblatt-Farrel, 2009; Volans & Wiseman, 2009; Mason, Goldsmith, 
Moore, McCarron, Leggett, Montgomery & Coulter, 2010). Echinocandins such as 
caspofungin stop the synthesis of fungal walls by inhibiting the enzyme that synthesizes 
glucan. Without glucan, fungal cells cannot produce cell walls and this leads to osmotic 
rupture (Bauman, 2012). Some antibiotics interfere with bacterial protein synthesis by 
binding to the machinery that builds proteins. Such antibiotics include aminoglycocides, 
chloramphenicol, tetracyclines and macrolides (Jensen et al., 1997; Rosenblatt-Farrel, 2009; 
Gillespie & Bamford, 2012).  
 
Gramicidin often disrupts the bacterial cytoplasmic membrane by forming a channel 
through the membrane, thereby damaging its integrity. A similar mode of action is 
displayed by a group of antifungal drugs called polyenes such as nystatin and amphotericin 
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B. These drugs are fungicidal because they attach to ergosterol, a lipid constituent of fungal 
membranes and in the process they disrupt the membrane leading to cell lysis (Bauman, 
2012). Sulfonamides or sulfa drugs are structually similar to para-aminobenzoic acid (PABA). 
PABA is crucial in the synthesis of nucleotides required for DNA and RNA production. Many 
organisms, including some pathogens, enzymatically convert PABA into dihydrofolic acid, 
and then dihydrofolic acid into tetrahydrofolic acid (THF), a form of folic acid that is used as 
a coenzyme in the synthesis of purine and pyrimidine nucleotides. Sulfonamides as analogs 
of PABA, compete with PABA molecules for active site of the enzyme involved in the 
synthesis of dihydrofolic acid. This competition leads to a decrease in the production of 
THF, and thus of DNA and RNA. The end result of sulfonamide competition with PABA is the 
cessation of cell metabolism, which in turn leads to cell death. Mammalian cells, however, 
do not synthesize THF from PABA but depend on pre-formed folic acid obtained in the diet. 
As a result, human metabolism is unaffected by sulfonamides (Jensen et al., 1997; Bauman, 
2012).  
 
Quinolones and fluoroquinolones inhibit nucleic acid synthesis by inhibiting DNA gyrase, an 
enzyme necessary for correct winding and unwinding of replicating bacterial DNA. These 
compounds have little effect on eukaryotes or viruses. Rifampin are bacteriocidal in activity. 
They function by binding to and inhibiting the action of RNA polymerase during the 
synthesis of mRNA from a DNA template. Rifampin bind more readily to prokaryotic RNA 
polymerase than to eukaryotic RNA polymerase and as a result rifampin is more toxic to 
prokaryotes than to eukaryotes (Mims et al., 2004; Bauman, 2012; Gillespie & Bamford, 
2012). Figure 2.9 on page 46 indicates the basic mechanisms of action of microbial agents 
as well as their representative drugs for each type of action. 
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    Figure 2.9: Mechanisms of action of antimicrobial agents plus their representative drugs 
           (Taken from Bauman, 2012) 
 
2.4.3 Resistance to antibacterial agents 
In the medical setting, resistance to antibacterial agents is defined as a type of drug 
resistance whereby a previously susceptible organism is no longer inhibited or killed by an 
antibacterial agent at concentrations of the drug achievable in the body after normal 
dosage (Gillespie & Bamford, 2012). There is a saying, some men are born great, some 
achieve greatness, and some have greatness thrust upon them. Similarly some bacteria are 
born resistant, others have resistance thrust upon them. This implies that some species are 
innately resistant to some families of antibiotics either by lack of a susceptible target or by 
being impermeable to the antibacterial agent. For instance, Gram-negative bacilli with their 
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complex outer membrane layer exterial to the peptidoglycan layer are less permeable to 
huge hydrophilic molecules than Gram-positive cells. On the other hand, within species that 
are innately susceptible, there are also strains that develop or acquire resistance (Mims et 
al., 2004, p. 475; Greenwood & Irving, 2012). Thus intrinsic resistance is dependent upon 
the natural insusceptibility of an organism while acquired resistance involves changes in the 
DNA content of a cell whereby the cell acquires a phenotype (i.e. antibiotic resistance) that 
is not inherent in that specific species (Towner, 2012). 
 
2.4.3.1 History of antibiotic resistance 
Antibiotics were first discovered through a providential experiment of the British 
bacteriologist Alexander Fleming in 1928. He reported the antibacterial action of penicillin 
released from the mould Penicillium notatum. His work eventually led to the large-scale 
production of penicillin in the late 1940s (Franklin & Snow, 1989; Bauman, 2012). During 
this period Alexander Fleming deduced that the microbes were educated to resist penicillin 
and other antibiotics. He observed that fast growing organisms were bred out that could 
cause pneumonia and septicaemia to individuals, showing high levels of penicillin resistance 
(Fleming, 1945; Sharma et al., 2011). This indicates that even in the late 1940s, resistant 
strains of bacteria began to appear. Currently, it is estimated that more than 70% of the 
bacteria that cause hospital-acquired infections are resistant to at least one of the 
antibiotics used to treat them (McCoy, Toussaint & Gallagher, 2011). According to 
Cheesbrough (2006), the following bacteria are among the commonest drug-resistant 
strains which include: Staphylococci, gonococci, meningococci, pneumococci, enterococci, 
Gram-negative bacilli (e.g., Salmonella, Shigella, Klebsiella, Pseudomonas) and M. 
tuberculosis. Some of these bacteria (Staphylococci, pneumococci and Pseudomonas) are 
among the bacteria of interest examined in this study, hence the need to expound on 
bacterial resistance to antimicrobial agents.  
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2.4.3.2 Scope of antibiotic resistance 
According to Cheesbrough (2006) and WHO (2012), antibiotic resistance continues to 
expand for a multitude of reasons which include: 
 Over-prescription of antibiotics by physicians. 
  Non-completion of prescribed antibiotic treatments by patients. 
  Use of antibiotics in animals as growth enhancers (primarily by the food industry). 
  Increased international travel. 
  Poor hospital hygiene. 
  Weak or absent surveillance and monitoring systems. 
  Inadequate systems to ensure quality and uninterrupted supply of medicines. 
 Depleted arsenals of diagnostics, medicines and vaccines as well as insufficient 
research and development on new products. 
 
In order to fully understand resistance to antimicrobials in organisms, the mechanisms   
behind the genetic variability in bacteria will be discussed. 
 
2.4.4 The genetic variability of bacteria 
Alterations in Bacterial DNA are due to spontaneous mutations in individual genes as well 
as recombination processes resulting in new genes or genetic combinations (Kayser et al., 
2005). Genes are composed of specific sequences of nucleotides that code for polypeptides 
or RNA molecules. Bauman (2012) described genetic recombination as the exchange of 
nucleotide sequences between two DNA molecules, often involving segments that are 
comprised of identical or nearly identical nucleotide sequences called homologous 
sequences. During this process, enzymes nick one strand of DNA at the homologous 
sequence and a seperate enzyme inserts the nicked strand into the second DNA molecule. 
Ligase then reconnects the strand in new combinations, and the molecules resolve 
themselves into novel molecules. Such DNA molecules with new nucleotide sequence 
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arrangements are termed recombinants. Thus, recombination is the breakage and rejoining 
of DNA into new combinations for survival of a strain and is a basic mechanism found in all 
organisms (Nath & Revanker, 2006). Vertical gene transfer is when both prokaryotes and 
eukaryotes replicate their genomes and supply copies to their offsprings (Bauman, 2012). 
However, Kayser et al. (2005) noted that bacteria have no sexual heredity in a strict sense, 
but they do have mechanisms that allow for intercellular DNA transfer. The process by 
which many prokaryotes acquire genes from other microbes of the same generation is 
called horizontal (lateral) gene transfer. In horizontal gene transfer, a donor cell transfers 
part of its genome to a recipient cell, which may be of a diverse species from the donor. 
Naturally, the recipient cell incorporates part of the donor’s DNA into its own chromosome 
thereby becoming a recombinant cell. The remaining unincorporated DNA is regularly 
degraded by the cellular enzymes (Bauman, 2012). The three horizontal gene transfer also 
known as parasexual processes by Kayser et al. (2005) and Sreekala et al. (2012), include 
transformation, transduction and conjugation. 
 
2.4.4.1 Transformation 
Transformation involves transfer of “naked” or “purified” DNA that a recipient cell receives 
from another cell present in the environment with at least one different observable 
characteristic. This implies that bacteria are able to take up soluble DNA molecules from 
other closely related species directly across their cell wall (Kayser et al., 2005; Cheesbrough, 
2006; Gillespie & Bamford, 2012). Such DNA fragments may be present in the environment 
of the competent cell because they might be released by other dead organisms (Mims et 
al., 2004; Bauman, 2012). In 1928 Frederick Griffith, while studying pneumonia 
demonstrated that the ability to produce a certain type of capsule could be transferred 
between different pneumococcal. Then Osward Avery showed in 1944 that the 
transforming principle at work was DNA. DNA must therefore be the carrier of genetic 
information (Voet & Voet, 2011). Cells that have the ability to incorporate DNA from their 
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environment are referred to as being competent. Competence results from alterations in 
the cell wall and cytoplasmic membrane that allows DNA to be inserted into the cell. 
Natural competency has been observed mainly in the genera Streptococcus, Haemophilus, 
Neisseria, Bacillus, Staphylococcus and Pseudomonas (Kayser et al., 2005; Bauman, 2012; 
Towner, 2012). 
 
2.4.4.2 Transduction 
Transduction is a mechanism whereby a defective bacteriophage which has erroneously 
acquired a segment of bacterial DNA rather than the viral chromosome, transfers this DNA 
to another bacterial cell (Voet & Voet, 2011). A bacteriophage or simply a phage is a virus 
that infects bacteria (Kayser et al., 2005; Cheesbrough, 2006; Bauman, 2012). Transduction 
can occur either between prokaryotic cells or between eukaryotic cells. The determining 
factor is the availability of a virus capable of infecting both donor and receptor. The whole 
process takes place in this manner. To replicate, a phage attaches to a bacterial cell and 
infuses its genome into the cell. Phage enzymes, translated by bacterial ribosomes, degrade 
the cell’s DNA. The phage genome now controls the cell’s functions and directs it to 
synthesize new phage DNA and phage proteins. Normally, phage proteins assemble around 
phage DNA to form new phage particles, but some phages mistakenly incorporate 
remaining fragments of bacterial DNA that are about the same length as phage DNA. This 
forms tranducing phages. Eventually the host cell lyses, releasing daughter and transducing 
phages. Transduction occurs when a transducing phage injects donor DNA into a new host 
cell. The recipient host cell incorporates the donated DNA into its chromosome by 
recombination (Bauman, 2012, p. 229).   
 
Transduction could be categorized as either generalized or specialized (Burton, 1992; 
Towner, 2012). Generalized transduction is not limited to a particular DNA. This involves 
nonspecific packaging and transfer of genetic material from a donor host cell’s 
chromosome or plasmid to a recipient host cell. On the other hand, in specialized 
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transduction only certain host sequences are transfered along with phage DNA. Genes 
encoding for certain bacterial toxins such as those responsible for diphtheria, scarlet fever, 
and E.coli causing bloody, life-threatening diarrhoea are transfered in this manner (Nath & 
Revanker, 2006; Bauman, 2012). 
 
2.4.4.3 Conjugation 
Conjugation involves direct contact between the donor (male cell) and the recipient (female 
cell) bacterial cell via an appendage (called a pilus) on the donor bacterium (Nath & 
Revanker, 2006; Towner, 2012). The gene coding for conjugation pili is located on a plasmid 
called an F (fertility) plasmid. Cell possessing F plasmid (F+ cells or ‘ef plus’) act as donors 
during conjugation while recipient cells (F- cells) lack F plasmid and therefore they have no 
conjugation pili (Franklin & Snow, 1989; Bauman, 2012).  
 
The process of conjugation in bacteria starts when a sex pilus connects a doner cell (F+ ) to a 
recipient cell (F-) such that the pilus draws the cells together even though DNA transfer may 
occur whilst the cells are still more than 10µm apart. The transfer of F plasmid DNA is 
initiated at a section called the origin of transfer. The F- recipient cell then synthesizes a 
complementary strand of F plasmid DNA, becoming an F+ cell. The donor cell also 
synthesizes a complementary plasmid DNA strand. However, in some bacterial cells, an F 
plasmid does not remain independent in the cytosol but instead amalgamates at a specific 
DNA sequence in the cellular chromosome and that chromosomal genes are transfered in 
the normal manner to a recipient cell at a relatively high frequency. Such cells are termed 
Hfr (high frequency of recombination) cells (Bauman, 2011; Towner, 2012). After the F 
plasmid has intergrated and the Hfr and the recipient cells join via a sex pilus, DNA transfer 
starts at the origin of transfer of the F plasmid, carrying with it a copy of the donor’s 
chromosome. Often, movement of the cells breaks the intercellular connection prior to the 
transfer of the entire donor chromosome. As the recipient receives only a portion of the F 
plasmid,  it remains an F- cell, however it also acquires some chromosomal genes from the 
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donor. Recombination can incorporate the donor DNA into the recipient’s chromosome. 
The recipient is now a recombinant cell that contains its own genes as well as some donor 
genes. The order in which genes are transfered is consistent because an F plasmid 
integrates into chromosomes at only a few locations (Bauman, 2012).  
Conjugation is quite promiscous as it can occur among diverse species of bacteria such as 
between a bacterium and a yeast cell or between a bacterium and a plant cell. This typical 
transfer of genes by conjugation among different organisms calls for heightened concern 
about the spread of resistance (R) plasmid among pathogens. Through this way, scientists 
have noticed that antibiotic resistance produced by one pathogen can spread to other 
pathogens  (Bauman, 2011, p. 228). Thus, bacterial plasmids are able to capture DNA and to 
spread within and between bacterial species by conjugation thereby facilitating the rapid 
dissemination of potentially beneficial genes through a bacterial population (Cottell et al., 
2011). 
 
2.4.4.4 Transposons and transposition 
Transposons are linear segments of DNA that have a repeat of an insertion sequence 
element at each end that can migrate from one plasmid to another within the same 
bacterium, to a bacterial chromosome or to a bacteriophage (Stegman & Branger, 2005). 
Integrons form an essential ‘building block’ of many transposons and allow the rapid 
formation and expression of new combinations of genes in response to selection pressures 
(Towner, 2012). The result of the action of a transposon is termed transposition and in 
effect, it is a kind of frameshift insertion. Transposition occurs between plasmids and 
chromosomes and within and among chromosomes. Although transposons are common, 
transposition and the frameshift mutations it causes are relatively rare occurrences 
(Bauman, 2012). 
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2.4.5 How do bacteria become resistant to drugs? 
Among bacteria, individual cells can acquire antimicrobial resistance in one of the following 
two ways: either through new mutations of chromosomal genes or by acquiring resistance 
genes on extrachromosomal pieces of DNA called R-plasmids (or R-factors) via the process 
of horizontal gene transfer which could be transformation, transduction or conjugation as 
described earlier on (Bauman, 2012). In order to substantiate the above mentioned factors, 
there are at least seven mechanisms of how bacteria gain resistance to antimicrobial drugs. 
The mechanisms are as follows: 
 
 Production of enzymes by resistant cells which destroy or inactivate antibiotics  
(Cheesbrough, 2006). Example of such enzymes produced by bacteria include beta-
lactamases, aminoglycosidases and chloramphenicol acetyl transferases (Mims et al., 
2004; Kayser et al, 2005; Kumble, 2006). Beta-lactamases (penicillinases) are enzymes 
that catalyze the hydrolysis of the beta-lactum rings of penicillin and similar molecules 
to yield microbiologically inactive products. Genes encoding these enzymes are rife in 
the bacterial kingdom and are found on the chromosome and on R-plasmids (Mims et 
al., 2004; Bauman, 2012; Sreekala et al., 2012). Many MRSA strains have evolved 
resistance to penicillin-derived antimicrobials in this manner (Heyman et al., 2009). To 
date, over 200 different lactamases have been described (Kayser et al., 2005; Bauman, 
2012). The genes for aminoglycosidases are often plasmid-mediated, located on 
transposons and are transferable from one bacterial species to another. 
Aminoglycosidases inactivate the drug by changing the structure of the 
aminoglycoside molecule (Mims et al., 2004). This is accomplished by means of 
phosphorylation and nucleotidylation of free hydroxyl groups (phosphotransferases 
and nucleotidyl transferases) or acetylation of free amino groups (acetyltransferases) 
(Kayser et al., 2005). Chloramphenicol acetyl transferases are intracellular, but are 
capable of inactivating all chloramphenicol in the cell by means of acetylation (Mims 
et al., 2004; Kayser et al., 2005). 
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 Changes in the bacterial cell structure or electrical charge of the cytoplasmic 
membrane proteins, slowing or preventing the uptake of an antimicrobial  
(Cheesbrough, 2006; Bauman, 2012). Bacterial cell membranous proteins are made up 
of channels or pores. Such proteins in the outer membranes of Gram-negative 
bacteria are called pollins. Altered pore proteins results from mutations in 
chromosomal genes. Resistance against drugs like penicillin and tetracyline are known 
to occur via this way (Bauman, 2012). For example, penicillin resistance in 
Streptococcus pneumoniae is mediated through genetic alterations in a number of the 
penicillin-binding proteins (PBPs) which are enzymes that perform essential functions 
in the assembly of the bacterial cell wall  (Mason et al., 2010). 
 Resistant bacteria may modify the target of the drug so that the drug either cannot 
attach to it or binds it less effectively. This kind of resistance is depicted against 
antimetabolites such as sulfonamides and against drugs that thwart protein 
translation such as erythromycin (Franklin & Snow, 1989; Bauman, 2012). For 
example, MRSA and other penicillin-resistant bacteria are unresponsive to β-lactam 
therapy because they are able to alter the Penicillin Binding Protein (PBP) through 
acquisition of the gene for a modified PBS. This protein codes for a new peptidoglycan 
transpeptidase which has low affinity for all currently available β-lactam antibiotics 
(Harvey, Champe & Fisher, 2007; Sreekala et al., 2012). 
 Development of metabolic pathways by resistant bacteria which enable the site of 
antimicrobial action to be bypassed  (Cheesbrough, 2006). In this mechanism, bacteria 
may either alter their metabolic chemistry or they may abandon the sensitive 
metabolic step altogether. For example, bacteria may produce more enzyme 
molecules for the affected metabolic pathway thereby effectively reducing the 
potency of the drug. Alternatively, bacteria become resistant to sulfonamides by 
abandoning the synthesis of folic acid and instead absorb it from the surrounding 
environment  (Bauman, 2012). 
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 Resistant bacteria may pump the antimicrobial out of the cell before the drug can act. 
This is done by active transport (powered by ATP) of antimicrobial agents from inside 
to outside of the cytoplasmic membrane of bacterial cell by means of efflux pumps. 
Some microbes become multi-drug resistant, towards perhaps as many as 10 or more 
drugs by utilizing resistant pumps (Kayser et al., 2005; Bauman, 2012; Gillespie & 
Bamford, 2012). 
 Bacteria within biofilms resist antimicrobial more effectively than free-living cells 
(Bauman, 2012). A bacterial biofilm is defined as a structured community of bacterial 
cells embedded in a self-produced polymer matrix and attached to either an inert 
surface or living tissue. Such films can develop considerable thickness (Kayser et al., 
2005). Biofilms retard diffusion of the drugs and often slow metabolic rates of species 
making up the biofilm. Lower metabolic rates diminish the effectiveness of anti-
metabolic drugs thereby preventing antibiotic concentrations from reaching inhibitory 
or lethal levels within biofilms (Bauman, 2012; Tyerman, Ponciano, Joyce, Forney & 
Harmon, 2013). 
 Some resistant strains of bacteria particularly Mycobacterium tuberculosis resist 
fluoroquinolone drugs that bind to DNA gyrase by protecting the target of the drug 
rather than altering the target or deactivating the drug. These strains synthesize an 
unusual protein known as MfpA. This protein forms a negatively charged rod-like helix 
about the width of a DNA molecule by binding to DNA gyrase in place of DNA, hence 
depriving fluoroquinolone of its target site. MfpA protein slows down cellular 
replication of M. tuberculosis, but that is better for the bacterium than being killed 
(Bauman, 2012).   
 
2.4.5.1 Multiple resistance and cross resistance 
Multiple-drug-resistant pathogens also known as superbugs are pathogens that are 
resistant to three or more types of antimicrobial agents. Some examples of multi-drug 
resistant organisms that cause inimitable problems to our world, include strains of 
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Staphylococcus, Streptococcus, Enterococcus, Pseudomonas, Mycobacterium tuberculosis, 
and Plasmodium (Cheesbrough, 2006; Bauman, 2012). 
 
A pathogen can become multiple-drug resistant especially when resistance is awarded by R-
plasmids which are exchanged readily among bacterial cells (Bauman, 2011). For instance, 
emerging plasmid-encoded extended-spectrum beta-lactamases (ESBLs) and 
carbapenemases are increasingly reported worldwide. Multiple plasmid-mediated 
mechanisms of resistance against the fluoroquinolone and aminoglycosides have also been 
described, and the combination of plasmid-mediated resistance with chromosomally 
encoded resistance mechanisms of multiple drug classes now results in strains that are 
resistant to all of the main classes of commonly used antibiotics (Schultsz & Geerlings, 
2012). Such multi-resistant strains of bacteria commonly arise in hospitals and nursing 
homes where the constant use of many types of antimicrobial agents eliminates sensitive 
cell thereby encouraging multiplication of resistant strains (Bauman, 2011).  
 
Cross resistance is a condition whereby resistance to one antimicrobial agent may confer 
resistance to similar drugs. This phenomenon typically occurs when drugs are similar in 
structure. For example, resistance to streptomycin which is an aminoglycoside drug may 
award resistance to similar aminoglycoside drugs (Bauman, 2012).  
 
2.4.5.2 How to slow down resistance of organisms 
Bauman (2012) provides at least four ways in which the expansion of resistant populations 
of pathogens could be forestalled. The first way is to maintain adequately high 
concentrations of the drug in a patient’s body for a long enough time to hinder the growth 
of pathogens while allowing the body’s defenses to defeat them. In this regard, 
discontinuing a drug too early would promote the development of resistant strains. It is 
therefore important that patients should finish their whole antimicrobial treatment as 
perscribed by the physician (Bauman, 2011). A second way is to employ the use of 
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combination therapy so that pathogens resistant to one drug will be killed by other drugs, 
and vice versa. For example, in tuberculosis three drugs are routinely prescribed and as 
many as twelve drugs may be required in resistant cases  (Burton, 1992; Jensen et al., 1997; 
Bauman 2011). In addition, one drug sometimes enhances the effect of a second drug in a 
process called synergism. For example, the inhibition of cell wall synthesis by penicillin 
makes it easier for streptomycin molecules to enter bacteria and interfere with protein 
synthesis. Synergism can also result from combining an antimicrobial drug with a chemical 
compound for example, clavulanic acid enhances the effect of penicillin by deactivating β-
lactamase. However, not all drugs can act synergistically, as some combinations could be 
antagonistic (Bauman, 2012).  
 
A third way is to limit the use of antimicrobial drugs to necessary cases. A final way is to 
scientifically develop new variations of existing drugs by adding novel side chains to the 
original molecule where applicable. In this way, second-generation drugs may be developed 
and if resistance to these drugs appears, then third generation-drugs may be established 
instead. Alternatively, research on new antibiotics, semisynthetics and synthetics should be 
explored for this is the only way to achieve a new golden era of antimicrobial drug 
discovery and development, hence the existence of this study (Bauman, 2011).  
 
2 .5 SELECTED PATHOGENS  
 
In the present study, the following pathogens which are known to cause pneumonia were 
selected for investigation: 
 
2.5.1 Streptococcus pneumoniae 
Streptococcus pneumoniae is also commonly known as pneumococcus  (Kilian, 2007, p. 
186). The bacterium is a Gram-positive oval to lancet shaped coccus which usually occurs in 
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pairs or short chains (Kayser et al., 2005; Bauman , 2012).  Paired cocci are so common that 
these organisms are frequently referred to as diplococci  (Jensen et al., 1997). Pneumococci 
are non-motile, capsulated, catalase negative and nonsporing bacteria (Cheesbrough, 
2006). They develop α-haemolytic colonies on blood agar which appear mucoid (smooth, 
shiny) as seen in Figure 2.10. Mutants without capsules produce colonies with a rough 
surface (Kayser et al., 2005).  
 
 
Figure 2.10: S. pneumoniae on blood agar depicting α-haemolytic colonies 
                       (Taken from Kayser et al., 2005) 
 
Streptococcus pneumoniae is a major pathogen commonly causing pneumonia, bronchitis 
(often with H. influenzae), otitis media, sinusitis, empyema, meningitis, conjuctivitis and 
bacteremia. It is widely known that S. pneumoniae is carried asymptomatically within the 
healthy community, particularly in the vulnerable populations of children and the elderly, 
and those with underlaying medical conditions (Cheesbrough, 2006; Gillespie & Bamford, 
2012; Moore, Coulter & Goldsmith, 2012).  
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2.5.2 Haemophilus influenzae 
Haemophili are small, pleomorphic, fastidious Gram-negative rods or coccobacilli with 
occasional longer, filamentous forms, are nonmotile and often encapsulated (Kayser et al., 
2005; Gillespie & Bamford, 2012). All species of Haemophilus are catalase and oxidase 
positive; they reduce nitrate to nitrite and ferment glucose (Slack, 2007). They require 
special growth factors that are found only in blood and other body fluids. Haemophilus 
influenzae is the key disease-producing species of this genus. Other species include 
Haemophilus ducreyi, Haemophilus aphrophilus, Haemophilus parainfluenzae, and 
Haemophilus paraphrophilus  (Jensen et al., 1997; Slack, 2007).  
 
H. influenzae requires haemin (X factor) and nicotinamide adenine dinucleotide (NAD+) (V 
factor) for growth and as a result it is an obligate parasite found in mucous membranes of 
both humans and some animals  (Slack, 2007; Bauman,  2012). The V factor is present in a 
variety of biological materials and is produced by bacteria such as Staphylococcus aureus 
and by yeast. H. influenzae will therefore grow on blood agar in the vicinity of S. aureus 
colonies supplying this growth factor. This phenomenon is termed satellitism as shown in 
Figure 2.11 (Wistreich, 2007). On the other hand, chocolate agar is a good general culture 
medium for H. influenzae which does not require further supplementation (Slack, 2007).  
 
H. influenzae can be divided into a number of subtypes based on metabolic reactions and 
antigenic capsular polysaccharides. There are six capsular types (a – f) and the most 
invasive infections are caused by H. influenzae type b (Hib). It also expresses a 
lipopolysaccharide (LPS) and an IgA1 protease (Jensen et al., 1997; Gillespie & Bamford, 
2012). H. influenzae generally are opportunistic organisms. Clinical disease usually occurs as 
a nose and throat infection. The infection may spread to the sinus and middle ear or 
develop into pneumonia. It is the most common cause of bacterial meningitis (Slack, 2007; 
Bauman, 2011). 
60 
 
 
Figure 2.11: Satellite colonies of H. influenzae surrounding  
the Staphylococcus aureus streak 
                                                    (Taken from Kayser et al., 2005) 
 
Generally, H. influenzae is responsible for the following invasive diseases: epiglottitis, 
purulent meningitis, pneumonia and empyema, sepsis, cellulitis and septic arthritis. Other, 
less serious infections due to H. influenzae include inner ear infection (otitis media), 
infectious conjuctivitis (pink eye) and nasopharyngitis (Jensen et al., 1997; Tortora, Funke & 
Case, 1998; Cheesbrough, 2006). 
 
2.5.3 Acinetobacter Species 
Acinetobacter species are saprophytes normally found in soil, water, sewage and moist skin 
areas of humans (Jensen et al., 1997; Govan, 2007; Greenwood et al., 2012). Two species 
are capable of causing human diseases and these are Acinetobacter baumannii and 
Acinetobacter johnsonii (Jensen et al., 1997). Other species include Acinetobacter 
calcoaceticus, Acinetobacter septicus, Acinetobacter lwoffii, Acinetobacter haemolyticus and 
Acinetobacter radioresistens  (McCarron et al., 2012).  
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Acinetobacter are Gram-negative, non-fermenting, oxidase negative, catalase positive, non 
motile and non-sporeforming coccobacilli. Most infections are found in immune-
compromised hospital patients as well as among patients in intensive care units (ICUs) 
(Bergogne-Berezin, Friedman & Bendinelli, 2008; Yang et al., 2013). A. baumannii tested in 
this study is associated with serious infections such as pneumonia, meningitis, 
osteomyelitis, wound infections and septicaemia (Jensen et al., 1997; Govan, 2007, p. 298). 
Its isolates are frequently resistant to many antimicrobial agents that include β-lactam 
agents (other than carbapenems), aminoglycosides and fluoroquinolones (Greenwood et 
al., 2012). A. baumannii have been reported to be troublesome and have a capacity for 
long-term survival in the hospital environment (Ziglam, Elahmer, Amri, Shareef, Grera, 
Labeeb & Zorgani, 2012; Mishra, Rijal & Pokhrel, 2013).  
 
2.5.4 Staphylococcus aureus 
Staphylococci are widespread in nature and are commonly present on the skin and in the 
mucous membranes of mammals and birds (Wistreich, 2007). Two species of 
Staphylococcus which are normally found on human skin as well as the upper respiratory, 
gastrointestinal, urinary and genital tracts are Staphylococcus epidermidis and 
Staphylococcus aureus (Bauman, 2012). In this study, the main focus was on one species, 
Staphylococcus aureus. 
 
S. aureus is a spherical shaped Gram-positive bacterium about 1 µm in diameter. It is 
usually clustered in grapelike arrangements but can also occur singly or in pairs as depicted 
in Figure 2.12 (Jensen et al., 1997; Cheesbrough, 2006; Bauman, 2012; Humphreys, 2012). 
The organisms are non-motile, non-sporing and usually non-capsulate. S. aureus is a 
falcutative anaerobe such that when grown on many types of agar for 24 hours at 37°C, 
individual colonies produced are circular, about 2-3mm in diameter and with a smooth, 
shiny surface. Colonies appear opaque and usually pigmented (golden-yellow, hence the 
‘aureus’). The golden colour is the result of the production of a lipid pigment contained in 
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the organism. Sometimes haemolytic zones are frequently seen around the colonies. Blood 
agar is the medium generally utilized for its isolation (Jensen et al., 1997; Kayser et al., 
2005; Humphreys, 2012).  
 
 
Figure 2.12: A Gram staining of Staphylococcus aureus in a pus preparation 
           showing Gram-positive cocci, some in grapelike clusters 
                                               (Taken from Kayser et al., 2005)  
 
Humphreys (2012) stated that Staphylococcus aureus is differentiated from other 
Staphylococci by its ability to clot plasma. This species secretes an extracellular enzyme 
called coagulase which converts plasma fibrinogen into fibrin aided by an activator found in 
plasma. This organism also produces a thermostable nucleases that degrades DNA (Jensen 
et al., 1997; Gillespie & Bamford, 2012; Humphreys, 2012). Staphylococci that do not 
produce coagulase are of no or low virulence and one of the most ubiquitous coagulase-
nagative species is S. epidermidis, a common inhabitant and accounts for up to 90% of 
bacteria on human skin (Jensen et al., 1997;  Bauman, 2012).  
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2.5.4.1 Virulence factors of S. aureus 
According to Bauman (2012), Staphylococci have at least three categories of virulence 
factors that permit them to cause diseases namely enzymes, structures (that enable them 
to inhibit phagocytosis), and toxins. Table 2.5 on page 64 shows some of the activities of the 
most important extracellular enzymes and toxins secreted by Staphylococcus aureus. 
 
Staphylococci are prime examples of pyogenic bacteria. Other pyogenic cocci include 
Streptococcus pyogenes, Streptococcus pneumoniae and Neisseria species (Jensen et al., 
1997; Cheesbrough, 2006). Staphylococcus aureus is more resistant to common 
disinfectants and antibiotics than most other vegetative bacteria. This is because genetic 
traits of S. aureus are readily transferred between strains by plasmids and phages (Jensen et 
al., 1997). Methicillin-resistant Staphylococcus aureus (MRSA) strains are resistant to 
methicillin and related penicillins and are typically difficult to treat because of the limited 
number of antibiotics that can be selected for use. Therefore, MRSA secretes a penicillin 
binding protein 2a (mediated through the mec A gene), which is conveyed on the 
staphylococcal cassette chromosome mec (SCCmec) of which there are at least six different 
types known, and this leads to resistance to all beta-lactam antibiotics. MRSA causes the 
same range of infections resulting in excess health care costs, prolonged hospital admission 
and escalated mortality (Humphreys, 2012).  
 
2.5.4.2 Pathogenesis 
S. aureus is an opportunistic pathogen affecting both immune competent and immune 
compromised individuals (Onanuga & Awhowho, 2012).  It is capable of causing a number 
of superficial infections such as boils, carbuncles, impertigo and wound infections on 
surgical site or burns. These infections result when Staphylococcus on the skin surface  
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     Table 2.5: Some of the most important virulence factors of Staphylococcus aureus 
     Virulence Factor                                Activity 
 
Category A:  Enzymes 
Coagulase Clots blood (converts fibrinogen to fibrin), which may 
hide the bacterium from phagocytosis 
Staphylokinase Degrades fibrin and allows staphylococci to spread to 
new locations 
Lipase Degrades lipids (breaks down host tissue) 
β-Lactamase Present in 90% of strains. Convey resistance to many 
beta-lactam antibiotics such as penicillin and 
cephalosporin—drugs with β-lactamase inactivates 
Deoxyribonuclease Degrades DNA 
Category B: Factors that inhibit phagocytosis 
Peptidoglycan Inhibits inflammatory response; endotoxin-like activity 
Protein A on cell surface Reacts with Fc region of IgG 
Category C: Toxins 
Leukocidine Destroys leukocytes 
Haemolysins Lyse red cells 
Toxic shock syndrome toxin-1 Induces shock, rash and desquamation of skin 
Enterotoxins Induce vomiting and diarrhoea; superantigen effects 
Epidermolytic toxins A & B Cause blistering of skin or generalized peeling of the skin 
Fibrinolysin Digest fibrin 
Exfoliatin Peel superficial skin layers 
Hyaluronidase Facilitates spread in tissues by destroying hyaluronic acid 
Cytolytic toxins Disrupts cytoplasmic membranes of cells 
Chemotaxis inhibitory 
protein 
Inhibits migration and activation of white blood cells 
     (Compiled from  Cheesbrough, 2006; Bauman, 2012; Humphreys, 2012; Harvey et al., 2013) 
 
grows into hair follicles and invades sebaceous glands. This induces fever and inflammation 
which are natural responses against infection followed by enlargement of follicle filled with 
pus (Jensen et al., 1997; Bauman, 2012; Gillespie & Bamford, 2012; Humphreys, 2012). 
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According to Jensen et al. (1997), S. aureus appears to be associated with the production of 
various enzymes and toxins which includes substances such as haemolysins, coagulase, 
lipases, leukocidin, hyaluronidase, fibrinolysin and protein A as outlined in Table 2.5. Some 
S. aureus secrete a toxin called exfoliatin that causes the excoriation of superficial skin 
layers of infected persons. Approximately 50% of the strains of S. aureus produce 
enterotoxins (six major antigenic types: A, B, C, D, E, and G) that cause acute intestinal 
symptoms (food poisoning) when these bacteria contaminate food and are allowed to grow 
(Harvey, Cornelissen & Fisher, 2013).  
 
Various types of trauma resulting around a superficial abscess, such as squeezing a boil, 
may introduce a large numbers of Staphylococci into the blood where they may be carried 
to many tissues of the body thereby causing systemic infections (Jensen et al., 1997). The 
presence of viable bacteria such as Staphylococcus aureus in the circulating blood is called 
bacteremia (Cheesbrough, 2006; Bauman, 2012). S. aureus may settle in the lungs to cause 
pneumonia and pleural empyema or in the pelvis of the kidneys to cause pyelonephritis. A 
patient with empyema is usually very ill, with a high fever and neutrophil leucocytosis  
(Jensen et al., 1997; Billinger, 2012). Thus Billinger (2012) and Gillespie and Bamford (2012) 
stated that S. aureus often causes pneumonia only after a preceding influenza viral illness 
or in staphylococcal septicaemia. Other infections caused by S. aureus include osteomyelitis 
in children, toxic shock syndrome, scalded skin syndrome, mastitis, meningitis, 
staphylococcal colitis, endocarditis and food poisoning (Jensen et al., 1997; Cheesbrough, 
2006; Bauman, 2012; Onanuga & Awhowho, 2012). 
 
The transmission of S. aureus in many cases is endogenous, meaning that it originates with 
the patient. For example, a burn on the hand could be infected from bacteria carried on the 
patient’s own skin or in the nose. Spreading from person to person may also occur by direct 
or indirect contact (Jensen et al., 1997). However, Gillespie and Bamford (2012) argued that 
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S. aureus can also spread by airborne transmission and via the hands of health care 
workers. 
 
2.5.4.3 Laboratory diagnosis 
In the laboratory, diagnosis is based on isolation of the organism from a lesion or site of 
infection. For example, pus from abscesses, wounds, burns and so forth whereas sputum is 
from patients with pneumonia. On the other hand, bronchoscopic lavage is increasingly 
used in critically ill pneumonic patients. Microscopic examination is done in order to 
observe characteristic clusters of Gram-positive cocci. Staphylococcus aureus cultured on 
blood agar plates will usually produce a zone of clear haemolysis around its typically 
golden-yellow colony (Jensen et al., 1997; Humphreys, 2012). Selective medium contains 
high salt, to which S. aureus is relatively tolerant (Gillespie & Bamford, 2012). Distinguishing 
S. aureus from the coagulase-negative species is achieved by the detection of the plasma 
coagulase or of the clumping factor. Immunological and molecular methods are used to 
detect the enterotoxins and the TSST-1 in S. aureus (Kayser et al., 2005). 
 
2.5.4.4 Therapy 
Other cases require surgical measures but generally therapy is based on administration of 
antibiotics (Kayser et al., 2005). When treating staphylococcal infections, the most effective 
antimicrobial agents should first be determined by sensitivity testing and then vigorously 
admistered until the infection is cured (Jensen et al., 1997).  
 
According to Bauman (2012), dicloxacillin which is a semisynthetic oral form of penicillin not 
inactivated by β-lactamase is the drug of choice for staphylococcal infections. However, this 
is not always the case. The development of drug-resistant Staphylococcus aureus poses a 
major health problem (Jensen et al., 1997; Bauman, 2011). These strains are known to 
resist many antimicrobial drugs such as penicillin, methicillin, macrolides, aminoglycosides 
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and cephalosporin. Vancomycin is used to treat such infections. However of late, reports 
about the increasing prevalence of vancomycin-resistant strains of S. aureus have been 
presented by various physicians. For instance, the first of multiple vancomycin-resistant S. 
aureus strains containing the vanA gene were reported in 2002 (Versalovic, Carroll, Funke, 
Jorgensen, Laundry & Warnock, 2011). MRSA is more common in hospitals as such it is 
mandatory that hospital workers take precautions against introducing such bacteria into 
patients. Staphylococcal infections cannot be entirely eradicated since staphylococcus 
forms part of normal microbiota of many humans. Fortunately, for a disease to occur, it 
requires a large inoculum of bacteria. Therefore with proper cleansing of wounds and 
surgical openings, attention to aseptic techniques and the appropriate use of antiseptics 
will help prevent MRSA infections in most susceptible patients (Jensen et al., 1997; 
Bauman, 2012). 
 
2.5.5 Klebsiella pneumoniae 
Klebsiella pneumoniae is an opportunistic enteric bacilli that infects the respiratory systems 
of humans and animals following inhalation (Jensen et al., 1997; Bauman, 2012). K. 
pneumoniae is a nonmotile, Gram-negative bacillus that usually possesses a large, mucoid 
polysaccharide capsule which protects the bacteria from phagocytosis (Cheesbrough, 2006; 
Bauman, 2011).  
 
People with AIDS and very young children are at greater risk of suffering from pulmonary 
diseases inclunding Klebsiella pneumonia. Klebsiella pneumoniae is a cause of primary 
pneumonia in older patients with such predisposing medical anomalies as chronic 
bronchitis, diabetes, alcoholism and malnourished conditions. This is because people with 
such conditions have poor ability to clear aspirated oral secretions from their respiratory 
tracts (Jensen et al., 1997; Tortora et al., 1998; Bauman, 2012). 
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2.5.5.1 Pathogenesis and epidemiology 
K. pneumoniae usually invades the blood by destroying alveolar cells resulting in 
bacteremia. Endotoxin released when bacterial cells die induces shock and disseminated 
intravascular coagulation leading to death (Bauman, 2012). Besides causing occasional 
severe bronchopneumonia, K. pneumoniae may also comparatively cause meningitis, 
urinary tract and wound infections (Jensen et al., 1997; Cheesbrough, 2006; Bauman, 2012; 
Correa et al., 2013).  
 
According to Cheesbrough (2006), Klebsiella species are aerobes and facultative anaerobes. 
They usually produce large grey-white mucoid colonies on blood agar. Most Klebsiella are 
lactose – fermenters that produce mucoid pink colonies on MacConkey agar and yellow 
mucoid colonies on CLED medium. Examination of specimen depend on the site of infection 
which include urine, pus, sputum and infected tissue (Jensen et al., 1997). 
 
There is no specific treatment for Klebsiella pneumoniae other than supportive care, rest, 
and fever-reducing drugs (Bauman, 2012). Although many strains of the bacterium show 
multiple resistance, antimicrobial drugs such as cephalosporin, β-lactamases-stable 
penicillins and aminoglycosides may be used in treating Klebsiella (Cheesbrough, 2006; 
Elliott et al., 2007). Due to tissue damage and the release of endotoxin, damage to the 
lungs is usually permanent and could be fatal despite treatment. There is no vaccine 
available and prevention requires good aseptic techniques by health care workers (Bauman, 
2012).   
 
2.5.6 Pseudomonas aeruginosa 
Pseudomonas aeruginosa belong to the family known as Pseudomonadaceae  (Kayser et al., 
2005). The three most frequently seen pseudomonads in human infections are 
Pseudomonas cepacia, Pseudomonas maltophelia and Pseudomonas aeruginosa (Jensen et 
al., 1997). However, according to Kayser et al. (2005), the most significant species from a 
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medical point of view is Pseudomonas aeruginosa which was also one of the organisms 
investigated in this study. 
 
P. aeruginosa is a non-fastidious Gram-negative, non-sporing, non-capsulate, plump, 
aerobic bacillus about 2-4 µm long (Jensen et al., 1997; Elliott et al., 2007; Greenwood et 
al., 2012). It is usually motile by virtue of having one or several polar flagella (Kayser et al., 
2005; Govan, 2012). P. aeruginosa metabolizes a wide range of organic carbon and nitrogen 
sources hence it grows well on most culture media (Jensen et al., 1997; Bauman, 2012). P. 
aeruginosa is present in soil, skin flora, decaying organic matter, and almost every moist 
environment, embodying swimming pools, water baths, sponges, washcloths and contact 
lens solutions (Tortora et al., 1998; Bauman, 2011). In hospitals, it grows in sinks, cleaning 
buckets, drains, toilets, floor mops, dialysis machines, respirators and humidifiers 
(Cheesbrough, 2006; Bauman, 2012). 
 
Most strains of P. aeruginosa secrete a variety of diffusible pigments, including pyocyanin 
(blue-green, water soluble), pyoverdine (yellow-green and fluorescent), pyorubrin (red) and 
melanin (brown) (Tortora et al., 1998; Kayser et al., 2005; Cheesbrough, 2006). The 
organism has the ability to grow at 42°C and is oxidase positive. P. aeruginosa differs from 
members of the Enterobacteriaceae by utilizing carbohydrates via oxidative method rather 
than fermentation (Jensen et al., 1997; Elliott et al., 2007; Govan, 2012).  
 
According to Cheesbrough (2006), P. aeruginosa on blood agar, produces large, flat, 
spreading colonies which are often haemolytic. More than 90% of P. aeruginosa strains are 
pigment-producing and when the culture is left at room temperature, pigment colour 
becomes more intense. Thus the colonies and surrounding medium become greenish-blue 
due to secretion of a soluble blue phenazine pigment (Govan, 2012; Elliott et al., 2007). 
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Figure 2.13: A nutrient agar plate of P. aeruginosa showing blue-green pigment 
 
P. aeruginosa produces pale coloured colonies on MacConkey agar and green colonies on 
CLED medium and the pigmentation is less marked than that on blood agar. The growing 
colonies give off a sweet odour variously termed as grape-like or corn tortilla-like. This 
distinctive smell of the cultures is due to the formation of 2-aminoacetophenone (Jensen et 
al., 1997; Cheesbrough, 2006).  
 
2.5.6.1 Pathogenicity 
Bauman (2012) stated that Pseudomona aeruginosa causes fever, chills and shock when it 
invades the bloodstream. It has an armoury of cell-associated and extracellular virulence 
factors that can initiate or sustain infection. It is able to attach to the host cell and form 
biofilms due to the presence of fimbriae and other adhesins. Its enzyme neuraminidase 
modifies receptors on the host cell in such a way that attachment of fimbriae is 
accentuated (Bauman, 2011; Govan, 2012). 
 
The virulence factors sysnthesized by this bacterium include exotocin A and exoenzyme S, 
and different cytotoxic proteases, phospholipases and rhamnolipids, as well as hydrogen 
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cyanide and the toxic pigment pyocyanin. Exotoxin A and exoenzyme S prevent protein 
synthesis by infected host cells thereby leading to host cell death (Jensen et al., 1997; 
Bauman, 2012; Gillespie & Bamford, 2012). The intracellular action of exotoxin A is the 
same as that of diphtheria toxin fragment A (Govan, 2012). The enzyme elastase 
disintegrates elastic fibres, degrades complement components, and cleaves IgA and IgG. On 
the other hand, pyocyanin triggers the production of superoxide radical (O2
-) and peroxide 
anion (O2
2-) which are two reactive forms of oxygen that lead to tissue damage in 
Pseudomonas infections (Bauman, 2012). Fluroscein provides P. aeruginosa with a potent 
bacterial siderophore to compete with mammalian iron-binding proteins such as transferrin 
(Govan, 2012). 
 
This organism is so ubiquitous in the environment that no open wound, burn or 
immunocompromised patient is free from exposure (Jensen et al., 1997; Bauman, 2012). A 
number of clinical conditions are highly correlated with P. aeruginosa infection, including 
cystic fibrosis, burns, urinary catheters, cancer chemotherapy or any other condition that 
lowers the patient’s immune responses. From any such infection, the patient may develop 
P. aeruginosa pneumonia or bacteremia. These conditions are severe and have mortality 
rates in the order of 60% to 70%. It is estimated that greater than 90% of morbidity and 
mortality rates in cyctic fibrosis patients are due to P. aeruginosa (Jensen et al., 1997; 
Bradbury, Tristram, Roddam, Reid, Inglis & Champion, 2011; Moore et al., 2011a). Once 
acquired, this organism is capable of forming bacterial biofilms in the lung which makes its 
eradication extremely difficult and often generally impossible thereby leading to a chronic 
state of colonisation, infection and inflammation (Moore et al., 2011a).  
 
P. aeruginosa is a regular cause of otitis externa in swimmers also known as swimmer’s ear 
which is a painful infection of the external ear canal (Tortora et al., 1998; Elliott et al., 2007; 
Bauman, 2012). P. aeruginosa infection of the eye is a severe condition that may cause 
perforation of the cornea with subsequent loss of the eye. Skin infection with this organism 
can occur in persons who bathe in contaminated hot tubs (Jensen et al., 1997).  
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2.5.6.2 Treatment of P. aeruginosa infections 
Treatment of P. aerugisosa infection remains challenging and frustrating. The bacterium is 
notoriously resistant to a wide range of antibacterial agents, including antimicrobial 
therapy, soaps, antibacterial dyes and quaternary ammonium disinfectants. Pseudomonas 
can even survive in solutions of antibacterial drugs and disinfectants (Jensen et al., 1997; 
Bauman, 2011; Govan, 2012). Resistance is due to the ability of Pseudomonas to 
remarkably metabolize many drugs, to the presence of non-specific proton/drug antiports 
that make many drugs exit the bacterium. In addition, resistance is also enhenced  due to 
the presence of its biofilms that enable the organism to resist the penetration of 
antibacterial drugs and disinfectants (Bauman, 2012). Aminoglycosides (gentamicin, 
amikacin and tobramycin) and β-lactam compounds (piperacillin, ticarcillin, ceftazidine and 
carbapenems) are usually applied, alone or in combination (Govan, 2012).  
 
2.5.7 Escherichia coli 
Naturally, Escherichia coli live in the intestinal tract of humans and animals. E. coli belong to 
a group of colon-dwelling bacteria called coliforms (Kayser et al., 2005; Bauman, 2012). 
Besides dwelling in the intestinal tracts of humans and animals, coliforms can also survive 
naturally in soil, on plants and in water. Their presence in water has facilitated E. coli to be 
used as an indicator organism in determining the amount of fecal contamination in water 
sources as well as in food (Jensen et al., 1997; Cheesbrough, 2006; Chart, 2012). Thus it is 
sometimes used as a sentinel for monitoring antimicrobial drug resistance in fecal bacteria 
because it is found more frequently in a wide range of hosts, acquires resistance easily and 
is reliable indicator of resistance in salmonellae (Tadesse, Zhao, Tong, Ayers, Singh, 
Bartholomew & McDermott, 2012). 
E. coli are aerobic or facultatively anaerobic Gram-negative bacilli. They are usually motile 
and may express fimbriae. Inactive strains (formerly described as Alkascens-Dispar) are 
nonmotile. A minority of strains, particularly those from extra-intestinal infections, may 
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produce a polysaccharide capsule (Cheesbrough, 2006; Bauman, 2012; Chart, 2012). They 
ferment lactose to produce gas in 48 hours of being put in a lactose broth at 35°C. 
Kayser et al. (2005) narrated that a complex antigen structure of E. coli is based on O, K,  
and H antigens. Fimbrial antigens have also been described. Specific numbers have been 
assigned to virulent antigens such as O157, O111, K1, H8 and H7. Virulent strains have 
genes for fimbriae, adhesins and a variety of toxins that enable these strains to colonize 
human tissue and induce disease (Kayser et al., 2005; Bauman, 2011). Shigar-like toxin of E. 
coli O157:H7 is one of the most dangerous toxin expressed by this organism. This toxin 
inhibits protein synthesis, destroys cells and can induce kidney failure leading to death. The 
polysaccharide of the O and K antigens protect E. coli from the bactericidal effect of 
complement and phagocytes in the absence of specific antibodies. However, opsonization 
may occur in the presence of antibody to K antigens alone or to both O and K antigens  
(Bauman, 2012; Chart, 2012). 
In addition, Bauman (2012) observed that E. coli O157:H7 produces a type III secretion 
system. This system comprises of one set of secreted proteins that disrupts a host cell’s 
metabolism. Another set is able to lodge in a cell’s cytoplasmic membrane whereas another 
one forms receptors for the attachment of additional E.coli O157:H7 bacteria. Ostensibly, 
such attachment enables this E. coli strain to displace normal harmless strains. 
 
2.5.7.1 Intestinal infections 
Diarrhoea causing E. coli are currently grouped into different categories based on their 
virulence properties (Jensen et al., 1997; Kayser et al., 2005). These major catergories 
include enterotoxigenic (ETEC), enteropathogenic (EPEC), verocytotoxin (VTEC), 
enteroinvasive (EIEC) and enteroaggregative (EAggEC) (Kayser et al., 2005; Cheesbrough, 
2006; Chart, 2012;  Gillespie & Bamford, 2012). 
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Bauman (2011) and Chart (2012) indicated that E. coli is the most common cause of acute, 
uncomplicated urinary tract infection outside hospitals, as well as causing hospital-
associated urinary tract sepsis. These organisms may also cause neonatal meningitis and 
septicaemia, sepsis in surgical wounds and abscesses in a variety of organs. Thus E. coli may 
cause pneumonia when it gains access to lungs, particularly in a compromised host (Jensen 
et al., 1997; Chart, 2012). Ballinger (2012) postulated that hospital-acquired (nosocomial) 
pneumonia is often due to infection with Gram-negative organism such as E. coli. 
  
2.5.7.2 Laboratory diagnosis 
 E. coli produces 1-4mm diameter colonies after overnight incubation on blood agar. Some 
strains are haemolytic and may demonstrate mucoid colonies on blood agar. These bacteria 
ferment lactose giving smooth pink colonies on MacConkey agar and yellow colonies on 
CLED agar as well as on xylose-lysine deoxycholate (XLD) agar (Cheesbrough, 2006). 
Microscopic examination of clinical specimen may be done by employing Gram staining 
technique (Chart, 2012).  
According to Chart (2012), E. coli is susceptible to a variety of antibacterial agents including 
ampicillin, cephalosporins, tetracyclines, quinolones, aminoglycosides, trimethoprim and 
sulphonamides. However many strains contain plasmids, hence they are resistant to one or 
more of these drugs and as such antimicrobial therapy should be guided by laboratory 
sensitivity test if possible. Thus, Ballinger (2012) agreed that antibiotic therapy in all cases 
should be adjusted on the basis of the results of sputum microscopy and culture. 
 
2.5.8 Candida albicans  
Opportunistic mycoses (OM) that affect skin and mucosa as well as internal organs are 
caused by both yeast and moulds (Kayser et al., 2005). Candidiasis is an endogenous 
infection. Other OMs are exogenous infections caused by fungi that normally inhabit the 
75 
 
soil or plants. Candidiasis refers to any kind of opportunistic yeast infection caused by the 
genus Candida (Tortora et al., 1998; Kayser et al., 2005; Bauman, 2012). Thus Candida is a 
genus of true yeasts that is not dimorphic and possesses chains of yeast cells, each 
measuring about 4-6 µm, sometimes linking together to form structures known as 
pseudohyphae (Jensen et al., 1997). 
In this study, the yeast-like fungus Candida albicans was the particular one investigated. In 
stained smears, C. albicans is revealed as budding, oval yeast cells which are frequently 
seen attached to pseudohyphae. Both the yeasts and pseudohyphae stained Gram-positive 
as is evident in Figure 2.14 (Cheesbrough, 2006). C. albicans is the most common cause of 
candidiasis (moniliasis). The organisms form part of the microbiota of the skin and mucous 
membranes of the mouth, respiratory tract, vagina and gastrointestinal tract (Jensen et al., 
1997; Prescott, Harley & Klein, 2005; Gillespie & Bamford, 2012; Mulu et al., 2013). 
Bauman(2012) deduced that about 40-80% of all healthy individuals harbour these yeasts in 
their digestive and reproductive tracts.  
 
 
Figure 2.14: Sputum Gram staining showing Gram-positive cells and pseudohyphae 
              (Taken from Kayser et al., 2005) 
 
Candida infections are generally endogenous but genital infection can be transmitted 
sexually. Candidiasis is commonly observed in immunocompromised individuals such as 
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HIV-infected patients (Kayser et al., 2005; Cheesbrough, 2006; Warnock, 2012). A common 
form of candidosis restricted to the epithelial surfaces in the mouth or vagina, is termed 
thrush. Thrush (basically inflammation of the mouth) may occur in newborn infants during 
birth from infected mothers or in immunocompromised persons (Jensen et al., 1997; 
Tortora et al., 1998). Vaginal candidiasis is common and is frequently observed during 
pregnancy or in diabetics. It is manifested as white mucoid colonies growing on the vaginal 
mucosal membrane including the skin covering the vaginal labia (Bauman, 2012). C. 
albicans is the most common cause of diaper rash. Candidiasis of the skin is irritating 
especially when the skin is kept damp such as between the upper legs or under the arms 
(Jensen et al., 1997).  
According to Bauman (2012), almost 100% of AIDS patients may develop candidiasis in their 
reproductive or digestive tracts. Other various predisposing conditions for the emergence 
of candidiasis include cancer, invasive hospital procedures, antibacterial therapy (which 
inhibit normal indigenous bacteria that compete with Candida), diabetes, severe burns and 
intravenous drug abuse. C. albicans may on occasion cause serious diseases such as 
endocarditis, septicemia, protracted urinary tract infection, including kidney and lung 
infection, esophagatis and other soft tissue infection (Burton, 1992; Jensen et al., 1997; 
Esperatti & Marti, 2010; Bauman, 2012). 
 
2.5.8.1 Cultural identification 
C. albicans grows well on Sabouraud dextrose agar on which they produce round, whitish 
coloured pasty colonies after 24-48 hours of incubation at 35°C-37°C. The colonies have a 
distinctive yeast smell and the budding cells can be easily identified both in stained and 
unstained preparations using a microscope (Kayser et al., 2005; Cheesbrough, 2006; Elliott 
et al., 2007). C. albicans can also be identified presumptively by a simple germ tube test. 
Currently, the use of serological tests and detection of fungal DNA by the polymerase chain 
reaction (PCR) is possible. For treatment, nystatin and azole creams can be used in topical 
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therapy. Amphotericin B is still the agent of choice and can be applied in cases of deep 
candidiasis. Amphotericin B is administered in combination with flucytosine in order to 
reduce resistance to flucytosine (Cheesbrough, 2006; Volans & Wiseman, 2009; Bauman, 
2012; Warnock, 2012). 
According to Mulu et al. (2013), the escalated incidence of mucosal and deep seated forms 
of candidiasis have resulted in the use of systemic antifungal agents, mainly flucanazole and 
itraconazole. However, the widespread use of these antifungal agents has been followed by 
an increase in antifungal resistance and there have been reports of the emergence of 
resistance to antifungal agents in HIV/AIDS patients with oropharyngeal candidiasis. In most 
cases the resistance of Candida isolates to currently available antifungal drugs, may lead to 
severe implications like morbidity and mortality. There is a need to engage in the search for 
new antifungal agents, hence the reason Candida albicans strains were included in this 
study. 
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 CHAPTER 3 
METHODOLOGICAL JUSTIFICATION 
 
In this chapter, justification of methods and materials applied will be discussed. Materials 
and testing methods were selected in order to verify in vitro antibacterial and antifungal 
activities of the study plants. Traditionally, the selected plants are used to treat various 
ailments including pneumonia hence it was important to scientifically justify their 
traditional claims. Figure 3.4 gives a summary of the screening procedures and some of the 
equipment utilised in this study. 
 
Ethnopharmacology, a branch of Ethnobotany is considered as the scientific evaluation of 
traditional medicinal plants which suggests that ethno-directed sampling is most likely to 
succeed in identifying drugs used in the curing of gastrointestinal, inflammatory and 
dermatological ailments (Raaman, 2006). Methods and materials used in the present study 
were selected taking into account that laboratory results, obtained when screening plants 
for their antimicrobial activity or when testing the sensitivity patterns of bacteria using 
antibiotic discs, are determined by several factors. Some of the factors include: the media 
used, density of bacteria applied, choice of particular solvents, incubation time, 
temperature, plant collection and the extraction method applied (McGowan, 2006; 
Lautenbach & Polk, 2007; Maheshwari, Dubey & Saravanamurthu, 2010). 
 
3.1 ETHNOMEDICINAL PLANTS AND THEIR IDENTIFICATION 
 
Since the existence of man on earth, plants have played a very important role in human 
welfare by providing food, clothes, shelter, juice and medicine. To keep himself alive, man 
has a tenacious relationship with plants, and herbal medicines obtained from plants are the 
oldest form of health care known to mankind (Vardhana, 2008). Collection and species 
identification of raw plant materials are considered to be the most important procedures of 
the entire process of production or study because they directly influence the quality of 
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products or results of a study. It is therefore of vital importance to ensure a correct 
selection of appropriate time with adaptable techniques for the collection of herbal 
materials. The colour, odour, taste, shape, texture and structure of a medicinal plant should 
all be considered as references for collection because they are reflections of the chemical 
compositions in the plant (Arrowsmith, 2009; Liu, 2011). 
 
Ethnomedicine involves various parts of plant material such as the leaves, the flowers, the 
seeds, the barks, the roots, the shrubs, etc (Raaman, 2006; Van Wyk et al., 2009). 
Ethnomedicine refers to the study of traditional medical practice, which is concerned with 
the cultural interpretation of health, diseases and illness, and also addresses the health care 
seeking process and healing practices (Rai et al., 2012, p. 70). 
 
 In this study, the following medicinal plants, Geranium incanum, Cassia abbreviata, 
Tecoma capensis and Pelargonium hortorum were selected on the basis of their reported 
ethno-medical properties in the treatment of several diseases (Schmelzer & Gurib-Fakim, 
2008; Van Wyk et al., 2009; Saraswathi et al., 2011). The selected medicinal plants are 
indigenous to the Eastern Cape region and are readily accessible. C. abbreviata is more 
common in places such as the Limpompo and Mpumalanga regions which constitutes the 
eastern region of South Africa. Mature plants of G. incanum, T. capensis, and P. hortorum 
were collected in the summer season of 2012 to 2013 from various sites in the 
Summerstrand area of Port Elizabeth, Eastern Cape Province, South Africa. These plants 
were collected in summer as during this period, the leaves are thick and green and display 
fairly good qualities (Liu, 2011). Kokate, Purohit, and Gokhale (2008) observed that crude 
drugs which constitute leaves and the flowering tops of plants should be collected just 
before they reach their flowering stage.  
 
However, C. abbreviata was collected in Malawi during summer since in early summer the 
plant cambium is active and as such it is not difficult to remove the bark from the stem 
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(Kokate et al., 2008). On the other hand, the investigator wanted to test at least one plant 
from a different location since it is stated that qualities of herbal materials from different 
locations may vary immensely even if they are processed with the same procedures. Thus, 
specimens of the same species collected at different times or from different places do not 
necessarily display the same biological activity (Watson & Preedy, 2008; Arrowsmith, 2009; 
Liu, 2011).  These plants were authenticated by Professor Eileen E. Campbell who is the 
Director of School of Environmental Sciences, Department of Botany at the Nelson Mandela 
Metropolitan University. 
 
Traditionally, herbs may be prepared and applied to various ailments as infusions, 
decoctions, tinctures, enemas, extracts, ointments, inhalations, macerations, poultices and 
compresses, powders, baths and bathing remedies (Odugbemi, 2008b; Arrowsmith, 2009; 
Wyk et al., 2009). In the present study, leaves of G. incanum, T. capensis and P. hortorum 
and the stem bark of C. abbreviata were used against the selected pathogens. Table 3.1 
summarizes the essential medicinal parts, phytoconstituents and their traditional medicinal 
properties of the plants under investigation. 
 
3.1.1 Maintenance of plant potency 
Draelos (2011) advised that proper processing of plant material is necessary to ensure 
herbal potency. Several methods of processing plant material should be adopted in order to 
meet the standard pharmacopoeial requirements. In general, these methods include proper 
collection and harvesting, drying and garbling. Sometimes, coating and bleaching are also 
necessary for converting the drug into a suitable form for the market (Kokate et al, 2008). 
Liu (2011) suggested that immediately the plant materials are collected, they need to be 
properly processed to avoid plant deterioration due to water contained inside. Thus the 
primary objective of processing raw herbal materials should be to maintain its efficacy, 
degrade its toxicity, prevent it from deterioration and enable easier storage as well as 
transportation. 
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Ponmari, Sathishkumar and Lakshmi (2011) observed that some herbs or crops are 
consumable in their fresh state and may deteriorate within a few days after harvest. Thus 
one way of preserving plant products is to dry them. In the present study, soon after 
collection, plant materials were washed thoroughly with fresh running water in order to 
remove soil and other debris as described in various literatures (Sarker, Latif & Gray, 2006; 
Selvamohan et al., 2010; Hossain & Nagooru, 2011; Sharma, Meena & Meena, 2012; Khan 
et al., 2013). According to Draelos (2011), the biological activity of the herbal extracts is 
affected by the condition of the plant, which must be healthy and disease free. In this 
regard, purity must be determined to ensure no destructive adulterants or microbes are 
present. That is why the leaves or the stem bark were first cleaned prior to drying in order 
to get rid of contaminants which may reduce activity since they may dilute the secondary 
metabolites out of the therapeutic concentration (Diederichs, 2006). Figure 3.1 shows plant 
material being washed with water. 
 
 
Figure 3.1: Pelargonium hortorum leaf being washed with fresh tap water 
 
3.1.2 Drying 
The timing, degree and type of processing determine the functionality of the herbal 
product. The first step in processing the plant material is drying  (Draelos, 2011). Plants 
must be dried or processed as soon as possible after harvest because they begin to 
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deteriorate immediately. Plants can be used for extraction while fresh but generally, they 
are dried first. Most plants contain about 60% to 80% moisture when harvested and must 
be dried to within 10% to 14% moisture prior to storage in order to prevent mildew 
(Raaman, 2006; Arrowsmith, 2009; Draelos, 2011). The purpose of drying is to reduce or 
remove sufficient moisture content of a crude drug so as to improve its quality and make it 
resistant to the growth of microorganisms. Hence, dry conditions are essential to prevent 
microbial fermentation and subsequent degradation of metabolites. Not only does drying 
enhance storage of the plant material but it also facilitates pulverizing or grinding of a crude 
drug (Sarker et al., 2006; Kokate et al., 2008). 
 
The type of plant or plant part being used will determine the appropriate drying technique. 
Plants can be dried either naturally (sun drying) or by applying a number of artificial 
methods for example, oven drying (Raaman, 2006; Kokate et al., 2008; Arrowsmith, 2009; 
Van Wyk et al., 2009). Not only does oven drying accelerate the drying process, but also 
minimizes enzymatic reactions (e.g., hydrolysis of glycosides) that can occur in the presence 
of even minimal residual moisture in the plant material. Even though sun drying is one of 
the drying techniques, protection from direct sunlight is advised to minimize chemical 
reactions and the formation of artifacts induced by ultraviolet rays (Diederichs, 2006; 
Sarker et al., 2006). 
 
In this study, both methods were employed in drying the plant materials. The leaves of G. 
incanum, P. hortorum and T. capensis were dried in an oven at 40°C for 72 hours while the 
stem bark of C. abbreviata was shade dried at room temperature for several days with 
occasional sun drying (Das, Tiwari & Shrivastava, 2010). To enhance homogenous drying of 
Cassia stem bark, it was sliced into evenly smaller pieces as illustrated by Sarker et al. 
(2006). In order to prolong the life of the Cassia plant, the bark was harvested from the 
sides of the tree thereby preventing ring-barking which eventually leads to the death of the 
plant (Diederichs, 2006;  Van Wyk et al., 2009). 
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3.1.3 Plant powder preparation 
Once thoroughly dried, plants can be stored before analysis for long periods of time 
(Raaman, 2006). The dry plant material may be stored as is, or may be reduced to powder 
(Van Wyk et al., 2009). In order to achieve the powder formulation, the dried leaves of G. 
incanum, P. hortorum and T. capensis were ground into fine powder using a mortar and a 
pestle (Sharma et al., 2012; Umer et al., 2013). Figure 3.2 is a photograph of a mortar and a 
pestle. On the other hand, the bark of C. abbreviata was ground into fine powder using a 
manual mill.  
                                                                                                          A pestle 
         A mortar 
Figure 3.2: A mortar and a pestle with G. incanum powdered leaf 
 
The study plant products were crushed into smaller macroscopic particles in order to 
render the plant sample more homogenous thereby allowing maximum surface area for the 
penetration of extracting solvents so as to facilitate the extraction of the active substances 
(Vercoe, Makkar & Schlink, 2010). Thus the greater the amount of surface area, the quicker 
a solute will dissolve in a solvent (Sackheim & Lehman, 1998; Troy, 2006). The dried 
powdered plant material was stored in a dessicated air tight glass jar (Figure 3.3) in a shade 
at room temperature (Ahameethunisa & Hopper, 2012). This was essential in order to  
ensure that the plant material was free from mould growth, viral, bacterial and fungal 
infections (Raaman, 2006; Arrowsmith, 2009). Van Wyk (2009) advised that care should be 
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taken so as to ensure that the active ingredients remain stable and that the packing 
materials do not degenerate and contaminate the medicine.  
 
                                               
 
Figure 3.3: An air tight glass jar containing dried packed plant material 
 
3.2 METHODS OF MEDICINAL PLANT EXTRACTION 
 
Extraction is defined as a process whereby the desired active constituents of a plant are 
removed using a suitable solvent such as water or alcohol (Raaman, 2006; Kokate et al., 
2008; Van Wyk et al., 2009). Both fresh plants and dried plants can be used for extraction.   
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Table 3.1: Plants under investigation and their reported ethnobotanical effects 
Family Name Scientific Name Plant Parts 
Traditionally 
Used 
Pontially Bioactive 
Phytoconstituents 
         Medicinal Uses    References 
Geraniaceae 
 
Geranium 
Incanum 
Leaves (rarely 
roots/fruits) 
Tannins (polyphenols), 
flavonoids 
Leaves are used to treat bladder 
infections, venereal diseases and 
menstruation-related ailments. 
Amabeoku, 2009; 
Van Wyk et al., 2009; 
Mohlakoana, 2010. 
Pelargonium 
hortorum 
 
 
Tuberous 
fleshy root 
stock 
Tannins, coumarins, 
monoterpenes, 
sesquiterpenes, phenolic 
acids, flavonoids,  
cinnamic acids, flavones, 
and flavonols 
Tubers are used to treat 
gastrointestinal disorders (diarrhoea 
and dysentery), fever, respiratory 
conditions, liver complaints, 
haemorrhage, kidney and bladder 
disorders. 
Bailey, 2013; Pienaar, 
1987; Seraswathi et al., 
2011; Kolodziej, 2011;  
Karamanoli et al., 2011;  
Watt & Breyer-Brandwijk, 
1962; Van Wyk et al., 
2009. 
Fabaceae 
 
Cassia abbreviata 
Oliv 
Roots, seeds,  
barks, leaves 
and twigs 
Anthraquinones, 
triterpenoids, flavanol 
derivatives and organic 
acids 
Used to treat everything from 
blackwater fever (Malaria), pneumonia, 
venereal diseases, headache, 
toothache and stomach ache 
Van Wyk et al., 2009; 
Motlhanka & Nthoiwa, 
2013; Schmelzer & Gurib-
Fakim, 2008. 
Bignoniaceae 
 
Tecoma capensis 
(Thunb.) Spach 
Leaves, 
flowers and 
bark 
Flavonoids, glycosides, 
and steroidal compounds 
Leaves are used to treat pneumonia, 
enteritis and diarrhoea.  Powdered 
bark is used for sleeplessness and pain 
Al-Hussaini & Mahasneh, 
2009; Tamiljothi, 
Ravichandiran, 
Chandrasekhar & Suba, 
2011; Mutshinyalo, 2008; 
Jothi et al., 2012b. 
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Figure 3.4: Summary of the screening procedures and some of the equipment used in this study 
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Dried plants are first ground into smaller particles and then thoroughly mixed with an 
appropriate solvent while fresh plants which contain wet tissues may be homogenised in 
solvent (Raaman, 2006; Kokate et al., 2008). Extracts contain primarily the active 
constituents of the crude drug, with a large portion of the inactive constituents and 
structural components of the crude drug having been removed (Allen, Popovich & Ansel, 
2011). 
 
A number of techniques and instruments have been devised and employed to meet the 
extraction of plant materials. Among the most often encountered extraction methods 
include: solvent extraction, steam distillation and supercritical fluid extraction [SFE] (Liu, 
2011). Methods of solvent extraction can be divided into two classess on the account of 
solvent flow state namely: continuous (percolation, soxhlet extraction) and discontinuous 
methods (maceration, sonication-assisted solvent extraction and extraction under 
refluxing) (Raaman, 2006; Liu, 2011).  
 
There are many extraction methods that have been applied in the past and each one has 
advantages and disadvantages (Lammerhofer & Weckwerth, 2013). In the present study, a 
centrifugation technique which is also applied in a maceration procedure was employed for 
extraction. According to Raaman (2006), maceration involves soaking and agitating the 
solvent and plant materials together. The solvent is then drained off, such that the 
remaining miscella (substances dissolved in the solvent) is removed from the plant material 
either through pressing or cetrifuging. Centrifugation is a common, cheap, readily available 
and an efficient method of performing extraction. It is a method of solids removal and/or 
clarification of plant extracts and homogenates because continuous or semicontinuous 
processing is feasible and as such it can handle a variety of different extracts (Gottschalk, 
2011) 
 
Biological centrifugation is therefore a process that sediments particles suspended in a 
liquid medium by exerting a force greater than that of gravity (Reed, Holmes, Weyers, & 
88 
 
Jones, 2007; Cheesbrough, 2009). The force on a sedimenting particle increases with the 
velocity of the rotation and the distance of the particle from the axis of rotation (Boyer, 
2012). The process is a key technique for isolating and analysing cells, subcellular fractions, 
supramolecular complexes and isolated macromolecules such as proteins or nucleic acids. 
The centrifugal field is generally expressed in multiples of the gravitational field (g). The 
relative centrifugal field or force (RCF) is the ratio of the centrifugal acceleration at a 
specified radius and the speed to the standard acceleration of gravity. RCF units are 
reported as dimensionless (denoting multiples of g) and revolutions per minute (rpm) 
(Wilson & Walker, 2010). Thus the actual sedimentation achieved at a given speed depends 
therefore on the radius of the centrifuge. Hence, a common feature in all centrifuges, is the 
central motor that spins a rotor containing samples to be separated (Cheesbrough, 2009; 
Wilson & Walker, 2010).  
 
3.2.1 Selection of solvents for extraction 
Extraction procedures can employ either water-miscible or water-immiscible solvents 
(Sarker et al., 2006). According to Liu (2011), both organic and aqueous solvents are widely 
used in the extraction of plant materials due to their effectiveness and low costs. The 
principle behind applying solvent for extraction is that of “solid-liquid” extraction. In the 
solid-liquid extraction, the plant material is placed in contact with a solvent, the solvent 
diffuses into the plant cells first, and the metabolites are then dissolved in the solvent and 
transferred out of the cells. The quality of plant extract depends on plant material, choice 
of solvents and the extraction methods (Das et al.,  2010). 
 
When selecting a solvent or solvent system to extract plant materials, different aspects 
need to be considered which include: solubility and selectivity of the target components, 
safety (low toxicity, low flammability, low risk of explosion), availability and economics (low 
costs), ease of solvent recovery and concentration (Bart & Stephan, 2011; Liu, 2011). The 
solvent is the key affecting the extraction efficiency. Hence, in order to extract the analytes 
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of interest (as many as possible from interfering compounds), the polarity of the solvent 
should closely match that of target compounds following the principle of “like dissolve like”  
(Tzanavaras & Zacharis, 2010; Liu, 2011; Kotz, Treichel, & Townsend, 2012). In this principle, 
a given solvent usually dissolves solutes that have polarities similar to its own (Zumdahl & 
DeCoste, 2011). Thus, nonpolar solvents (pet-ether, n-hexane, chloroform, and so on) are 
used to solubilize mostly lipophilic components in plants such as alkanes, fatty acids, 
sterols, pigments, waxes, some terpenoids coumarins and alkaloids (Sarker et al., 2006). 
Medium-polarity solvents (ethyl acetate, dichloromethane, and so on) are used to extract 
compounds of intermediate polarity for example, flavonoids and quinones (Sarker et al., 
2006; Liu, 2011). More polar solvents (water, methanol, ethanol, acetone, and so on) are 
used for more polar compounds such as glycosides, some alkaloids,  polyphenols including 
tannins and anthocyanins (Liu, 2011). 
 
Bart and Stephan (2011) and Ramaswamy, Huang and Ramarao (2013) have outlined 
commonly used solvents for plant extraction which include water, alcohols (mainly 
methanol, ethanol and isopropanol), glycols, hydrocarbons (e.g., hexane, heptane), ketones 
(e.g., acetone, methyl ethyl ketone), acetates (e.g., ethyl, propyl, butyl acetate) and 
compressed or supercritical gases (e.g., carbon dioxide, propane, butane, nitrous oxide). In 
the present investigation, water, acetone and methanol were the solvents of choice.  
 
3.2.2 Traditional way of extraction 
Sarker et al. (2006) described that traditional methods of extraction rely principally on the 
use of cold or hot water, alcohol and aqueous alcoholic mixtures that are prepared and 
applied either externally or administered intenally as herbal tea for example, infusions or 
decoctions. Decoctions are prepared when a plant is immersed in boiling water. In this way, 
substances are decomposed while their medicinal properties are extracted, and their 
volatile or aromatic virtues are dissipated. On the other hand, infusions or teas are made by 
pouring water, either hot or cold on plant material and the preparation is left to brew for a 
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proper period of time in a covered vessel before it is poured or strained off for use ( 
Janowski, 2008; Odugbemi, 2008b;  Arrowsmith, 2009). 
 
3.3 ANTIMICROBIAL SCREENING OF EXTRACTS  
 
The antimicrobial susceptibility test (AST) is an essential technique in modern biological 
science. In pathological settings AST is used to determine resistance of certain microbial 
strains to various antimicrobials, while in pharmacological research it is used to determine 
the efficacy of novel antimicrobials from biological extracts against different 
microorganisms. Currently, AST methods are employed to screen the plant extracts for 
antimicrobial activity and to determine Minimum Inhibitory Concentration (MIC) of the 
antimicrobial resistance (Cheesbrough, 2006; Das et al., 2010). In this study, the 
antimicrobial activity of four selected plants were carried out against particular microbial 
strains. The standard ATCC strains and other clinical microbial strains were used in the 
screening of antimicrobial activity of Geranium incanum, Cassia abbreviata, Tecoma 
capensis and Pelargonim hortorum extracts.  
 
The antimicrobial properties were investigated by applying agar disc diffusion and agar 
dilution methods, as recommended by the Clinical and Laboratory Standards Institute 
(CLSI), which was previously known as The National Committee for Clinical Laboratory 
Standards (NCCLS) (Gangoue-Pieboji et al., 2009). Thus a laboratory antimicrobial 
susceptibility testing can be done using either a dilution technique or a disc diffusion 
technique (Cheesbrough, 2006).  
 
3.3.1 Agar disc diffusion method 
According to Das et al. (2010), the Agar disc diffusion method of antimicrobial test was 
developed in 1940. The procedure which was accepted by CLSI and which is currently 
widely utilized, is a modification of that described by Bauer, Kirby, Sherris and Truck and is 
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commonly referred to as the Kirby-Bauer test (Cheesbrough, 2006). Literature reveals 
several researchers who have used the Agar disc diffusion technique to assay plant extract 
for antimicrobial activity (Duraipandiyan & Ignacimuthu, 2009; Zaouia, Segni, Noureddine & 
Redha, 2010; Onanuga & Awhowho, 2012; Singaria, Mourya & Kumar, 2012).  
 
In this procedure, a disc of blotting paper is impregnated with a known volume and 
appropriate concentration of antimicrobial, and this is placed on a suitable plate of 
susceptibility testing agar (i.e., Mueller Hinton agar or Nutrient agar) uniformly inoculated 
with the test organism (Cheesbrough, 2006; Das et al., 2010). The test organism is adjusted 
to match 0.5 McFarland standard turbidity suspension (Mendez-Vilas, 2011). Then the 
antimicrobial diffuses from the disc into the medium and the test organism is inhibited at a 
distance from the disc that is related to the susceptibility of the organism. Strains that are 
susceptible to the antimicrobial are inhibited at a distance from the disc, whereas those 
that are resistant form smaller zones of inhibition or grow up to the edge of the disc 
(Torrence & Isaacson, 2003; Cheesbrough, 2006; Bauman, 2012). 
 
In the present study, the agar disc diffusion technique was employed in order to screen the 
antimicrobial activity of plant extracts on three strains of Streptococcus pneumoniae and 
three strains of Haemophilus influenzae. This procedure was also conducted on standard, 
commercially available antibiotics in order to compare their antimicrobial activity with 
crude extracts on bacteria and fungi employed in this study in accordance with 
Selvamohan, et al. (2010). 
  
3.3.2  Agar dilution technique 
In the agar dilution method, the antimicrobial agent (i.e., the plant extract) is incorporated 
into the agar medium with each plate containing a different concentration of the agent. The 
inocula can be applied rapidily and simultaneously to the agar surfaces using an inoculum 
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replicating apparatus such as the Mast Multipoint Inoculator (Gillespie & Hawkey, 2006), as 
seen in Figure 3.5. Most available replicators transfer 32-36 inocula to each plate.  
 
 
Figure 3.5: A plate being inoculated with a Mast Multipoint Inoculator 
 
In this study, Mueller-Hinton agar was prepared by autoclaving and allowed to cool to 
about 50°C before the addition of the extracts as illustrated by Kambizi and Afolayan (2001) 
and Adebiyi, Koekemoer, Adebiyi, Smith, Baxter, Naude & Van de Venter (2009). The agar 
medium was diluted to a desired concentration of 20mg/ml with respective extracts and 
was poured into petri dishes. Similarly, the procedure was also performed for Candida using 
Sabouraud dextrose agar. Thus, agar dilution technique was employed to screen the 
antimicrobial activity of extracts on the following bacteria: Klebsiella pneumoniae, 
Staphylococcus aureus, Escherichia coli, Acinetobacter baumannii, Pseudomonas aeruginosa 
and fungus, Candida albicans. The advantages of this technique include the reproductability 
of results and satisfactory growth of most nonfastidious organisms. With this method, 
multiple strains and species of organisms can be evaluated on the same agar plate 
containing the antimicrobial agent. However, its disadvantages are: intensive training in 
personnel, more labour required to prepare the agar dilution plates, and their relatively 
short life (Torrence & Isaacson, 2003; Dougherty & Pucci, 2012).  
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3.4 MINIMUM INHIBITORY CONCENTRATION (MIC) 
 
Minimum inhibitory concentration (MIC) is defined as the lowest concentration of an 
antimicrobial agent that will inhibit growth and reproduction of a particular organism after 
overnight incubation (Mendez-Vilas, 2011; Anderson, Groundwater, Todd & Worsley, 2012; 
Umer et al., 2013). The inhibited growth of organisms can be determined visually with an 
eye or by more automated methods, such as microtitre plate readers (Dougherty & Pucci, 
2012). The determination of the MIC via a broth dilution test involves a standardized 
amount of bacteria which is added to serial dilutions of antimicrobial agents in tubes or 
wells containing broth (Bauman, 2012). After incubation, turbidity (cloudness) in the tubes 
indicates bacterial growth whereas lack of turbidity entails that bacteria were either 
inhibited or killed by the antimicrobial agent. The MIC in microwells may be calculated as 
the concentration where growth is inhibited (Vercoe et al., 2010;  Bauman, 2011). 
 
According to Anderson et al. (2012), the MIC usually indicates the efficacy of an antibiotic 
agent. The MIC gives an indication of the susceptibility of an organism to a particular 
antimicrobial agent. This implies that the knowledge of the MIC is important in order to 
apply the minimum essential concentration capable of preventing microbial growth 
(Chorianopoulos, Lambert, Skandamis, Evergetis, Haroutounian & Nychas, 2006). Thus, the 
lower the MIC, the more susceptible the microorganism is. This assists, particularly in the 
determination of bacterial resistance in a way that resistance strains will have higher MICs 
than those which are susceptible to an agent. The other advantage is that MIC is used to 
inform the treatment of a bacterial infection and the dosing regimen for the antibacterial 
used. When the MIC level of a drug for a given organism is low, the organism is considered 
sensitive to the drug meaning that the drug will kill it. On the other hand, when the MIC is a 
moderate value, the organism’s sensitivity to the drug will be intermediate. Furthermore, 
when the MIC is high, the organism will be resistant to the drug hence laboratory values 
often report sensitivities as S, I, or R to indicate sensitive, intermediate and resistant 
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respectively (Bardal, Waechter & Martin, 2011; Anderson et al., 2012). In this study, MIC 
was achieved mainly by using microtitre-plate method and agar disc diffusion method. 
 
3.5 PHYTOCHEMICAL ANALYSIS 
 
Plants not only produce chemical compounds for human and animal consumption such as 
carbohydrates, proteins and fats but also a multitude of other compounds (glycosides, 
alkaloids, terpenes etc.) that exert physiological effects (Coker, Adesegun & Sofidiya, 2008; 
Liu, 2011). The use of plants as medicine involves extraction and isolation of active 
compounds. The phytochemical screening was therefore carried out using the standard 
qualitative methods in order to determine the bioactive compounds such as alkaloids, 
amino acids, anthraquinones, flavonoids, glycosides, phytosterol, saponins, tannins and 
triterpenoids. These common standard phytochemical methods were first described by 
Harbone in 1973 (Anowi, Cardinal, Ezugwu & Utoh-Nedosa, 2012; Noumedem et al., 2013).  
 
3.5.1 Thin-Layer Chromatography (TLC) 
Chromatography is a physical method of separation in which the compounds to be 
separated are distributed between two phases, one of which moves in a definite direction 
(the mobile phase) while the other is stationary (the stationary phase) (Deyl, 1984; Wixom 
& Gehrke, 2010; Boyer, 2012). These two phases can be solid-liquid or gas-liquid. Even 
though there are many different variations of chromatography, the principles are 
essentially the same. Chromatographic methods are the workhouse for the identification of 
interesting constituents, which should be purified on the preparative scale for sample 
testing, efficacy screening and structure analysis (Bart & Stephan, 2011). Chromatographic 
methods include paper chromatography (PC), thin-layer chromatography (TLC), gas liquid 
chromatography (GLC), high-performance liquid chromatography (HPLC), column 
chromatography (CC) and high-performance thin-layer chromatography (HPTLC) (Raaman, 
2006; Shah & Seth, 2010). 
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A very versatile tool for process development in plant compound isolation is thin-layer 
chromatography (Bart & Stephan, 2011). Thin-layer chromatography or TLC, is a solid-liquid 
form of chromatography where the stationary phase is normally a polar absorbent and the 
mobile phase can be a single solvent or combination of solvents. TLC is an easy, economical 
(many samples can be analysed on the sample plate), and quick microscale techinique that 
can be used for qualitative and quantitative analysis as well as purification of natural 
products (Dayan & Krominadas, 2011; Liu, 2011). As an auxiliary tool, TLC is used to 
determine appropriate conditions for column chromatography, including selecting the 
mobile and solid phases, analyzing the fractions obtained from column, as well as 
confirming purity of the isolates (Odugbemi, 2008a; Liu, 2011). 
 
In TLC, the solution of herbal extract in an appropriate solvent (methanol or ethanol) is 
spotted on a TLC plate using capillaries in a horizontal line about 1-2cm from the lower end. 
The plate is then transferred to a chamber containing a sufficient volume of solvent systems 
at the bottom, with the level of the solvent slightly below the sample spot (the sample spot 
or line should be above the solvent (Kurian & Sankar, 2007). The developing solvent will 
slowly migrate up the plate due to adsorption of the sorbent (solid phase) on the plate (see 
Figure 3.6) (Liu, 2011). 
                                                                                                           Original sample spot or line 
         Top of solvent 
Figure 3.6: Thin layer chromatography indicating compounds' development 
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The appropriate selection of the mobile phase can be determined through trial and error  
(Fanali, Haddad, Poole, Schoenmakers & David, 2013). However, the solvent system 
mixtures of petroleum ether, ethyl acetate, chloroform and formic acid (8:7:5:1) or ethyl 
acetate, methanol and water (20:2.7:2) adapted from Chinyama (2009) and Iwalewa, 
Suleiman, Mdee and Eloff (2009)  were employed in the present work. 
 
Every good thing has its limitations and downsides, and it is important to be realistic about 
those as well (Reich & Schibli, 2007). Similarly, TLC has its own limitations. TLC is an open 
system and as such some of the parameters influencing TLC are difficult to standardize, for 
example: climatic factors (temperature, humidity, light) and composition of the gas phase in 
the TLC chamber (Dayan & Krominadas, 2011; Boyer, 2012). The separation power of 
TLC/HPTLC is lower than that of HPLC. Particularly for complex samples like botanicals, it is 
often difficult to achieve sufficient resolution for all components. This is the main reason 
why HPLC is generally preferred for quantitative determination. TLC involves several drying 
steps therefore it is not suitable for samples that must remain in solution such as 
biopolymers (Reich & Schibli, 2007). Furthermore, several spots in TLC may overlap and 
often the components do not show up, even when a stain is applied (Diederichs, 2006). 
 
3.5.2 Bioautography 
Bioatography is a very convinient way of testing plant extracts and pure phytochemical 
compounds for their effect on both human and plant pathogenic microorganisms (Das et 
al., 2010). It can explain how many biologically active compounds are present in a plant 
extract (Ahmad, Owais, Shahid & Aqil, 2010). Bioatography methods are usually achieved in 
three approaches, agar diffusion or contact bioautography, immersion or agar overlay 
bioautography and direct bioautography (Ahmad, Aqil & Owais, 2006; Das et al., 2010; 
Joshi, 2012). In the present work, direct TLC – bioautography was employed. In this 
particular procedure, a suspension of test bacteria is sprayed onto the TLC plate. The 
bioautogram is then incubated at 37°C for 24 hours in humid conditions. Following 
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incubation, zones of inhibition are observed, either unaided or following development with 
compounds such as methylthiazoldiphenyltetrazolium (MTT) or p-iodonitrotetrazolium-
violet (INT) (Ahmad et al., 2006). These salts are converted by the dehydrogenases of living 
microorganisms to intensely coloured formazen. The salts are sprayed onto the 
bioautogram and are re-incubated at 37°C for 24 hours. Clear white zones against a purple 
backgraound on the TLC plate indicate antimicrobial activity of the extract (Das et al., 2010). 
Thus the advantage of this technique is that it permits localizing of antimicrobial activity on 
the chromatogram (Ahmad et al., 2010). 
 
3.6 MUTAGENICITY IDENTIFICATION  
 
Bauman (2012) proposed that numerous chemicals in food, the workplace and the 
environment have been suspected of being carcinogenic mutangens. This means that they 
are capable of causing mutations that induce cancer. Therefore mutation of genes in cells is 
the basic factor of cancer formation. This implies that cancer normally begins after a 
mutational episode in a single cell and then it progressively transforms to malignancy in 
multiple stages through sequential acquisition of additional mutations (Mashele & Fuku, 
2011). However, the reduction in the frequency of genetic mutation may decrease tumor 
formation to a certain degree (Hong, Cho, Jang & Lyu, 2011a). Mashele and Fuku (2011) 
projected that deaths from cancer are continuing to escalate, with an estimate of nine 
million deaths from cancer in the year 2015 and 11.4 million deaths by 2030. Since animal 
tests to prove mutagens carcinogenic are expensive and time consuming, researchers have 
used a fast and inexpensive method for screening mutagens called an Ames test. It is 
named after its inventor, Bruce Ames (Bauman, 2012). 
 
The Ames test is a well-known bacterial mutagenicity test which determines whether a 
substance affects (mutates) the structure of DNA (Mashele & Fuku, 2011; Moore & Langley, 
2011b). It uses mutant Salmonella bacteria possessing a point mutation that prevents the 
synthesis of the amino acid histidine and so are histidine auxotrophs, indicated by the 
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abbreviation his – (Bauman, 2012). In the Ames test, tester strain bacteria are spread on a 
culture plate that lacks histidine. A mixture of several his –  strains is used so that mutations 
due to both base changes and nucleotide insertions or deletions can be detected. A 
mutagen placed in the culture medium causes some of these his –  bacteria to revert to the 
his + phenotype which is detected by their growth into visible colonies after 2 days at 37°C 
(Voet, Voet & Pratt , 2013). 
 
Different bacterial strains are available to identify different types of mutations. Strain TA98 
gives an indication of frame-shift mutations, while a positive response from strain TA100 
denotes base-pair substitution (Mashele & Fuku, 2011). The strain TA100 was the one 
employed in this study. The Ames test was carried out in order to determine possible 
mutations caused by extracts from study plants namely, Geranium incanum, Pelargonium 
hortorum, Tecoma capensis and Cassia abbreviata. A positive response in any single 
bacterial strain either with or without metabolic activation is sufficient to designate a 
substance as a mutagen (Mashele & Fuku, 2011; Bauman, 2012). The advantages of the 
Ames test as noted earlier on, are that the test is simple, rapid, inexpensive and exquisitely 
sensitve. It can detect some chemicals as mutagenic in amounts as small as 10-9 g and a 
condensate of as little as 1/100 of cigarette can be shown to be mutagenic with the test. 
The test is also highly quantitative  (Hartl & Jones, 2009; Liu, Jin, Cheng, Zhang & Gao, 
2009). 
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CHAPTER 4 
MATERIALS AND METHODS 
 
This chapter is concerned principally with the performance of the materials and methods 
used in the determination of antimicrobial activity of Geranium incanum, Pelargonium 
hortorum, Tecoma capensis and Cassia abbreviata. The performances of the agar dilution 
method employing the Mast multipoint inoculators, the agar disc diffusion method, the 
minimum inhibitory concentration procedure using microtitre plates, qualitative 
phytochemical screening, thin-layer chromatography and the Ames test are discussed. In 
addition, the traditional methods of extraction as well as bacterial and fungal isolation are 
reviewed. 
 
4.1 BACTERIAL AND FUNGAL ISOLATION 
 
The bacteria and fungi used in this study are clinical isolates known to cause pneumonia 
and were obtained from the National Health Laboratory Services (NHLS) and from the 
department of Biomedical Technology and Radiography at the Nelson Mandela 
Metropolitan University in Port Elizabeth. A total of 41 microorganisms were screened. This 
included four strains of Methicillin Resistant Staphylococcus aureus, six strains of 
Staphylococcus aureus, three strains of Streptococcus pneumoniae, three strains of 
Haemophilus influenzae, five strains of Pseudomonas aeruginosa, five strains of Klebsiella 
pneumoniae, two strains of Acinetobacter baumannii, nine strains of Escherichia coli, and 
four strains of Candida albicans. The bacteria used were composed of both Gram-positive 
and Gram-negative bacteria. Table 4.1 summarises the differences between Gram-positive 
and Gram-negative bacteria. 
 
The following American Type Culture Collection (ATCC) of S. aureus 43300, E. coli 38218, E. 
coli 25218, P. aeruginosa 27853, and C. albicans 66027 were used as reference strains in 
this study. 
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  Table 4.1: Distinctions between Gram-positive and Gram-negative bacteria 
Characteristics Gram-positive Gram-negative 
1. Cell wall structure  Smooth and single 
layered 
 20-80 nm thick 
 Outer membrane is 
absent 
 Wavy and double 
layered 
 8-12 nm thick 
 Outer membrane is 
present 
2. Chemical composition 
 Aromatic amino acids, 
arginine protein 
 Peptidoglycan  
 
 
 Teichoic acid 
 Mesosomes 
 Solubility in 1%KOH 
 Susceptibility to 
penicillin 
 
 Absent 
 
 80% of cell wall 
 
 
 Present 
 Quite prominent 
 Negative 
 High 
 
 Present 
 
 3-12% of cell wall and is 
mainly composed of 
lipopolysaccharides 
 Absent 
 Less prominent 
 Positive 
 Low 
3. Rigidity of cell wall Very rigid due to high 
proportions of 
peptidoglycans 
Elastic due to plastic 
nature of lipoprotein- 
polysaccharide 
4. Colour at the end of 
the bacterial staining 
Blue-to-purple Pink-to-red 
5. Isoelectric range  pH 2-3 pH 5 
6. Inhibition of growth in 
acid media 
Pronounced Less 
(Compiled from Prescott et al., 2005; Elliott et al., 2007; Parija, 2009; Engelkirk & Duben-      
Engelkirk, 2010; Kumar & Lazarus, 2010; Singh, 2010;  Mukhopadhyay, 2012; Harvey et al., 
2013) 
 
The microorganisms were stored on Microbank beads in a freezer at -20°C. The beads were 
supplied in vials containing 0.5ml cryopreservation fluid and were purchased from Davies 
Diagnostics. To prepare and resuscitate the culture isolates from beads, the beads were 
removed aseptically from their vials and were placed in sterile tubes containing nutrient 
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broth. The tubes were capped, suspension mixed and incubated at 37°C over night. 
Cloudiness of the broth in the tubes indicated growth of the organisms. The microbes were 
then cultured into different agar media using a sterile loop. The following media were used: 
Blood agar obtained from the NHLS was used for the initial subculturing of Gram-positive 
bacteria, Chocolate agar (NHLS) for Haemophilus influenzae, MacConkey agar (Biolab) for 
the Gram-negative bacteria and Sabouraud Dextrose agar (Biolab) for the fungi. Nutrient 
agar was used after the initial sub-culturing for either Gram-positive or Gram-negative 
bacteria. The microorganisms were incubated at 37°C for 24 hours or 48 hours for Candida 
albicans. The bacterial strains were then preserved on nutrient agar plates or Sabouraud 
Dextrose agar plates in the case of Candida at 2°C - 8°C for short-tem storage. In order to 
achieve reproducibility and reliability of the test results in this study, all the tests were 
performed in triplicate.  
 
4.1.1 General culture media preparation 
Blood agar and chocolate agar were supplied ready to use from the NHLS. Nutrient agar 
(Biolab), MacConkey agar (Biolab), Sabouraud Dextrose agar (Biolab), Mueller-Hinton agar 
(Biolab) and Davies Minimum salt agar (SIGMA-ALDRICH) were prepared according to the 
manufacturer’s instructions as shown in Appendix A. Davies Minimum salt agar was 
employed in the present work for the analysis of the Ames test. 
 
4.1.2 Antimicrobial media preparation 
In order to perform the plant antimicrobial assays, 25ml McCartney bottles were employed 
(see, Figure 4.1). Clean, capped and empty McCartney bottles as well as those McCartney 
bottles to which 25ml of Mueller-Hinton agar (MH) or Sabouraud Dextrose agar (SAB) was 
added, were first sterilized by autoclaving (with caps loosened) at 121°C  for 15 minutes 
(Cheesbrough, 2006). After autoclaving, sterile McCartney bottles containing media were 
allowed to cool at about 50°C prior to addition of particular plant extracts. Sterile 
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serological pipettes were used in dispensing the desired measured media into sterile plain 
McCartney bottles. 
 
Figure 4.1: McCartney bottles containing Mueller-Hinton agar 
 
The initial plant extract media concentration for antimicrobial activity employed in this 
study was 20mg/ml. To prepare a 20mg/ml plate, a small required amount of concentrated 
stock crude solution was added to a plain sterile McCartney bottle. This was followed by 
the addition of media (MH or SAB) to bring the volume up to 25ml (Brown & Holme, 2006). 
Then the McCartney bottle was properly capped, well mixed by inversion (five to eight 
times) for a homogenous suspension with subsequent pouring of media into sterile petri 
dishes. The media were then allowed to set at room temperature. The following equation 
was adopted to calculate the new desired concentration of the antimicrobial media: 
 
                                               C1 x V1 = C2 x V2 
 
Where C1 and C2 indicate the initial and final concentrations respectively, and V1 and V2 are 
the initial and final volumes, respectively (Sackheim & Lehman, 1998; Mikulecky, Gilman & 
Brutlag, 2009; Feher, 2012; Marianski & Marianski, 2012). 
 
After solidification, the plates were labelled (e.g., Geranium incanum acetone plate, 
20mg/ml) and dated. The plates were stored at 2°C – 8°C in sealed plastic bags in order to 
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prevent loss of moisture (Cheesbrough, 2006). The surface of the agar was dried for 15 
minutes in an incubator at 37°C prior to inoculation. 
 
4.2 TRADITIONAL METHODS OF DOSAGE PREPARATION 
 
Van Wyk et al. (2009) described the method of dosage preparation as critical because it 
involved the amount of fresh or dry plant material to be used, the addition of suitable 
volumes of solvents such as water or alcohol and additional activities such as boiling for a 
specified period of time, or partial burning to achieve colour. Traditionally, plant extracts 
are prepared with water as maceration, infusions or decoctions (Arrowsmith, 2009; 
Waksmundzka-Hajnos & Sherma, 2011). However, Schneider (2002) argued that decoction 
was a good way to crack the outer protective coating of the plants in a saucepan. The main 
disadvantage of decoctions is that their shelf-life is short (Pole, 2013). In this study, infusion 
preparation was used for G. incanum and T. capensis while decoction preparation was done 
for P. hortorum and C. abbreviata. 
 
4.2.1 Infusion preparation 
The procedure was carried out as illustrated by Schneider (2002), Van Wyk et al. (2009) and 
Wong (2009): 
   6g of fresh leaves was placed in a glass beaker. 
   100ml of freshly boiled water was added to the beaker. 
   The beaker was left to stand covered until the water developed colour. 
   The infusion was used within 12 hours of its preparation. 
 
4.2.2 Decoction preparation  
According to Wong (2009) and Pole (2013), roots, fruits, barks and woody parts of the plant 
need to be left to simmer in order to extract the essential ingredients, a process called 
decoction. Hence the stem bark of C. abbreviata and tuberous roots of P. hortorum could 
be better traditionally extracted by using a decoction procedure. Van Wyk et al. (2009) and 
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Saraswathi et al. (2011) indicated that the fleshy root stock of Pelargonium species is boiled 
in milk for treatment. In this study, the leaves of P. hortorum were boiled in milk for a few 
minutes before use. The following procedure adapted from Schneider (2002), Arrowsmith 
(2009) and Wong (2009) was used: 
 
     Plant material immersed in boiling milk 
                                     
     P. hortorum decoction preparation                                     C. abbreviata decoction preparation 
Figure 4.2: Decoction preparation of the plant material 
                               
   6g of fresh leaves (P. hortorum) or dried powdered stem bark (C. abbreviata) were 
placed in a glass beaker. 
   100ml of milk or distilled water was added to the beaker 
   This was placed over a Bunsen burner and allowed to boil for 10-15 minutes, then left 
to simmer for 10 minutes. 
   The decoction was left to cool before use. 
 
4.3 PLANT EXTRACTION PROCEDURE AND ASSAYS 
 
The extraction procedure is a process involving separation of medicinally active fractions of 
plant tissues from inactive/inert compounds by using selective solvents and extraction 
technology. The quality of the plant extract depends on plant material, choice of solvents 
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and the extraction procedure employed (Raaman, 2006; Das et al., 2010). Appendix B 
exhibits the schematic diagram of the extraction methods used in the preparation of the 
plant material employed in this study.  
 
The following procedure adopted from Ellof (2000), Kambizi and Afolayan (2001), Pallant 
and Steenkamp (2008) and Iwalewa et al. (2009) was performed: 
 
Day 1: 
   3g of powdered plant material was weighed and dispensed into a 50ml screw cap 
polyethylene tube. 
   30ml of the solvent was added to the tube, which was tightly closed and vigorously 
shaken for 5 minutes using a vortex in order to provide room for plant-solvent 
interaction. 
 
 
                          Figure 4.3: Screw cap tubes containing solvents and plant material 
 
   The tubes were centrifuged at 4000rpm for 5 minutes. This was done to separate the 
liquid phase from the solid phase of the mixture. 
   The supernatant was removed with a pasteur pipette, filtered with a Whatman 
number 1 filter paper (Figure 4.4) as it was being placed in a labelled sterile, pre-
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weighed glass beaker. This was important in order to remove any particular insoluble 
residues in the extracted liquid. 
   In order to exhaustively extract the plant material, each tube was re-extracted twice 
and the three supernatants were combined. This was performed for each of the 
three solvents (methanol, aqueous, acetone). 
   The methanol and acetone extracts were placed in the fume cupboard at room 
temperature and the aqueous extracts were placed in a water bath at 40°C in the 
fume cupboard overnight or for up to two days, to ensure complete evaporation of 
the solvents. 
 
supernatant 
                                                                                                      Whatman number 1 filter paper 
       extracted liquid 
      Figure 4.4: Pre-weighed beaker containing the extracted liquid 
 
Day 2: 
   The dried beakers were re-weighed and the weight of the extracts were calculated. 
   The calculated extracts were re-dissolved in pure Dimethyl Sulphoxide (DMSO) and a 
less than 5% solution with sterile, distilled water was prepared. DMSO, at a 
concentration of less than 5%, re-dissolved the extracts adequately and did not affect 
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the growth of bacteria and fungi, hence there was not any effect on the test results 
(Pallant & Steenkamp, 2008). 
   Plant extract concentrations were then standardized between the different plants 
and solvents utilized for extraction.  
 
4.3.1 The antibiotic disc sensitivity assay 
This method was employed to determine the susceptibility of study organisms to standard 
antibiotics. The principle of this assay is dependent upon the inhibition of reproduction of a 
micrco-organism on the surface of a solid medium by an antimicrobial agent which diffuses 
into the medium from a filter paper disc  (Cheesbrough, 2006). Thus, the organism’s growth 
(resistance to the drug) or lack of growth (sensitivity to the drug) is monitored (Harvey et 
al., 2007). Table 4.2  below indicates the antibiotics tested in this study and their potency. 
 
    Table 4.2: Antibiotics and their disc identifier 
Number Antibiotic and disc identifier Disc content 
1 Ciprofloxacin (CIP5) 5µg 
2 Gentamicin (GM10) 10µg 
3 Cephalexin (CFX30) 30µg 
4 Ampicillin (AP10) 10ug 
5 Penicillin G (PG10) 10 units 
6 Amoxycillin (A10) 10µg 
7 Streptomycin (S10C) 10µg 
8 Erythromycin (E5) 5µg 
9 Chloramphenicol (C) 30µg 
ANTIFUNGAL 
10 Amphoterecin B (AMB20) 20µg 
11 Nystatin (NY100) 100 units 
 
 
The antibiotic susceptibility testing for nine antibiotics (Ampicillin, AP, 10µg; Amoxycillin, A, 
10µg; Cephalexin, CFX, 30µg; Chloramphenicol, C, 30µg; Ciprofloxacin, CIP, 5µg; 
Erythromycin, E, 5µg; Gentamicin, GM, 10µg; Penicillin G, PG, 10 units; and Streptomycin, S, 
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10µg) and two antifungal (Amphoterecin, AMB, 20µg; and Nystatin, NY, 100 units) from 
Mast Diagnostics UK, was conducted according to the approved method of the modified 
Kirby-Bauer disc diffusion technique as stated by the Clinical and Laboratory Standards 
Institute guidelines (CLSI) [M100-S17] (2007).  All tests were done in triplicate. 
 
Kirby-Bauer CLSI modified disc diffusion technique adopted from Cheesbrough (2006); 
Patient Safety Monitoring and International Laboratory Evaluation (pSMILE) (2006); 
Selvamohan et al. (2010); Han, Sheng and Xu (2012);  Onanuga and Awhowho (2012); Jindal 
et al. (2012); Tadesse et al. (2012); Ziglam et al. (2012) and Linhares, Raposo, Rodrigues and 
Almeida (2013) was carried out as illustrated below: 
 
Agar plates and discs handling: 
   Antibiotic discs and the following agar plates were brought to room temperature 
before use. 
1. Mueller-Hinton agar was used for nonfastidious bacteria namely, 
Staphylococcus aureus, Pseudomonas aeruginosa, Klebsiella pneumoniae, 
Acinetobacter baumannii and Escherichia coli. 
2. Blood agar was used for Streptococcus pneumoniae. 
3. Chocolate agar was used for Haemophilus influenzae. 
4. Sabouraud dextrose agar was used for Candida albicans. 
 
Inoculum preparation, plating procedure and disc application: 
   3-5 well isolated appropriate colonies from an 18 – 24 hour agar plate, were 
suspended in 5ml sterile physiological saline in a sterile test tube using a sterile wire 
loop. 
   The turbidity of the bacterial and fungal suspension was adjusted and visually 
compared to a 0.5 McFarland turbidity standard. This was to ensure that the 
suspension contained approximately 1 to 2 x 108 CFU/ml. 
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    Agar plates were inoculated using a sterile swab within 15 minutes after adjusting 
the turbidity of the inoculum suspension. In order to remove excess inoculum, the 
swab was pressed and rotated against the side of the tube above the level of the 
suspension prior to inoculation. 
   The entire surface of the agar was swabed in three directions by rotating the plate 
approximately 60 degrees between streaking in order to ensure even distribution of 
inoculum. The rim of the agar was then swabbed as a final step. 
   The inoculated plate was allowed to stand for at least 3 minutes but no longer than 
15 minutes before applying antimicrobial discs. 
 
 
              Figure 4.5: Inoculation of the plate 
 
   Using a sterile forceps, appropriate antimicrobial discs were evenly placed on agar 
surface so that they were no closer than 24mm from centre to centre. Since 90mm 
petri dishes were used in this procedure, no more than six discs were applied to each 
plate at a time to avoid overlapping of zones. Each disc was gently pressed down 
with a sterile forceps to ensure its complete, level contact with the agar. Once placed 
on the agar plate, the discs were not relocated since some of the antibiotic diffuses 
almost instantaneously. 
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              Figure 4.6: Tapping discs to ensure complete contact with the agar 
 
   Within 15 – 30 minutes of disc application, plates were inverted and incubated at 
35°C for 16 – 18 hours. Mueller-Hinton agar plates for nonfastidious microorganisms 
and Sabouraud Dextrose agar plates for Candida albicans were incubated aerobically. 
Blood agar plates for Streptococcus pneumoniae and chocolate agar plates for 
Haemophilus influenzae were incubated in a glass jar containing 5% carbon dioxide 
(CO2). The CO2 was induced in a glass jar either by using a lighted candle or applying 
AnaeroPack-CO2 sachet (Davis Diagnostics). 
 
 
              Figure 4.7: Air tight glass jar with a lighted candle for CO2 induction 
111 
 
   After 18 hours of incubation, the plates were examined while making sure that the 
growth was confluent. A ruler was used on the underside of the plate to measure the 
diameter of each zone of inhibition in mm. The endpoint of inhibition is where 
growth starts. 
   Following the CLSI (2007) guidelines (Table 4.3) for interpretation of inhibition zone 
ranges, results were reported as susceptible, intermediate, or resistant to the 
agents tested in this study. 
   The zones of inhibition diameters of each antibiotic were also obtained for the 
control strains Staphylococcus aureus ATCC 43300, Streptococcus pneumoniae ATCC 
49619, Escherichia coli ATCC 38218, Escherichia coli ATCC 25218, Pseudomonas 
aeruginosa ATCC 27853 and Candida albicans ATCC 66027 to ensure the method was 
being performed correctly. Table 4.4 indicates acceptable limits for some of the 
Quality Control strains used in this study to ensure accuracy of disc diffusion testing. 
 
  Table 4.3: Kirby-Bauer technique: Interpretative chart of zone sizes 
Antimicrobial Class 
 
Antimicrobial Agent Disc 
Potency 
Zone Diameter, 
Nearest whole mm 
Interprative standards 
S I R 
Beta-lactams                   Ampicillin when testing: 
 Gram-negative organisms 
 Haemophilus spp. 
 Staphylococcus spp. 
 Enterococcus spp. 
 
10 µg 
10 µg 
10 µg 
10 µg 
 
≥ 17 
≥ 22 
≥ 29 
≥ 17 
 
14 – 16 
19 – 21 
_ 
_ 
 
≤ 13 
≤ 18 
≤ 28 
≤ 16 
Amoxycillin when testing: 
 Enterobacteriaceae 
 Haemophilus & 
Staphylococcus spp. 
 
10 µg 
10 µg 
 
≥ 18 
≥ 20 
 
14 – 17 
_ 
 
≤ 13 
≤ 19 
Penicillin when testing: 
 Staphylococcus spp. 
 Streptococcus 
pneumoniae 
 Streptococcus spp. 
 
10 units 
1µg oxac. 
 
10 units 
 
≥ 29 
≥ 20 
 
≥ 24 
 
_ 
_ 
 
_ 
 
≤ 28 
_ 
 
_ 
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 Haemophilus spp. 
 Enterococcus spp. 
10 units 
10 units 
≥ 47 
≥ 15 
27 – 46 
_ 
≤ 26 
≤ 14 
Cephalexin when testing: 
 Staphylococcus spp. 
 
30 µg 
 
≥ 18 
 
15 – 17 
 
≤ 14 
Macrolides Erythromycin when testing: 
 Streptococcus spp. 
 Enterococcus spp. 
 
15 µg 
15 µg 
 
≥ 21 
≥ 23 
 
16 – 20 
14 - 22 
 
≤ 15 
≤ 13 
Aminoglycosides Gentamicin when testing: 
 Staphylococcus spp. 
 
10 µg 
 
≥ 15 
 
13 – 14 
 
≤ 12 
Streptomycin when testing: 
 Gram-negative organisms 
 
10 µg 
 
≥ 15 
 
12 – 14 
 
≤ 11 
Phenicols Chloramphenicol when testing: 
 Gram-negative enteric 
bacilli 
 Haemophilus spp. 
 Streptococcus spp. 
 Streptococcus 
pneumoniae 
 
30 µg 
 
30 µg 
30 µg 
30 µg 
 
≥ 18 
 
≥ 29 
≥ 21 
≥ 21 
 
13 – 17 
 
26 – 28 
18 – 20 
_ 
 
≤ 12 
 
≤ 25 
≤ 17 
≤ 20 
Fluoroquinolones Ciprofloxacin when testing: 
 Gram-negative enteric 
bacilli 
 Staphylococcus spp. 
 Haemophilus spp. 
 
5 µg 
 
5 µg 
5 µg 
 
≥ 21 
 
≥ 21 
≥ 21 
 
16 – 20 
 
16 – 20 
_ 
 
≤ 15 
 
≤ 15 
_ 
Antifungal Disc Susceptibility Testing 
 Zone Diameter in mm 
Class Antifungal agent Disc 
potency 
Code S I R 
Polyene 
 
Amphotericin B 20µg AMB 20 ≥ 15 10 – 14 ≤ 10 
Nystatin 100 units NY100 ≥ 15 10 – 14 None  
 
   Key: R: Resistant;  I: Intermediate resistance;  S: Susceptibility; Oxac.: Oxacillin; None: No zone 
   (Compiled from Cheesbrough, 2006; CLSI, 2007;  ROSCO Diagnostica, 2011) 
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Table 4.4: Susceptibility interpretation table for Quality Control strains showing expected 
zone diameter 
Antimicrobial 
Agent 
Disc 
Potency 
E. coli 
ATCC 35218 
P. aeruginosa 
ATCC 27853 
S. pneumoniae 
ATCC 49619 
Zone Diameter Zone Diameter Zone Diameter 
Ampicillin 10µg 6 _ 30 – 36 
Cephalexin 30µg _ _ 26 – 32 
Chloramphenicol 30µg _ _ 23 – 27 
Ciprofloxacin 5µg _ 25 – 33 _ 
Erythromycin 15µg _ _ 25 – 30 
Gentamicin 10µg _ 16 – 21 _ 
Penicillin 10 units _ _ 24 – 30 
Streptomycin 10µg _ _ _ 
     (Compiled from CLSI, 2007) 
 
4.3.2 Plant antimicrobial activity determination using the disc diffusion assay  
The antimicrobial activity of each crude extract against Streptococcus pneumoniae and 
Haemophilus influenzae strains were investigated by disc diffusion method. The procedure 
illustrated by Morteza-Semnani, Saeedi, Mahdavi and Rahimi (2006); Duraipandiyan and 
Ignacimuthu (2009); Gangoue-Pieboji et al. (2009); Zaouia et al. (2010); Sadeghian et al. 
(2012); Sharma et al. (2012) and Sunita et al. (2012) was carried out in the following 
manner:  
 
Standard size Whatman filter paper discs (6mm in diameter) were firstly sterilized in an 
autoclave at 121°C for 15 minutes. The bacterial strains of S. pneumoniae and H. influenzae 
were grown on Blood agar and Chocolate agar plates respectively in a CO2 environment at 
37°C for 24 hours. The 24 hour test culture suspension of S. pneumoniae and H. influenzae, 
adjusted to 0.5 McFarland turbidity standard, was swabbed on respective solidified media 
and allowed to dry for 10 minutes. The screening tests were conducted at an initial 
concentration of 40mg/ml of each crude extract. In order to reach the desired 
concentration, 0.16g of each crude extract was suspended in 4000µl of sterile water. Sterile 
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filter paper discs (6mm in diameter) placed on the pre-inoculated agar surface were 
impregnated with 50µl of 40mg/ml plant extract concentration. Sterile distilled water was 
used as a negative control while penicillin (10 units) for S. pneumoniae and ciprofloxacin 
(5µg) for H. influenzae were utilized as positive controls (Kumar et al., 2012; Luciano-
Montalvo, Boulogne & Gavillan-Suarez, 2013). The plates remained for one hour at room 
temperature for compound diffusion across the agar surface prior to incubation at 37°C for 
24 hours. All tests were repeated twice and the antimicrobial activity was expressed as the 
mean of inhibition diameters (mm) produced by the plant extracts.  
 
4.3.3 Mast multi-point agar dilution method 
Antimicrobial assay of nonfastidious bacteria and Candida was performed using the Mast 
multi-point inoculator. The antimicrobial screening of bacteria was done on Mueller-Hinton 
agar (MH) while that of Candida was done on Sabouraud dextrose agar (SAB). Cheesbrough 
(2006) and CLSI (2007) recommend MH as a medium for sensitivity testing. The plates with 
diffrent extracts were all prepared at an initial concentration of 20mg/ml.  A standardized 
inoculum was prepared by emulsifying colonies in 5ml normal sterile saline and was 
adjusted to a density of 0.5 McFarland units, which is equivalent to 106 – 108 CFU/ml 
(Mendez-Vilas, 2011; Luciano-Montalvo et al., 2013).  
 
The bacterial or Candidal suspensions were transferred into the sterile multi-point 
inoculator buckets possessing 36 wells. 1000µl of prepared inoculums were thus dispensed 
into each well of the sterile inoculum buckets. Aseptic measures were employed in the 
transferring of the microbial suspensions in order to prevent cross-contamination of the 
wells. From the wells, 36 sterile inoculating pins embedded on the head of a Mast multi-
point inoculator were used to transfer inoculums to the media. The multi-point inoculator 
can pick and transfer about 3µl of each of the 36 samples simultaneously. Following 
inoculation, the plates were incubated at 37°C for 24 hours for bacteria and for 48 hours for 
Candida albicans. 
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                              Head embedded with 36 inoculating pins 
                                  
                                                                                           A 36 well bucket, each contaning 
                                                                                          1000 µl of a specific inoculum 
 
Figure 4.8: Mast Multi-point inoculator 
  
Control plates were also included where the highest and the lowest DMSO volumes that 
were used in the dissolving of plant extraction were mixed with Mueller-Hinton agar. Two 
pure Mueller-Hinton agar plates were also utilized as controls before and after inoculation 
of the plates containing plant extract. This was to make sure that no growth was affected by 
the DMSO contained in plates having extracts. On the other hand, it was to ensure that the 
Mast Multi-point Inoculator dispensed the appropriate volumes of inoculums onto plates 
throughout the inoculation process. The other control plate was a sterile Blood agar plate 
which was hired for purity checks. Purity plates were included in order to ascetain that 
purity growth of each organism was achieved and that there was no cross-contamination 
between the wells. Extracts were also checked for contamination by plating them on sterile 
MH plates (see Figure 5.6, plate f). 
 
The plates were read after incubation time (24 hours for bacteria and 48 hours for C. 
albicans) in comparison to the purity plate and also to the two pure Mueller-Hinton agar 
plates. For C. albicans, it was compared to the two pure Sabouraud dextrose agar plates.  
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If there was no visible growth on control plates (pure BA plate, pure MH plates, pure SAB 
plates) for a particular organism, or contamination of a certain organism encountered, such 
a test was repeated. The criterion used in reading plates was to consider the organism 
inhibited or not inhibited. The orgainism was read inhibited if there was no growth 
observed on the plate incorporated with plant extract and there is growth on the control 
plates. Simultaneously, the organism was interpreted not inhibited when there was visible 
growth on both the control plates and the plate containing plant extract. Slight inhibitions 
were also observed by comparing the colony sizes on the extract containing plate with that 
of controls. All tests were performed in triplicate. 
 
The major limitation of using the multi-point inoculator is its all or nothing results, which 
masks the different degrees of bacterial susceptibility (Mohlakoana, 2010).   
 
4.3.4 Determination of minimum inhibitory concentration 
The MIC of the extracts for the following strains of bacteria: Streptococcus pneumoniae and 
Haemophilus influenzae, was determined by agar disc diffusion method. The microtitre 
plate assay was used to determine the MIC of the following strains of bacteria: 
Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, 
and Acinetobacter baumannii. Microtitre plate assay was performed only on those extracts 
that showed inhibition in the agar dilution screening procedure as demonstrated by Kaur 
and Arora (2009). On the other hand, the agar dilution assay was  employed to determine 
the MIC for Candida albicans’ strains.  
 
4.3.4.1 Microtitre plate determination of the MIC of the plants 
MIC was determined for the extracts of G. incanum, C. abbreviata, P. hortorum and T. 
capensis only on those organisms that showed inhibition during the agar dilution bioassay. 
The MIC was performed using the 96-well microtitre plate (Figure 4.9). 
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Figure 4.9: An example of the microtitre plate layout used during the MIC assay 
 
The plate was divided into four sections; each section was comprised of three colums. The 
sections were categorised as follows: Aqueous (1-3 colums), Methanol (4-6 colums), 
Acetone (7-9 colums), and Quality Control (10-12 colums). Each section contained three  
microwells in rows ranging from A to H. Table 4.5 demostrates the microtitre plate layout 
used for MIC determination of the study plants. 
 
The MIC procedure was carried out on the studied bacteria using the rapid INT (p-
iodonitrotetrazolium-chloride, Sigma) colorimetric assay with some modifications as 
previously described by Ellof (2000); Iwalewa et al. (2009); Selvamohan et al. (2010); 
Mouokeu et al., (2011); Duraipandiyan, Al-Harbi, Ignacimuthu and Muthukumar (2012); 
Voukeng, Kuete, Dzoyem, Fankam, Noumedem, Kuiate & Pages (2012); Bothon, Debiton, 
Avlessi, Forestier, Teulade  & Sohounhloue, (2013); Guilherme da Cunha et al., (2013); 
Luciano-Montalvo et al. (2013) and Noumedem et al. (2013). In this procedure, an 
overnight bacterial culture grown in nutrient broth, diluted with fresh broth, was used for 
the assay. 
  
Stock solutions of lyophilized aqueous, methanol, and acetone extracts was diluted with 
sterile distilled water plus <5% DMSO to obtain working solution. Thus, the initial 
concentration of the extract for an MIC was either 10mg/ml or 20mg/ml depending on the 
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screening results. MIC was then performed in 96-well microtitre plates using nutrient broth 
medium in the following manner:  
 
     Table 4.5: Microtitre plate layout 
Extract 
e.g., T. 
capensis 
AQUEOUS METHANOL ACETONE                    QC 
1 2 3 4 5 6 7 8 9 10 11 12 
A Neat preparation: 100µl extract + 100µl bacterial 
suspension 
Water 
200µl 
Water 
200µl 
Water 
200µl 
B 1: 2 dilution NB NB NB 
C 1:4 dilution Bact. Bact. Bact. 
D 1:8 dilution DMSO 
+ Bact. 
DMSO 
+ Bact. 
DMSO 
+ Bact. 
E 1:16 dilution AQ. 
Extract 
AQ. 
Extract 
AQ. 
Extract 
F 1:32 dilution Meth. 
Extract 
Meth. 
Extract 
Meth. 
Extract 
G 1: 64 dilution Aceto. 
Extract 
Aceto. 
Extract 
Aceto. 
Extract 
H 1: 128 dilution Blank Blank Blank 
Key: NB: Nutrient broth; Bact.: Bacterial suspension; AQ.: Aqueous; Meth.: Methanol;          
Aceto.: Acetone; QC: Quality control 
 
   100µl of sterile distilled water was added to each well in rows A to H, columns 1 to 9, 
which are sections for aqueous, methanol and acetone extracts of a particular plant. 
One microtitre plate was used only for a single plant and a single bacterial strain. 
   100µl aliquot from stock solutions (i.e., 10mg/ml) of aqueous, methanol and acetone 
extracts was added into the first wells (row A: columns 1-3; 4-6; and 7-9; 
representing aqueous, methanol and acetone respectively). This was then mixed 
thoroughly using a multi-channel micropipette. 
   Then, the test concentration in the first wells (row A) was serially diluted two-fold in a 
96 well plate by transferring 100µl into seven consecutive wells (i.e., from row A to 
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row B, then from row B to row C, and so forth until row H). The remaining 100ul in 
row H was then discarded. The contents were mixed thoroughly during the 
transferring process using a multi-channel micropipette. 
  100µl of suspension containing 106-108 CFU/ml of bacteria was added to each well in 
columns 1 to 9 and rows A to H. 
  For the controls: A10 – A12 wells were for water control (200µl distilled water), B10 – 
B12 wells contained nutrient broth control (100µl distilled water + 100µl nutrient 
broth), C10 – C12 contained the bacterium control (100µl distilled water + 100µl 
bacterial suspension), D10 – D12 was the DMSO bacterium control (100µl distilled 
water + 100µl bacterial suspension + 7µl DMSO), E10 – E12 was the aqueous extract 
control (100µl nutrient broth + 100µl aqueous extract), F10 – F12 was the methanol 
extract control (100µl nutrient broth + 100µl methanol extract), and G10 – G12 was 
the acetone control (100µl nutrient broth + 100µl acetone extract). Nothing was 
added to the wells H10 – H12. 
  The final volume in each well was 200µl. The microtitre plates were sealed with 
parafilm, placed in a moist container and incubated overnight (18-24hrs) at 37°C. The 
following day, the turbidity at 550nm was determined using the microtitre plate 
reader. Figure 4.10 displays a micrtotitre plate on the ELISA microplate reader before 
addition of p-iodonitrotetrazolium-chloride (INT). 
 50µl of 0.2mg/ml INT dissolved in water was added to each well. Microplates were 
incubated at 37°C  for 30 -120 minutes. Figure 4.11 is a photograph of an INT vial.  
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Microtitre plate on the ELISA reader prior to INT initiation 
 
Figure 4.10: ELX 800 Universal Microtitre Plate Reader for  
               detecting absorbency of plates at 550 nm 
 
 
             Figure 4.11: p-iodonitrotetrazolium chloride, Sigma vial (INT) 
 
    After 30 minutes INT incubation, a reading was taken at 55nm. The bacterial growth 
was indicated by the red colour of the INT reduced to formazan. The percentage 
growth was determined by means of the following formula: 
   (INT 30 minute reading – initial turbidity reading / DMSO bacterium control) x 100 
121 
 
           
                  
a)  Plate before INT addition                        (b) Plate after INT addition. Pink / red 
                                                                                 colour indicates bacterial growth                                                                       
            Figure 4.12: Microtitre plate before and after INT reading 
 
   The percentage inhibition was deduced by subtracting the percentage growth from 
100. Each test was repeated twice to ensure accuracy and precision of the test 
results. The average of the three runs was used as the final result. 
 
4.3.4.2 Calculation of the MIC 
The MIC of each extract in this study, was defined as the lowest concentration that 
inhibited the growth of a particular bacteria after incubation at 37°C between 18 and 24 
hours (Marzouk, Marzouk, Mastouri, Fenina & Aouni, 2011). The lowest concentration at 
which a decrease in the red or pink colour is apparent compared to the next dilution or at 
which the sample concentration prevented the colour change of the medium is considered 
as the MIC value (Ellof, 2000; Heyman et al., 2009; Voukeng et al., 2012). The amount of 
growth in the wells containing the extracts was compared to the amount of growth in the 
growth control wells (DMSO control and bacterium control) used in each set of tests. For a 
test to be valid, acceptable growth in bacterium control well was to be ≥ 100% as compared 
to that of the DMSO bacterium control. There should be no turbidity nor growth in the 
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water and nutrient broth control wells. This was to ensure that there was neither 
contamination with the water nor broth medium used during MIC preparation. The 
procedure to calculate MIC as described by Eloff (1998b) and Wilson (2004) was employed 
in this study. 
Firstly, initial concentration of the plant material was prepared by dissolving the dried plant 
extract in <5% DMSO concentration to achieve the desired concentration of either 
10mg/ml or 20mg/ml. The addition of the 100µl bacterial suspension and 50µl INT to the 
extract, diluted this concentration further in the ratio 1:1:0.5. If 10mg/ml was the initial 
strength of the extract in the wells, the addition of bacterial suspension and INT would 
result in a concentration of 4.0mg/ml (1/2.5 x 10mg/ml). 
Secondly, in order to deduce the MIC in a particular well, the MIC was calculated in the 
following manner: 
                                  MIC = dilution factor  x  initial concentration 
For example, if the MIC occured at the 1:8 dilution well, then the resulting MIC would be 
(1/8) x 4.0 giving a concentration of 0.5mg/ml. MIC values were thus recorded as the 
lowest concentration of the extract that entirely inhibited bacterial growth. 
  
4.3.4.3 Determination of MIC by agar disc diffusion method 
The agar disc diffusion method was carried out to determine the MICs for three strains of 
Streptococcus pneumoniae (ATCC 49619, 7909 and UF00123106) and Haemophilus 
influenzae (8993636, 8907 and 1893772). This method was employed because S. 
pneumoniae and H. influenzae do not grow on Mueller-Hinton agar without blood 
supplements. These bacteria are termed as fastidious bacteria  (Cheesbrough, 2006). 
The MIC procedure adopted from Duraipandiyan et al. (2012) was conducted at five 
different concentrations of the crude extracts (40mg/ml, 20mg/ml, 10mg/ml, 5mg/ml and 
123 
 
2.5mg/ml) as demonstrated in Figure 4.13. The MIC was therefore determined as smallest 
concentration among the five that would induce a zone of inhibition to the growth of 
bacteria. Zones of inhibition were recorded in millimetres and the experiment was repeated 
twice. The measured inhibition zones were compared with the standard reference 
antibiotics and the activity index for each extract was calculated (Table 5.8) as 
demonstrated by Sharma et al. (2012) and Singaria et al. (2012). 
 
                                             Inhibition Zone of the sample 
   Activity index (AI) =      
                                             Inhibition Zone of the standard 
 
  Schematic plate with MIC discs                                Blood agar plate with discs of variant extract 
  in mg/ml (40, 20, 10, 5, 2.5)                                      strength as shown in schematic diagram                                                                      
                                                                                        
          QC1: Sterile distilled water disc; QC2: PG, 10 units’ disc  
    Figure 4.13: Crude extract discs of different concentrations showing zones of inhibition 
 
                  20 
QC1 
5               40             2.5 
                                 QC 2              
                 10 
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4.3.4.4 Candidal MIC determination 
In this study, four strains of Candida albicans (ATCC 66027, 868102, 1879415 and 1879083) 
were tested. The determination of MIC for C. albicans was performed with some 
modifications as decribed by Gangoue-Pieboji et al. (2009). The minimal inhibitory 
concentrations (MIC) of each active extract (extract which inhibited growth of the majority 
of the tested Candida) were then determined using agar plate dilution method. Each target 
strain of C. albicans was cultured overnight on Sabouraud Dextrose Agar (SAB) and then 
emulsified in sterile physiological saline to give a density of 0.5 McFarland standard. The 
extracts were dissolved in sterile distilled water plus < 5% Dimethyl Sulfoxide (DMSO) as 
explained by Duraipandiyan et al. (2012). Each extract was then serially diluted with sterile 
molten SAB agar to give final concentrations between 5mg and 20mg dried extract/ml. 
 
After properly mixing the agar, it was immediately dispensed into a petri dish. A 3µl 
suspension of 1.5 x 106 CFU/ml of C. albicans adopted from Noumedem et al. (2013) was 
spotted on the solidified cold agar with a micropipette. The inoculated plates were 
incubated at 37°C for 48 hours. At the end of the incubation cycle, the plates were 
evaluated for the presence or absence of Candidal growth. The lowest concentration of an 
extract at which there was no visible growth of C. albicans was considered as the MIC of the 
extract under investigation. 
 
4.4 QUALITATIVE PHYTOCHEMICAL ANALYSIS  
 
In order to establish the profile of a given extract for its chemical composition, there are 
different qualitative chemical tests that can be performed (Raaman, 2006). Qualitative 
assay for the presence of secondary plant metabolites were carried out on aqueous, 
methanol, and acetone extracts of the leaves of Geranium incunum, Pelargonium hortorum, 
Tecoma capensis and the stem bark of Cassia abbreviata. The major secondary metabolites 
constituents such as alkaloids, amino acids, anthraquinones, flavonoids, glycosides, 
phytosterol, saponins, tannins and triterpenoids were therefore determined using adopted 
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standard phytochemical techniques as described by Raaman (2006); Odugbemi (2008a); 
Kalimuthu et al. (2010); Selvamohan et al. (2010); Hussain et al. (2011); Hossain and 
Nagooru (2011);  Kavishankar, Lakshmidevi and Mahadeva (2011); Anowi et al. (2012) and  
Boyer (2012). The qualitative phytochemical analysis of the four study plants were 
determined as follows: 
 
a) Alkaloids (Mayer’s test) 
To 50mg of solvent free plant extract, a few ml (i.e., 5ml) of hydrochloric acid was added. 
The mixture was filtered using Whatmann number 1 filter paper. Then, a drop or two of the 
Mayer’s reagent by the side of the test tube was added. A white or creamy precipitate 
indicates the presence of alkaloids. 
 
Mayer’s reagent was prepared by dissolving 1.358g mercuric chloride into 60ml of distilled 
water. Then 5g of potassium iodide was dissolved in 10ml of distilled water. The two 
solutions were mixed and made up to 100ml with distilled water. 
 
b) Amino acids (Biuret test and Ninhydrin test) 
100mg of extract was dissolved in 10ml of distilled water and filtered through Whatmann 
number 1 filter paper. An aliquot of 2ml of the filtrate was treated with one drop of 2% 
copper sulphate solution. To this, 1ml of 95% ethanol was added, followed by excess pellets 
of potassium hydroxide. Purple colour in the ethanolic layer indicates the presence of 
amino acids. A second test of Ninhydrin was done by adding a few drops of Ninhydrin 
reagent to 1ml of crude, stock extract solution. Similarly, the appearance of purple colour 
indicates the presence of amino acids. 
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                  (purple colour) After addition of Biuret or Ninhydrin reagent 
   Before addition of Biuret or Ninhydrin reagent 
    Figure 4.14: A positive control of Biuret test using an egg white 
 
c) Anthraquinones (Bontrager’s test) 
50mg of extract was macerated with 5ml of ether and the mixture was filtered. Then 2ml of 
the plant extracts were treated with 1ml of dilute ammonia and shaken vigorously. Pink, 
red or violet colour in the ammonical layer indicates the test is positive. 
 
                Positive tube (red colouration)                                             Negative tube 
 
                                      
     Figure 4.15: C. abbreviata extract in a tube showing a positive test for anthraquinones 
 
d) Flavonoids (Alkaline reagent test) 
To 1ml of extract stock solution, a few drops of dilute sodium hydroxide was added. The 
mixture became intense yellow in colour. The formation of an intense yellow colour which 
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turns to colourless upon addition of a few drops of dilute acetic acid indicated the presence 
of flavonoids. 
     Colourless layer 
 
 
 
 
 
         Yellow layer                    
Figure 4.16: Positive tube for flavonoids, T. capensis extract 
 
e) Glycosides (Borntrager’s test) 
50mg of extract was hydrolysed with concentrated hydrochloric acid for two hours. The 
mixuture was filtered with Whatmann number 1 filter paper. Then to 2ml of filtered 
hydrolysate, 3ml of chloroform was added and shaken. The chloroform layer was separated 
and 10% ammonia solution was added to it. Pink colour indicates the presence of 
glycosides. 
 
f) Phytosterol (Libermann-Burchard’s test) 
50mg of extract was dissolved in 2ml acetic anhydride. This was treated with one or two 
drops of concentrated sulphuric acid by adding it slowly along the side of the test tube. An 
array of colour changes showed the presence of phytosterol.  
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  (a)Before addition of concetrated H2SO4         (b) After addition of H2SO4 
   Figure 4.17: G. incanum methanol extract positive for phytosterol 
 
g) Saponins (Foam test) 
50ml of extract was diluted with distilled water in a graduated cylinder and was filled up to 
20ml. The suspension was shaken vigorously for 15 minutes. An equal to 2cm or greater 
(i.e., 5cm) layer of foam indicated the presence of saponins as shown in Figure 4.18. 
                         5cm foam in a tube 
 Foamless tube 
Figure 4.18: A C. abbreviata test tube positive for saponins 
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h) Tannins (Lead acetate test) 
To 50mg of the extract dissolved in distilled water, 3ml of 10% lead acetate solution was 
added. A bulky white precipitate indicated the presence of phenolic compounds and 
tannins. 
                                                            White precipitate 
  no precipitation 
Figure 4.19: Two test tubes of P. hortorum positive for tannins 
 
i) Triterpenoids 
To 5mg of dry, crude plant extract dissolved in 2ml of chloroform, 1ml of concentrated 
sulphuric acid was added. The test tube was shaken well and allowed to stand for some 
time. Appearance of a reddish violet colour indicated the test was positive for triterpenoids. 
 
Figure 4.20: A test tube positive for triterpenoids 
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4.5 THIN LAYER CHROMATOGRAPHY ANALYSIS OF EXTRACTS 
 
Silica thin layer chromatography (TLC) plates (silica gel 60 F254, 25 units, 20cm x 20cm, 
Merck) were used to determine the chemical ingredients of the extracts. The procedure by 
Chinyama (2009), Iwalewa et al. (2009),  Kurian and Sankar (2007) and Reed et al. (2007) 
was applied in this study. TLC plates were developed using two solvent systems of different 
polarities. The solvent system mixtures that were employed are as follows: 
 Ethyl acetate: methanol: water (EMW) / (20:2.7:2) / (polar/neutral) (Iwalewa et al., 
2009). 
 Petroleum ether: ethyl acetate: chloroform: formic acid (PECF) / (8:7:5:1) / 
(intermediate polarity) (Chinyama, 2009). 
A few milligrams of extract material was completely dissolved in a volatile solvent (e.g., 
methanol for methanol extract) creating a dilute solution. Then a spotting capillary (micro 
haematocrit tubes, length = 75mm ± 1.00mm, diameter = 1.55mm ± 0.05mm, non 
heparinized, BRAND) was used to add the sample to the plate. Samples were spotted on a 
TLC plate in a horizontal line about 1 to 2cm from the lower end. The 1 to 2cm line from the 
lower end of a TLC plate is termed as the hash mark or the original sample spot (Liu, 2011). 
A pencil was always used in labeling a TLC plate since it is made up of graphite carbon which 
is inert. 
In order to spot the plate, a capillary tube with the sample was touched to the coated side 
of a TLC plate. The spotting of the plate was done a couple of times to ensure the material 
was present. However, care was taken not to spot too much sample which could result in 
poor separation of the compounds. The plates were then transferred to a glass chamber 
containing solvent systems for development over a distance of 14cm. Care was taken to 
ensure that the level of the solvent was slightly below the level of spots. Airtight lids were 
used for glass chambers to prevent the solvent systems from evaporating. The solvent 
migrated up during development and upon reaching the upper end (80% - 90% of plate’s 
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length), plates were removed from the chambers and allowed to air dry. The separated 
componets were then detected by observation under UV light using BTL UV-lamp as 
recommended by Kurian and Sankar (2007). 
                                                                     A TLC plate in the UV detection device 
 
Figure 4.21: A BTL UV lamp for locating compounds in a chromatogram 
 
4.5.1 Bioautography assay 
After eluting TLC plates spotted with the extracts in EMW and PECF, the plates were 
allowed to air dry for at least two days to ensure adequate removal of the eluting solvents 
(Iwalewa et al., 2009).  
The following bacteria were tested for bioautography: Gram-positive included three strains 
of Staphylococcus aureus (ATCC 43300, 867716 and MRSA 9708) whereas Gram-negative  
included two strains each of Pseudomonas aeruginosa (ATCC 27853 and 891975), 
Acinetobacter baumannii (1940242 and UH2880), Escherichia coli (891230 and 892476) and 
Haemophilus influenzae (8993636 and 1893772). 
A suspension of actively growing cells of bacteria (106 CFU/ml) in Mueller-Hinton broth was 
sprayed on chromatograms and incubated overnight at 37°C in a moist chamber. After 
overnight incubation, the plates were sprayed with a 0.2mg/ml solution of INT as a bacterial 
indicator. Then plates were re-incubated for 30 minutes following the addition of INT. 
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Inhibition of bacterial growth was indicated by white spots or zones on the chromatogram. 
The white spots on the front of the mobile phase were therefore used to determine the Rf 
values. Liu (2011) described the Rf value as an important qualitative parameter in TLC of a 
particular sorbent and solvent system. Rf value was calculated as ratio of distance travelled 
by compound at its point of maximum concentration (i.e., from origin spot to the 
developed spot) to the distance covered by solvent (i.e., from origin spot to the developed 
front) (Kurian & Sankar, 2007; Kaur & Arora, 2009). 
                             Distance travelled by the compound 
             Rf =         Distance travelled by the solvent 
 
4.6 THE AMES TEST 
 
The Ames Salmonella mutagenicity assay is a short-term bacterial reverse mutation 
specifically devised to determine a great deal of chemical compounds that can produce 
genetic damage that leads to gene mutations (Mortelmans & Zeiger, 2000). The Ames test 
is used world wide as an initial screen to detect the mutagenic potential of new chemicals 
and drugs. A positive test indicates that the chemical might act as a carcinogen (Hong, Ju & 
Lyu, 2011b). The four plants, G. incanum, P. hortorum, C. abbreviata and T. capensis were 
tested in order to determine whether they had mutagenicity effects on Salmonella 
typhimurium TA 100 (ATCC 49416) used in the experiment. The S. typhimurium tester strain 
(ATCC 49416) was purchased from Microbiologics. 
The plant extracts in this study were tested at two different concentrations of 2.5mg/ml 
and 5mg/ml. The mutagenicity (Ames) test, without metabolic activation was performed by 
the standard plate incorporation assay as described first by Maron and Ames (1983). On the 
other hand, the ideas incorporated in the procedure with some modifications were in 
accordance with Magesh, Raman and Pudupalayam (2008); Jin, Liu, Zhang, Tian, Cai & Gao 
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(2009); Lupi, Marconi, Paiaro, Fochesato and Gregorio (2009); Reyes, Reyes-Esparza, 
Angeles and Rodriguez-Fragoso (2010); Hong et al. (2011a); Hong et al. (2011b);  
Marczewska, Karwicka, Drozd, Anuszewska, Sliwinska, Nosov & Olszowska (2011) and 
Jadczyk and Kolwzan (2013).  
Prior to the day of testing, S. typhimurium strain TA100 (Microbiologics) was cultured in 
20ml nutrient broth (biolab) for 16 hours at 37°C in a shaking incubator at 210rpm. On the 
day of testing, 500µl of phosphate buffered saline (PBS) was dispensed into sterile test 
tubes. Then the following components were added: 100µl plant extract, 100µl overnight 
broth culture of S. typhimurium strain TA 100 (1 x 108 cells/ml), 2ml TOP agar at 45°C 
containing 200µl 0.5 mM histidine and biotin. The contents of the test tube were mixed and 
within 20 seconds poured over the surface of a Davis Minimal Agar (DMA) plate. The petri 
dishes were incubated for 48 hours at 37°C. After incubation, revertant (mutant) colonies 
were manually counted and compared to the number of colonies formed in unexposed 
cultures. The controls were treated in a similar manner as the samples. The standard 
mutagens used as a positive control without metabolic activation was 4-Nitroquinoline N-
oxide (4NQO) (20µg/ml) while sterile PBS was employed as a solvent (negative) control. In 
order to ensure extract quality and sterility, the different concentrations of the extract 
were exposed to 15 minutes UV-C light in a VIVID AIR Microbiological Safety Cabinet Class 
II. The absence of contaminant growth was further checked by culturing extracts on blood 
agar in the absence of bacteria (Figure 4.22). All samples were tested on duplicate plates, 
and the experiments were repeated thrice. The results for each extract was executed as 
mutagenic index (MI), that is, the average number of revertants per plate divided by the 
average number of revertants per plate in the negative control. 
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Figure 4.22: No growth of bacteria on control BA plates (left) and growth  
of S. typhimurium on BA plate (right) 
 
The S. typhimurium was first confirmed by using an API 10 S assay prior to Ames testing. An 
example of an API 10 S plate before inoculation is shown below in Figure 4.23. An API 10 S 
is a standardized identification system for Enterobacteriaceae and other non-fastidious 
Gram-negative rods, which uses 11 miniaturized biochemical tests and a database 
(Biomerieux, 2006). This is why the test was employed in this study in order to confirm 
Salmonella tester strains. 
 
 
Figure 4.23: An API 10 S strip before inoculation 
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CHAPTER 5 
RESULTS 
 
The current chapter discusses the outcomes of the assays performed in this study. The 
study was undertaken to determine whether traditional medicinal plants used to treat 
pneumonic infections have any significant antibacterial and anticandidal effects.  
 
5.1 ANTIMICROBIAL SCREENING ASSAY RESULTS 
 
Four medicinal plants used to treat pneumonia in the Eastern Cape were selected for this 
study, namely Geranium incanum, Tecoma capensis, Pelargonium hortorum and Cassia 
abbreviata (Table 3.1). The antimicrobial activity of the four study plants were determined 
by using various solvent extracts as well as infusions and decoctions. The agar dilution 
method and the agar disc diffusion method were used in the antimicrobial screening 
procedure of the plant extracts. The extracts were screened against 13 Gram-positive 
bacterial strains, 24 Gram-negative bacterial strains and four fungal strains. The Gram-
positive bacteria comprised of strains from Staphylococcus aureus and Streptococcus 
pneumoniae. The Gram-negative bacteria included strains from Klebsiella pneumoniae, 
Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Haemophilus 
influenzae. The only fungal species tested were strains of Candida albicans. The 
antimicrobial screening assays were performed in triplicate on a total of 41 microbial 
strains. Infusions and decoctions were carried out in order to represent the traditional way 
of preparing medicine. Methanol, distilled water and acetone were solvents that were used 
in extracting powdered leaves and a stem bark. 
 
5.1.1 Agar dilution assay results 
In agar dilution assay, the antimicrobial screening was carried out at a concentration of 
20mg/ml. An extract is considered as possessing antimicrobial activity with a particular 
solvent if it inhibits a specific microorganism in triplicate runs performed at 20mg/ml 
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concentration. All of the four plants exhibited notable activity against bacteria. P. hortorum, 
C. abbreviata and G. incanum showed some activity against Candida at 20mg/ml. The 
results of agar dilution screening assay which were based on visible growth and no growth 
of microorganisms are reported in Table 5.1. Some of the results from extracts are also 
demonstrated on plates as shown in Figures 5.1 to 5.8. 
  
                N                             Pelargonium acetone plate                   control plate 
  
 
Plate layout for C. albicans strains            
Key: A= ATCC 66027 B= 868102 C= 1879083 D= 1879415 
 
Figure 5.1: SAB plate containing Pelargonium hortorum acetone extract showing  
slight inhibition of C. albicans strains 
 
In Figure 5.1, the plate on the left is showing slight inhibition by Pelargonium hortorum 
acetone extract on Candida albicans strains (868102 and 1879083) as compared to the 
control plate on the right. Strains ATCC66027 and 1879415 were not inhibited by the P. 
hortorum acetone extract at 20mg/ml concentration. 
 
               A 
 B                         C 
             D 
 
 
 
 
 
 
 
               DDD 
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In Figure 5.2 below P. hortorum methanol plate on the left showed notable inhibition of 
growth for C. albicans strains (ATCC66027, 1879083 and 868102) except for strain 1879415 
which depicted slight inhibition as compared to the control plate on the right. 
 
                          
Figure 5.2: P. hortorum methanol SAB plate (left) showing Candida inhibition 
 
According to Figure 5.1 and Figure 5.2, C. albicans strain number 1879415 showed 
persistent resistance to both acetone and methanol extracts of P. hortorum plant. Aqueous 
extract of P. hortorum did not inhibit any of the Candida strains tested in this study. 
Similarly, the traditional preparation of P. hortorum did not inhibit any of the selected C. 
albicans stains. The results indicated that P. hortorum methanol extract exhibited more 
potency to C. albicans strains than acetone extract at 20mg/lm concentration. 
 
On the other hand, C. albicans strain number 1879415 on P. hortorum methanol plate in 
Figure 5.1 (SAB plate left) showed some stunted growth. The diameter of the colony is 
smaller than that of the control on the right. This implies that increasing the concentration 
above 20mg/ml would probably result in P. hortorum methanol extract subsequently 
inhibiting the organism. 
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                    a                                                        b                                                    c 
 (T. capensis acetone extract)   (T. capensis methanol extract)  (T. capensis traditional         
preparation) 
 
           
                  d                                                          e                                                       f 
(T. capensis aqueous extract)     (QC before inoculation)          (QC after inoculation) 
 
Figure 5.3: SAB plates of T. capensis extracts showing no inhibition of C. albicans strains 
 
The results in Figure 5.3 above reveal that strains of C. albicans (ATCC 66027, 1879415, 
868102 and 1879083) were not inhibited by T. capensis extracts at 20mg/ml as shown in 
the plates from a to d when matched to control plates e and f. C. albicans strains exhibited 
further resistance to C. abbreviata methanol and aqueous extracts at 20mg/ml as shown in 
Figure 5.4 and Figure 5.5. The decoction preparation of C. abbreviata did not inhibit any of 
the C. albicans strains as displayed in Figure 5.5 
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      Candida albicans plate layout                 C. abbreviata methanol SAB plate 
 
      Key: A= ATCC 66027 B= 1879415 
               C= 868102  D= 1879083 
 
         Figure 5.4: Cassia methanol plate (right) showing no inhibition of C. albicans strains 
 
 
                
                 a                                                   b                                                       c 
(Cassia aqueous plate)           (Cassia acetone plate)                (Cassia traditional 
                                                                                                            preparation) 
 
Figure 5.5: C. abbreviata extracts showing growth of C. albicans strains 
             A 
             B             C 
             D 
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In Figure 5.5 on page 139, acetone extracts of Cassia abbreviata exhibited slight inhibition 
of Candida albicans strains at 20mg/ml. The diameter of C. albicans colonies in plate b of 
Figure 5.5 is smaller than those of the control plates in Figure 5.3, plate e and f. 
 
 
       
                 a                                                   b                                                    c 
(QC plate prior to plating)  (QC plate after plating)       (Blood agar purity plate) 
 
 
                                                                                                                                              
                   d                                                   e                                                    f 
(3.2% DMSO control plate)  (2.2% DMSO control plate) (Extracts control plate)    
  
Figure 5.6: Control plates of agar dilution method 
 
In order to ensure consistency in producing accurate and reproducible results, quality 
control was incorporated in the agar dilution assay as shown in Figure 5.6. Plate a is the 
initial control plate used before the inoculation of the plates containing extracts. This was 
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incorporated in order to check on accuracy and performance of the procedure. Plate b was 
applied to confirm that the technique was done properly with the Mast Multi-point 
inoculator. Plate c, also known as the purity plate, was to ensure and ascertain that no cross 
contamination occured between the microwells during inoculation. Plates d and e were 
employed to rule out that the DMSO added to extracts did not interfere with the growth of 
bacteria. Plate f was to check the sterility of the extracts. For the interpretation of results, 
the growth on the extract plates was  compared to the growth on the control plates. 
 
In Figure 5.7 on page 142, on average Pelargonium hortorum extracts (plate g, h, and i) 
showed more markedly inhibition of bacterial strains than Cassia abbreviata and Tecoma 
capensis plant extracts. Many colonies of bacteria were inhibited by P. hortorum extracts 
denoting its ability to kill those micro-organisms. For example, acetone P. hortorum extract 
on plate g (Figure 5.7) revealed only 10 colonies of bacteria out of 31 colonies growing on 
control plate c in Figure 5.6. On plate h, P. hortorum methanol extract depicted 9 bacterial 
colonies growing. Bacterial colonies growing on plate i of P. hortorum aqueous extract were 
fewer in number as compared to those growing on plate c (C. abbreviata aqueous extract) 
and f (T. capensis aqueous extract).  Thus, P. hortorum extracts exhibited much more 
pronounced antibacterial activity when compared with control plates (plates a to c) in 
Figure 5.6.  Extracts from T. capensis showed less antibacterial activity as shown in Figure 
5.7, plates d to f. For example, methanol extract of T. capensis on plate e (Figure 5.7) 
displays only six colonies of bacteria that were inhibited as compared to 31 colonies 
growing on control plate c in Figure 5.6. 
 
On the other hand, C. abbreviata methanol extract inhibited 23 bacterial colonies since they 
were only 8 colonies which grew on the plate as displayed in Figure 5.7, plate b. Table 5.1 
on page 145, revealed the growth of 14 and 15 colonies from C. abbreviata acetone and 
aqueous extracts respectively. This was also demonstrated in Figure 5.7 on plates a and c. 
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                             a                                                    b                                                     c 
     (C. abbreviata acetone plate)    (C. abbreviata methanol plate)  (C. abbreviata aqueous plate) 
 
                           
                          d                                                     e                                                    f 
       (T. capensis acetone plate)       (T. capensis methanol plate)    (T. capensis aqueous plate) 
 
                          
                        g                                                       h                                                     i 
      (P. hortorum acetone plate)     (P. hortorum methanol plate)    (P. hortorum aqueous plate) 
Figure 5.7: Agar plates showing inhibition of bacterial strains 
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                                   a                                                                                            b 
                        (Control plate)                                                         (G. incanum methanol plate) 
 
                               
                                   c                                                                                            d 
               (G. incanum acetone plate)                                        (G. incanum aqueous plate) 
                                          Figure 5.8: Antibacterial activity by G. incanum extracts 
 
All three extracts of G.incanum (methanol, acetone and aqueous) revealed good potency to 
inhibit the growth of the tested microbes as presented in plates: b, c, and d in Figure 5.8. 
Plates: c and d of G. incanum extracts also demonstrated slight inhibition, even to those 
bacteria which grew on them. Their sizes in terms of diameter were smaller than in control 
plate a. 
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                                               a                                                                     b 
Figure 5.9: Some traditional preparation plates showing no antibacterial activity 
 
In this study, both decoction and infusion preparation of plants did not show any 
antimicrobial activity. Plates a and b in Figure 5.9, T. capansis and C. abbreviata 
decoction/infusion preparation did not inhibit any bacteria on the plates when compared to 
control plates (a to c) in Figure 5.6. Simultaneously, the decoction of P. hortorum and 
infusion of G. incanum did not inhibit any of the organisms tested in this study. Therefore, 
no further dilutions of traditional preparations against the micro-organisms were 
performed. 
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Table 5.1: Screening results of plant extracts tested against bacteria and Candida strains at    
20mg/ml 
Bacteria Name Strain C. abbreviata G. incanum P. hortorum T. capensis 
   A 
 q 
 u 
M 
t 
h 
A 
c 
t 
A 
q 
u 
M 
t 
h 
A 
c 
t 
A 
q 
u 
M 
t 
h 
A 
c 
t 
A 
q 
u 
M 
t 
h 
A 
c 
t 
A. baumannii 1940242 - + + + + + + + + - - + 
A. baumannii UH2880 - + + + + + + + + - - + 
E. coli ATCC 25218 - - - - - - - - - - - - 
E. coli ATCC 38218 - - - - - - - - - - - - 
E. coli 893080 - + - - - - - + - - - - 
E. coli 892894 + + + - - - + + + + + + 
E. coli 894482 - - - - - - - - - - - - 
E. coli 891230 + + + + + + + + + + + + 
E. coli 892476 + + + + + + + + + + + + 
E. coli 893806 + + + + - - + + + + + + 
E. coli Clinical #9 - - - - - - - - - - - - 
K. pneumoniae UB4088 - + - - - - - - - - - - 
K. pneumoniae 1890912 - - - - - - - - - - - - 
K. pneumoniae Clinical #1 - - - - - - - - - - - - 
K. pneumoniae 1890640 - - - - - - - - - - - - 
K. pneumoniae 1881247 - - - - - - - - - - - - 
MRSA Clinical #1 + + - + + + + + + + + + 
MRSA 9708 + + + + + + + + + + - + 
MRSA 1879918 + + + + + + + + + + - + 
MRSA 1884230 + + + + + + + + + - - + 
S. aureus ATCC 43300 + + + + + + + + + + - + 
S. aureus 891564 + + + + + + + + + + - + 
S.aureus 891826 + + + + + + + + + + - + 
S. aureus 867716 + + + + + + + + + + - + 
S. aureus 867181 + + + + + + + + + + - + 
S. aureus 864651 + + + + + + + + + + - + 
P. aeruginosa ATCC 27853 - + - + + + SI + + - - - 
P. aeruginosa 1882480 - + - SI + + SI + + - - - 
P. aeruginosa 891975 + + + + + + + + + + + + 
P. aeruginosa 864263 + + - + + + + + + - - + 
P. aeruginosa UB4094 - + + SI SI SI + + + - - - 
Antifungal activity of plant extracts 
 Fungus   Strain             
C. albicans ATCC 66027 - - SI - - - - + SI - - - 
C. albicans 1879415 - - SI - - - - SI SI - - - 
C. albicans 868102 - - SI - - - - + SI - - - 
C. albicans 1879083 - - SI - - + - + SI - - - 
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Key: (+) = Inhibition      (-) = No inhibition     SI = Slight inhibition  
Aqu = Aqueous     Mth = Methanol        Act = Acetone 
 
The data shown in Table 5.1 are the final results of the three individual experiments of agar 
dilution method at 20mg/ml. The different extracts of Cassia abbreviata revealed total 
inhibition against twenty-three of thirty-five organisms, bacterial and fungal strains. C. 
abbreviata extracts completely inhibited two strains of A. baumannii, five strains of E. coli, 
one strain of K. pneumoniae, four strains of MRSA,  six strains of S. aureus, and five strains 
of P. aeruginosa (Table 5.1 and Figure 5.10). Acetone extract of C. abbreviata exhibited 
slight inhibition of C. albicans strains tested in this study. All of the strains of A. baumannii 
were inhibited by methanol and acetone extracts of C. abbreviata. On the other hand, 
acetone, aqueous and methanol extracts of C. abbreviata inhibited four strains of E.coli 
(892894, 891230, 892476 and 893806), six strains of S. aureus (ATCC 43300, 891564, 
891826, 867716, 867181 and 864651), three strains of MRSA (9708, 1879918 and 1884230) 
and one strain of P. aeruginosa (891975). C. abbreviata methanol extract, inhibited E. coli 
strain # 893080, K. pneumoniae strain # UB4088 and P. aeruginosa strain # 1882480. P. 
aeruginosa (864263) was inhibited by aqueous and methanol extracts while P. aeruginosa 
(UB4094) was inhibited by methanol and acetone extracts of C. abbreviata (Table 5.1).  
 
The antibacterial activity of C. abbreviata by agar dilution method was configured in 
percentages as shown in Figure 5.10. For example, only one of the five K. pneumoniae was 
inhibited, signifying a 20% bacterial inhibition by C. abbreviata extracts. There was 100% 
inhibition on MRSA, S. aureus, A. baumannii and P. aeruginosa bacterial strains while E. coli 
strains achieved a 56% of inhibition by C. abbreviata extracts. 
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Figure 5.10: Number of bacterial strains inhibited by C. abbreviata extracts  
expressed in percentage at 20mg/ml 
 
G. incanum extracts inhibited twenty of the thirty-five of the tested bacterial and fungal 
strains. In Figure 5.11 below, all of the A. baumannii strains tested were inhibited by all  
 
                
Figure 5.11: Inhibitory percentage of bacterial strains by G. incanum extracts at 20mg/ml 
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G. incanum extracts representing a 100% inhibition. Three E. coli strains were inhibited by 
G. incanum denoting 33% of crude potency (Figure 5.11). E. coli strain 893806 was only 
inhibited by the aqueous extract while the other two strains (891230 and 892476) were 
inhibited by all extracts of G. incanum as presented in Table 5.1. Aqueous, methanol and 
acetone extracts of G. incanum inhibited all S. aureus plus MRSA strains tested in this study 
signifying a 100% remarkable potency (Figure 5.11). Four strains of P. aeruginosa were 
totally inhibited, three of them by all extracts and one by methanol and acetone extracts of 
G. incanum. P. aeruginosa strain (UB4094) showed slight inhibitory activity with G. incanum 
extracts, while strain number 1882480 was slightly inhibited by G. incanum aqueous 
extract. No K. pneumoniae strain was inhibited by G. incanum extracts at 20mg/ml (Table 
5.1).  
 
                      
Figure 5.12: Inhibitory effects of P. hortorum expressed in percentage at 20mg/ml 
 
Prominent effects of medicinal plants were also shown by P. hortorum extracts as indicated 
in Table 5.1 and Figure 5.12. Twenty-five of thirty-five pathogens (bacterial and fungal 
strains) were inhibited by extracts of P. hortorum. Aqueous, methanol and acetone extracts 
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of P. hortorum inhibited all strains of A. baumannii, MRSA and S. aureus tested in three 
individual experiments at 20mg/ml. Five strains of E. coli were inhibited representing a 56% 
of plant potency. E. coli strain 893080 was inhibited only by an aqueous extract of P. 
hortorum while strains 891230, 892476, 892894 and 893806 were inhibited by all extracts 
of P. hortorum. All strains of P. aeruginosa were inhibited in the following manner: three P. 
aeruginosa strains (891975, 864263 and UB4094) were deterred by all extracts of P. 
hortorum and two strains (ATCC27853 and 1882480) were inhibited by methanol and 
acetone extracts of P. hortorum. Slight inhibition by aqueous extract of P. hortorum was 
noticed on P. aeruginosa strains number ATCC 27853 and 1882480. No strain of K. 
pneumoniae was prevented from growing by P. hortorum at 20mg/ml denoting 0% effect 
(Figure 5.12).  
 
T. capensis extracts exhibited some antibacterial activity as well. Eighteen of the thirty-five 
study organisms were inhibited by different extracts of T. capensis. The two strains of A. 
baumannii were inhibited by the acetone extract of T. capensis signifying a 100% inhibition 
(Table 5.1 and Figure 5.13). Four strains of E. coli were inhibited by aqueous, methanol and 
acetone extracts of T. capensis as shown in Table 5.1. All the different strains of S. aureus 
were inhibited by aqueous and acetone extracts of T. capensis. Two MRSA strains (9708 and 
1879918) were inhibited by aqueous and acetone extracts, one MRSA strain (clinical #1) 
was killed by all three extracts, and one MRSA strain (1884230) was only inhibited by 
acetone extract of T. capensis. One strain of P. aeruginosa (891975) was inhibited by all 
three extracts while P. aeruginosa strain number 864263 was only inhibited by acetone 
extract of T. capensis representing a 40% inhibition as shown in Figure 5.13. No K. 
pneumoniae strain was inhibited by T. capensis extracts at 20mg/ml (Table 5.1). 
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         Figure 5.13: Number of organisms inhibited by T. capensis extracts expressed in percentage 
 
5.1.1.1 Antifungal activity 
It is apparent from Table 5.1 that medicinal plants in this study possessed strong 
antimicrobial activity against bacterial strains. They however, showed moderate effects 
against Candida strains. C. abbreviata acetone extract showed slight inhibition on Candida 
strains. G. incanum acetone extract inhibited C. albicans (1879083) at 20mg/ml. No strain of 
C. albicans was inhibited by any of T. capensis extracts at 20mg/ml. Methanol extract of P. 
hortorum completely inhibited three strains of C. albicans (ATCC 66027, 868102 and 
1879083) and slightly inhibited one strain of C. albicans (1879415). P. hortorum acetone 
extract showed some slight activity on all strains of C. albicans employed in this study. 
 
Summary of the organisms in percentage that were inhibited by each individual plant 
extracts are indicated in Figure 5.14.  The results in Figure 5.14 reveal that on average, P. 
hortorum methanol extract at 20mg/ml has good potency to inhibit the majority of the 
tested micro-organisms, hence approximately 71% of the tested organisms were inhibited. 
P. hortorum acetone extract inhibited 60% of the tested pathogens while the aqueous 
extract of P. hortorum inhibited only 54% of the studied organims. T. capensis methanol 
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extract showed the lowest antimicrobial activity inhibiting about 17% of the tested micro-
organisms. 
 
                  
                   Key: Aqu = Aqueous   Mth = Methanol  Act = Acetone 
                  Figure 5.14: A summary of organisms inhibited by individual plant extract at 
 20mg/ml using agar dilution method 
 
On the other hand, acetone and aqueous extracts of T. capensis killed 51% and 40% 
respectively of the tested pathogens. Both G. incanum aqueous and methanol extracts 
inhibited 51% of the studied organisms. Acetone extract of G. incanum hindered the growth 
of 54% of the tested micro-organisms. Antimicrobial activity displayed by C. abbreviata 
indicated 66% inhibition of micro-organisms by methanol extract while 49% and 46% were 
achieved by acetone and aqueous extracts of C. abbreviata respectively.  The results of the 
agar dilution screening procedure further revealed that Gram-positives (e.g., S. aureus) 
were more susceptible than Gram-negative species to study plants. C. albicans showed a 
moderate degree of sensitivity. These differences in susceptibility among Gram-positive, 
152 
 
Gram-negative bacteria and C. albicans could be due to the nature of their respiration 
pathway or their oxygen requirements (Al Momani, Alkofahi & Mhaidat, 2011). 
Pelargonium hortorum plant leaves showed most salient antimicrobial activity with agar 
dilution technique at 20mg/ml. 
 
                     
Figure 5.15: Overall antimicrobial activity of medicinal plants 
 
In Figure 5.15, the overall antimicrobial activity of P. hortorum plant leaves is 71% whereas 
that of T. capensis is 51%. On the other hand, the overall antimicrobial activity displayed by 
C. abbreviata stem bark is 66% while that of G. incanum leaves is 57%. 
 
5.1.2 Standard antibiotic susceptibility patterns of the tested micro-organisms 
Antibiotic susceptibility testing was performed with the use of  standard antibiotic discs by 
the disc diffusion method. Prior to placing antibiotic discs on the media surface, the 
pathogenic bacterial isolates from an 18 to 24 hour culture were streaked on each of the 
Mueller-Hinton agar plates. The antibiotic discs were placed on each of the Mueller-Hinton 
agar plates using a sterile forceps (Akintobi et al., 2011). Saboraud dextrose agar plates 
were used for Candida albicans strains. The agar plates were then incubated at 37°C for 24 
153 
 
hours. Following incubation, the plates were evaluated for zones of inhibition. The zones of 
inhibition around each antibiotic disc were measured in millimetres using a transparent 
ruler and were interpreted according to CLSI (2007) guidelines (Table 4.3 and Table 4.4). 
Table 5.2 and Table 5.3 display the susceptibility results of the standard antibiotics on 
bacteria and Candida respectively. All determinations were done in triplicate. 
 
According to results displayed in Table 5.2, there were nine antibiotics which were used for 
sensitivity testing on both Gram-positive and Gram-negative bacteria. The antibiotics and 
their names are displayed in Table 4.2.  
 
In Table 5.2, all A. baumannii strains were sensitive to gentamicin, chloramphenicol and 
ciprofloxacin and were resistant to the rest of the tested antibiotics. All E.coli strains were 
sensitive to gentamicin and ciprofloxacin and were all resistant to penicillin. Seven of the E. 
coli strains investigated were resistant to ampicillin and amoxycillin except two stains of E. 
coli (Clinical #9 and 894482).  
 
    Table 5.2: Antibiotic susceptibility patterns of the tested bacteria 
 
 
Bacterial stains 
Antimicrobial agent 
GM10 C30 CIP5 AP10 
 
PG10 
 
E5 CXF30 
 
A10 
 
S10 
M 
I 
Z 
I 
N 
T 
M 
I 
Z 
I 
N 
T 
M 
I 
Z 
I 
N 
T 
M 
I 
Z 
I 
N 
T 
M 
I 
Z 
I 
N 
T 
M 
I 
Z 
I 
N 
T 
M 
I 
Z 
I 
N 
T 
M 
I 
Z 
I 
N 
T 
M 
I 
Z 
I 
N 
T 
A. baumannii                   
              1940242 
              UH 2880 
20 S 18 S 24 S 0 R 0 R 11 R 0 R 0 R 9 R 
16 S 18 S 23 S 12 R 0 R 9 R 0 R 11 R 0 R 
E. coli                                  
       ATCC 38218 
       ATCC 25218 
               892476 
               892894 
               891230 
               893080 
21 S 0 R 36 S 0 R 0 R 9 R 21 S 0 R 21 S 
22 S 0 R 34 S 0 R 0 R 0 R 21 S 0 R 0 R 
22 S 20 S 25 S 0 R 0 R 26 S 0 R 0 R 21 S 
27 S 21 S 27 S 0 R 0 R 28 S 0 R 0 R 23 S 
23 S 21 S 27 S 0 R 0 R 27 S 0 R 0 R 22 S 
23 S 24 S 36 S 0 R 0 R 0 R 19 S 0 R 8 R 
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          Clinical #9 
               894482 
               893806 
24 S 26 S 36 S 21 S 11 R 0 R 20 S 18 S 16 S 
21 S 23 S 33 S 21 S 11 R 0 R 19 S 18 S 15 S 
24 S 22 S 27 S 0 R 0 R 28 S 0 R 0 R 23 S 
K. pneumoniae                   
             UB 4088 
             1890912 
          Clinical #1 
             1890640 
             1881247 
25 S 22 S 31 S 11 R 0 R 0 R 21 S 0 R 20 S 
0 R 24 S 10 R 0 R 0 R 0 R 0 R 0 R 0 R 
0 R 23 S 29 S 0 R 0 R 0 R 0 R 0 R 0 R 
0 R 0 R 22 S 0 R 0 R 0 R 0 R 0 R 0 R 
0 R 21 S 15 R 0 R 0 R 0 R 0 R 0 R 0 R 
S. aureus                   
MRSA Clinical #1 
        MRSA 9708 
  MRSA 1879918 
  MRSA 1884230 
     ATCC  43300 
               867716 
               891826 
               891564 
               864651 
               867181 
35 S 28 S 35 S 12 R 10 R 13 R 0 R 11 R 0 R 
8 R 26 S 17 I 10 R 7 R 20 I N N 8 R 16 S 
0 R 0 R 0 R 10 R 12 R 9 R 0 R 8 R 0 R 
10 R 0 R 0 R 0 R 0 R 15 R 0 R 0 R 0 R 
0 R 25 S 28 S 12 R 11 R 0 R 25 S 11 R 15 S 
22 S 22 S 28 S 36 S 38 S 25 S 25 S 35 S 15 S 
14 I 22 S 28 S 16 R 16 R 25 S 27 S 16 I 16 S 
23 S 23 S 26 S 16 R 16 R 25 S 27 S 15 I 17 S 
14 I 25 S 28 S 18 R 17 R 27 S 28 S 16 I 27 S 
14 I 24 S 29 S 17 R 16 R 28 S 27 S 17 I 18 S 
 S.pneumoniae                                 
    ATCC 49619 
                7909 
   UF00123106 
9 R 27 S 21 S 34 S 30 S 27 S 23 R 33 S 10 R 
0 R 24 S 18 I 25 S 23 S 24 S 23 S 27 S N N 
0 R 24 S 20 I 38 S 38 S 26 S 25 S 36 S 8 R 
H. influenza                   
          8993636 
                8907 
          1893772 
14 I 0 R 31 S 0 R 0 R 0 R 20 S 0 R 0 R 
24 S 32 S 38 S 20 I 0 R 16 I 18 S 16 R 24 S 
18 S 0 R 35 S 0 R 0 R 0 R 21 S 0 R 0 R 
P. aeruginosa                   
   ATCC 27853 
             891975 
             864263 
           UB4094 
           1882480 
20 S 0 R 30 S 0 R 0 R 0 R 0 R 0 R 13 I 
24 S 21 S 28 S 0 R 0 R 27 S 0 R 0 R 22 S 
23 S 21 S 27 S 0 R 0 R 26 S 0 R 0 R 22 S 
30 S 0 R 30 S 0 R 0 R 0 R 0 R 0 R 16 S 
16 S 0 R 30 S 0 R 0 R 0 R 0 R 0 R 8 R 
Key: MIZ= Mean inhibition zones (mm); INT = Interpretation of zones of inhibition; S: 
Sensitive; R: Resistant; I: Intermediate sensitivity; N: Not tested; GM10: Gentamicin; 
C30: Chloramphenicol; CIP5: Ciprofloxacin; AP10: Ampicillin; PG10: Penicillin; E5: 
Erythromycin; CFX: Cephalexin; A10: Amoxycillin; S10: Streptomycin. 
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Most E. coli strains showed resistance to at least four of the tested antibiotics except the 
reference strains which resisted five of the antibiotics used. All the MRSA displayed greater 
resistance pattern. MRSA (clinical #1) was only susceptible to gentamicin, chloramphenicol 
and ciprofloxacin while MRSA (9708) was sensitive to two drugs, chloramphenicol and 
streptomycin. All the other S. aureus strains showed remarkable sensitivity to most 
antibiotics. However, the majority of S. aureus strains resisted ampicillin and penicillin 
except strain 867716 which was sensitive to ampicillin and penicillin. Three strains of S. 
aureus (891826, 864651 and 867181) exhibited intermediate susceptibility to gentamicin 
while four strains (891826, 891564, 864651 and 867181) showed intermediate sensitivity to 
amoxycillin. One strain of S. aureus (867716) was sensitive to all the tested drugs thereby 
signifying a 100% susceptibility pattern. In contrast, two MRSA strains (1879918 and 
1884230) demonstrated the highest level of resistance to all the tested standard drugs 
signifying a 100% resistance pattern. 
 
All S. pneumoniae strains were resistant to gentamicin while two strains (7909 and 
UF00123106) displayed intermediate sensitivity to ciprofloxacin. Two strains of S. 
pneumoniae (ATCC 49619 and UF00123106) were resistant to streptomycin and ATCC 
49619 showed resistant to cephalexin. 
 
All K. pneumoniae were sensitive to chloramphenicol except one strain (1890640). Only one 
strain (UB4088) of the tested K. pneumoniae was sensitive to gentamicin, cephalexin and 
streptomycin. On the other hand, two K. pneumoniae strains were resistant to 
ciprofloxacin.  K. pneumoniae strains demonstrated moderate resistance to the tested 
antibiotics when compared to MRSA strains. All strains of P. aeruginosa were sensitive to 
two drugs (gentamicin and ciprofloxacin) and were resistant to ampicillin, penicillin, 
cephalexin and amoxycillin. Two strains of P. aeruginosa (891975 and 864263) were 
sensitive to chloramphenicol, ciprofloxacin and erythromycin while three strains were 
sensitive to streptomycin (Table 5.2). P. aeruginosa reference strain (ATCC 27853) showed 
intermediate sensitivity to streptomycin. 
156 
 
All H. influenzae strains were sensitive to two drugs (ciprofloxacin and cephelexin) as well 
as resistant to two of the tested drugs (penicillin and amoxycillin). One starin of H. 
influenzae (8993636) showed intermediate susceptibility to gentamicin while the other 
strain (8907) displayed intermediate susceptibility to ampicillin and erythromycin. 
 
              
              
Figure 5.16: Overall antibiotic resistance by ATCC and clinical isolates 
   Key: GM10: Gentamicin; C30: Chloramphenicol; CIP5: Ciprofloxacin; AP10: Ampicillin; 
       PG10: Penicillin; E5: Erythromycin; CXF: Cephalexin; A10: Amoxycillin; S10:   
Streptomycin. 
 
In Figure 5.16 above, the antimicrobial resistance to standard antibiotics as demonstrated 
by ATCC and clinical strains employed in this study are displayed. 89% of the tested micro-
organisms clinically proven to cause pneumonia and other acute lower respiratory tract 
infections exhibited resistance to penicillin. Data reveal a high level of resistance to other 
commonly used antibiotics such as ampicillin (81%), amoxycillin (73%), cephalexin (53%) 
and streptomycin (43%). Only 11% of the tested organisms resisted ciprofloxacin.  
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Data in Figure 5.16 suggests that the number of multiple-drug resistant microbial strains 
and the appearance of strains with reduced susceptiblity to antibiotics are continuously 
increasing. Similar findings were expressed by Selvamohan et al. (2010).  
 
5.1.3 Antifungal sensitivity testing 
Two antifungal drugs namely, Amphotericin B and Nystatin were used to determine the 
resistant patterns of C. albicans strains tested in this study. Table 5.3 displays the sensitivity 
results of C. albicans strains. 
 
     Table 5.3: Antifungal susceptibility pattern of the tested Candida albicans 
Candida 
albicans 
stains 
                                    Antimicrobial agent 
Amphotericin B (AMB20) Nystatin (NY100) 
Mean inhibition 
zones (mm) 
   Status Mean inhibition 
zones (mm) 
  Status 
ATCC 66027 22 Sensitive 17 Sensitive 
868102 24 Sensitive 18 Sensitive 
1879083 21 Sensitive 21 Sensitive 
1879415 19 Sensitive 22 Sensitive 
 
 
In Table 5.3, all tested C. albicans strains were sensitive to Amphotericin B and Nystatin. 
Figure 5.17 exhibits C. albicans (868102) susceptible to Amphotericin B and Nystatin. 
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                                                  Zones of inhibitions for AMB20 and NY100 
 
                                          
 
Figure 5.17: C. albicans sensitive to antifungal drugs 
 
5.1.4 Antibacterial activity of plant extracts in disc diffusion screening assay 
The four plant species investigated are reported in Table 3.1, with the parts commonly used 
for traditional medicinal uses. The antimicrobial activity of crude extracts from these plants 
against Gram-positive bacteria, S. pneumoniae and Gram-negative bacteria, H. influenzae 
were assessed qualitatively by measuring the inhibition zone diameters, and were 
quantitatively measured by determining minimal inhibitory concentrations. The plant 
extract results of the screening test at 40mg/ml by agar disc diffusion assay are presented 
in Table 5.4. Zones of inhibition equal to or greater than 7mm were considered susceptible 
to the tested plant extract as illustrated by Humnabadkar and Kareppa (2012). 
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Table 5.4: Antibacterial activity of medicinal plants against strains of S. pneumoniae and H.    
influenzae at 40mg/ml 
Mean inhibition zone Micro-organisms diameter (mm) 
Bacteria C. abbreviata G. incanum P. hortorum T. capensis 
Aqu Mth Act Aqu Mth Act Aqu Mth Act Aqu Mth Act 
S. pneumoniae             
     ATCC 49619 
                  7909 
    UF00123106 
13 15 14 0 18 18 15 17 22 0 0 0 
NT NT NT 0 16 17 NT NT NT NT NT NT 
13 17 18 0 12 12 15 16 13 0 0 0 
H. influenzae             
            8993636 
                  8907 
            1893772 
0 0 0 15 17 18 0 13 10 0 0 0 
15 16 0 0 0 0 NT NT NT 0 0 0 
0 0 0 0 0 0 0 14 0 0 0 0 
Key: Aqu = Aqueous; Mth = Methanol; Act = Acetone; NT = Not tested 
 
In Table 5.4, all extracts of C. abbreviata showed notable activity against two strains of S. 
pneumoniae (ATCC 49619 and UF00123106). Only one strain of H. influenzae (8907) was 
susceptible to aqueous and methanol extracts of C. abbreviata. Methanol and acetone 
extracts of G. incanum inhibited the growth of the three tested S. pneumoniae strains. One 
strain of H. influenzae (8993636) was inhibited by all extracts of G. incanum. P. hortorum 
extracts showed strong activity on two strains of S. pneumoniae while the methanol and 
acetone extracts of P. hortorum inhibited H. influenzae strain number 8993636. The 
methanol extract of P. hortorum showed antibacterial activity on one strain of H. influenzae 
(1893772). No organism was inhibited by T. capensis extracts at 40mg/ml. Two organisms 
(S. pneumoniae, 7909 and H. influenzae, 8907) were not screened by some plant extracts 
because they died in the course of the study. The susceptible bacteria in Table 5.4 were 
further tested for minimum inhibitory concentration as displayed in Table 5.6 and Table 5.7.  
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5.1.5 Antibacterial activity of traditional plant preparations 
Traditional preparations, Cassia abbreviata and Pelargonium hortorum were prepared as 
decoctions for antimicrobial activity testing. Infusions of Geranium incanum and Tecoma 
capensis were also performed against the study organisms. The traditional preparation of 
the plant extracts did not inhibit any of the tested microorganisms as shown in Table 5.5 
and some illustrations in Figure 5.18. 
 
     Table 5.5: Antimicrobial activity of traditional plant preparation on agar plates 
     Medicinal 
plants 
Traditional 
preparation 
     Tested   Bacterial strains 
 A.baumannii (2); S. aureus (10); 
E. coli (9); K. pneumoniae  (5); S. 
pneumoniae (3); H. influenzae (3); 
P. aeruginosa (5) 
 Tested Candida 
albicans 
      (4 strains) 
C. abbreviata Decoction - - 
G. incanum Infusion - - 
P. hortorum Decoction - - 
T. capensis Infusion - - 
     Key: ( ) = Number of strains; (-) = No inhibition on plates; (+) = Inhibition on plates 
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(a)                                                              (b) 
     Control before extract inoculation                          Purity plate 
 
 
           
(c)                                                              (d) 
            Cassia decoction plate                           Pelargonium decoction plate 
 
                                                          
Figure 5.18: Decoction plates of medicinal plants showing no inhibition of organisms 
 
Plates a and b in Figure 5.18 are control plates for the tested bacteria. All colonies of 
bacteria grew on Cassia decoction plate c indicating no activity of the plant. Plate d of P. 
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hortorum was observed with swarming colonies showing that the decoction stimulated the 
growth of bacteria rather than inhibiting them.  
 
5.2 ANTIMICROBIAL SUSCEPTIBILITY TESTING  
 
The MIC for S. pneumoniae and H. influenzae was performed by employing the agar disc 
diffusion method while the MIC for the rest of the tested bacteria was done by use of 
microtitre plate dilution method. 
 
5.2.1 Bacterial susceptibility testing by agar disc diffusion method 
Strains of S. pneumoniae and H. influenzae that were inhibited during screening were 
further tested for minimum inhibitory concentration using the agar disc diffusion assay. The 
MIC was conducted at five different concentrations of the crude extracts (40mg/ml, 
20mg/ml, 10mg/ml, 5mg/ml, and 2.5mg/ml). The MIC was determined as smallest 
concentration among the five that induced a zone of inhibition to the growth of bacteria. 
Zones of inhibition were recorded in millimetres as displayed in Table 5.6  and Figure 5.19.  
 
     Table 5.6: MIC results of inhibition zone diameter (mm) of the plant extracts on S. pneumoniae 
Plant species  Inhibition zone diameter (mm) 
Concentration (mg/ml) 
Strain  # ATCC49619 UF00123106 7909 
mg/ml 40 20 10 5 2.5 40 20 10 5 2.5 40 20 10 5 2.5 
C. abbreviata Aqueous 13 12 8 0 0 13 0 0 0 0 N N N N N 
Methanol 15 12 11 11 7 17 14 14 0 0 N N N N N 
Acetone 14 12 12 11 0 18 17 14 10 0 N N N N N 
G. incanum Methanol 18 11 0 0 0 12 0 0 0 0 16 9 0 0 0 
Acetone 18 8 0 0 0 12 0 0 0 0 17 0 0 0 0 
P. hortorum Aqueous 15 12 11 0 0 15 13 9 0 0 N N N N N 
Methanol 17 13 13 9 0 16 14 13 0 0 N N N N N 
Acetone 22 0 0 0 0 13 0 0 0 0 N N N N N 
  Key: N = Not tested 
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            5mg/ml disc                                                  zones of inhibition      QC standard antibiotic 
 
               
                                         a                                                                    b 
     Figure 5.19: C. abbreviata methanol extract inhibiting S. pneumoniae strains 
 
In Table 5.6, the MIC range of extracts on Streptococcus pneumoniae strains ranged from 
2.5mg/ml to 40mg/ml. The zones of inhibition produced were from 7mm to 22mm in 
diameter. The lowest concentration to inhibit the growth of S. pneumoniae (ATCC 49619) 
was produced by C. abbreviata methanol extract at 2.5mg/ml. The lowest MIC displayed by 
P. hortorum extracts on S. pneumoniae strains was 5mg/ml while that produced by G. 
incanum was 20mg/ml. The most effective activity was provided by P. hortorum acetone 
extract with maximum zone of inhibition of 22mm against S. pneumoniae, ATCC 49619. 
Overall, methanol extracts demonstrated greater antimicrobial potential than water and 
acetone extracts. 
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      Table 5.7: MIC results of inhibition zone diameter (mm) of the plant extracts on H. influenzae 
Plant 
species 
 Inhibition zone diameter (mm) 
Concentration (mg/ml) 
Strain  # 8907 8993636 1893772 
mg/ml 40 20 10 5 2.5 40 20 10 5 2.5 40 20 10 5 2.5 
C. 
abbreviata 
Aqueous 15 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Methanol 16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Acetone 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
G. 
incanum 
Aqueous 0 0 0 0 0 15 14 8 0 0 0 0 0 0 0 
Methanol 16 9 0 0 0 17 15 9 0 0 0 0 0 0 0 
Acetone 17 0 0 0 0 17 12 0 0 0 0 0 0 0 0 
P. 
hortorum 
Methanol N N N N N 13 12 0 0 0 14 12 0 0 0 
Acetone N N N N N 10 0 0 0 0 0 0 0 0 0 
 Key: N = Not tested 
 
The results in Table 5.7 exhibit that inhibition zone diameter of plant extracts on H. 
influenzae strains ranged from 8mm to 17mm. The lowest concentration of plant extracts 
to inhibit the growth of H. influenzae strains was 10mg/ml and was produced by G. incanum 
methanol and aqueous extracts. H. influenzae strains require stronger concentrations to be 
inhibited than S. pneumoniae strains as shown in Table 5.6 and Table 5.7. C. abbreviata 
acetone extract did not show bioactivity on any of the H. influenzae strains examined in the 
present study. 
 
Activity index was calculated for each plant extract against its minimal inhibitory 
concentration. The mean of the zones of inhibition for each MIC produced by each plant 
extract was used for calculating the activity index of the plant as shown in Table 5.8. The 
activity index of the lowest concentration of C. abbreviata extracts that inhibited growth of 
bacteria ranged from 0.23mm to 0.42mm. 
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   Table 5.8: Activity index of the plant extracts 
Plant 
species 
Ext Micro-organism tested 
Streptococcus pneumonia Haemophilus influenzae 
ATCC 
49619 
UF00123 
106 
7909 8907 8993636 1893772 
I.Z A.I I.Z A.I I.Z A.I I.Z A.I I.Z A.I I.Z A.I 
C. 
abbreviata 
Aqu 8 0.27 13 0.34 N N 15 0.39 N N N N 
Mth 7 0.23 14 0.37 N N 16 0.42 N N N N 
Act 11 0.37 10 0.26 N N N N N N N N 
 
G. incanum 
Aqu N N N N N N N N 8 0.26 N N 
Mth 11 0.37 12 0.32 9 0.39 9 0.24 9 0.29 N N 
Act 8 0.27 12 0.32 17 0.74 17 0.45 12 0.39 N N 
 
P. 
hortotum 
Aqu 11 0.37 9 0.24 N N N N 12 0.39 N N 
Mth 9 0.30 13 0.34 N N N N 10 0.32 12 0.34 
Act 22 0.73 13 0.34 N N N N N N N N 
Control I.Z I.Z I.Z I.Z I.Z IZ 
Penicillin 30 38 23    
Ciprofloxacin    38 31 35 
     Key: I.Z = Inhibition zone; A.I = Activity index; N = Not tested; Aqu = Aqueous; Mth = Methanol; 
    Act = Acetone; Ext = Extract 
 
The activity index of G. incanum extracts ranged from 0.27mm to 0.74mm while that of P. 
hortorum ranged from 0.30mm to 0.73mm. The most susceptible pattern was 
demonstrated by one strain of S. pneumoniae (ATCC 49619) which was inhibited at 
2.5mg/ml (Table 5.6) signifying an inhibition zone diameter of 7mm and an activity index of 
0.23mm. Similarly, one strain of H. influenzae (8993636) exhibited an IZ of 8mm and an AI 
of 0.26mm.  
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5.2.2 MIC determination of plant extracts by microtitre broth dilution method 
The MIC’s of the four plants (Cassia abbreviata, Geranium incanum, Pelargonium hortorum 
and Tecoma capensis) was carried out in triplicates using the microtitre plate assay. The 
MIC’s were determined against selected non fastidious bacterial strains. The bacterial 
strains were chosen according to the inhibition exhibited during the screening (Table 5.1) as 
well as their varied antibiotic susceptibility patterns (Table 5.2). 
 
The number of bacterial strains inhibited by the specific plant extracts is presented in Table 
5.9. Twenty-three bacterial strains from a total of thirty-one were used for determining the 
MIC’s of the different plant extracts in the microtitre plate assay. The different plants 
exhibited different patterns of activity. In Table 5.9, aqueous extract of C. abbreviata 
inhibited sixteen of the tested bacterial strains whereas methanol and acetone extracts of 
C. abbreviata inhibited twenty-three and seventeen of the tested bacterial strains 
respectively. Each respective extract of G. incanum inhibited eighteen of the tested 
bacterial strains. Aqueous extract of P. hortorum inhibited nineteen of the tested bacterial 
strains. P. hortorum methanol extract inhibited twenty-two whereas P. hortorum acetone 
extracts inhibited twenty-one of the selected bacterial strains. Aqueous extracts of T. 
capensis inhibited fourteen of the tested bacterial strains. Methanol extract of T. capensis 
showed lowest bioactivity by inhibiting only six of the tested bacterial strains. Acetone 
extract of T. capensis inhibited eighteen of the tested bacterial strains. Since the microtitre 
MIC method is more sensitive than the agar dilution method, all the twenty-three bacterial 
strains that were inhibited by the agar dilution screening technique were further tested for 
MIC determination and the results are displayed in Tables 5.11 to 5.14. 
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 Table 5.9: A summary of the number of bacterial strains inhibited by the specific plants during screening 
Plant Extract Bacteria 
A. baumannii E. coli K. pneumoniae MRSA S. aureus P. aeruginosa Total 
n = 2 n = 9 n = 5 n = 4 n = 6 n = 5 31 
C. abbreviata Aqueous 0 4 0 4 6 2 16 
Methanol 2 5 1 4 6 5 23 
Acetone 2 4 0 3 6 2 17 
G. incanum Aqueous 2 3 0 4 6 3 18 
Methanol 2 2 0 4 6 4 18 
Acetone 2 2 0 4 6 4 18 
P. hortorum Aqueous 2 4 0 4 6 3 19 
Methanol 2 5 0 4 6 5 22 
Acetone 2 4 0 4 6 5 21 
T. capensis Aqueous 0 4 0 3 6 1 14 
Methanol 0 4 0 1 0 1 6 
Acetone 2 4 0 4 6 2 18 
Key: n = number of bacterial strains; MRSA = Methicillin – resistant Staphylococcus aureus 
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Figure 5.20 shows a microtitre plate with wells that developed colour change after INT 
incubation of the plate indicating the growth of the ATCC 43300, S. aureus reference strain. 
Where a bacterium (ATCC43300) was inhibited, there was no colour development after INT 
incubation. 
 
 
     Wells A to G, no colour change               DMSO and bacterial controls with  
      after INT incubation                                 intense colour change 
 
                               
                                               
                                    Extract controls showing no contamination 
 
                         Figure 5.20: Microtitre plate showing colour intensity and MIC wells 
 
The MIC procedure performed by the microtitre plate involves the dilution of plant extracts. 
The undiluted plants extracts of Cassia abbreviata, Geranium incanum, Pelargonium 
hortorum and Tecoma capensis were serially diluted in the microtitre plate assay as shown 
in Figure 5.20 in order to obtain the MIC’s of various plant extracts. Table 5.10a and Table 
5.10b exhibit the dilutions where the MIC values were determined for the specific plant 
extracts. The twenty-three bacterial strains that were used in the microtitre plate assay 
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were comprised of two Gram-positive bacteria (Staphylococcus aureus and methicillin-
resistant Staphylococcus aureus) and four Gram-negative bacteria (Escherichia coli, 
Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae). 
 
The undiluted extract concentrations of G. incanum were prepared at 20mg/ml whereas 
that of the other medicinal plants was prepared at 10mg/ml. Therefore the dilutions in 
Table 5.10a and Table 5.10b display different concentrations of the plant extracts where 
the MIC values (Table 5.11 to Table 5.14) were calculated. 
 
Table 5.10a and Table 5.10b indicate to what degree the plant extracts were diluted to 
determine an inhibition of the bacteria in the microtitre plate assay. The dilutions in Table 
5.10a and Table 5.10b correlate with the MIC values (mg/ml) in Tables 5.11 to 5.14. The 
specific plant extract dilutions in Tables 5.10a and 5.10b serve as a point of reference for 
the visible observation of the MIC’s of medicinal plant extracts. 
 
The MIC will escalate when the organism develops resistance to the plant extract hence a 
greater concentration will be needed to inhibit growth of that particular bacterial 
population. The MIC’s for the medicinal plants were expressed as values in mg/ml 
depending on the undiluted plant extract and the smallest dilution that exhibited inhibition 
of the bacteria. The values are expressed as an average of the results obtained in triplicate 
runs.  
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Table 5.10a: Extract dilutions where the MIC's of medicinal plants were obtained for Gram-positive bacterial strains 
Extract dilutions where MIC’s were determined for medicinal plants 
Bacteria tested Strain Cassia abbreviata Geranium incanum Pelagonium 
hortorum 
Tecoma capensis 
Gram-Positive Aqu Mth Act Aqu Mth Act Aqu Mth Act Aqu Mth Act 
MRSA 9708 1:128 1:128 1:128 1:128 1:128 1:128 1:128 1:128 1:128 1:128 NA 1:128 
Clinical #1 1:64 1:128 NA 1:128 1:128 1:128 1:128 1:128 1:128 1:64 UE UE 
1879918 1:64 1:128 1:64 1:128 1:128 1:128 1:128 1:128 1:128 1:128 NA 1:128 
1884230 1:128 1:128 1:128 1:128 1:128 1:128 1:128 1:128 1:128 NA NA 1:32 
S. aureus ATCC43300 1:128 1:128 1:128 1:128 1:128 1:128 1:128 1:128 1:128 1:64 NA 1:64 
891564 1:64 1:64 1:128 1:128 1:128 1:128 1:64 1:128 1:128 1:8 NA UE 
891826 1:64 1:128 1:128 1:128 1:128 1:128 1:64 1:128 1:128 1:32 NA 1:64 
867716 1:128 1:128 1:128 1:128 1:128 1:64 1:128 1:128 1:128 1:128 NA 1:128 
867181 1:128 1:64 1:128 1:32 1:32 1:64 1:128 1:128 1:128 1:64 NA 1:128 
864651 1:64 1:64 1:128 1:128 1:128 1:128 1:64 1:128 1:32 1:8 NA UE 
Key: Aqu: Aqueous; Mth: Methanol; Act: Acetone; MRSA: Methicillin-resistant Staphylococcus aureus; 
         ATCC: American type culture collection; NA: Not applicable; UE: Undiluted extract 
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Table 5.10b: Extract dilutions where the MIC's of medicinal plants were obtained for Gram-negative bacterial strains 
Extract dilutions where MIC’s were determined for medicinal plants 
Bacteria tested Strain Cassia abbreviata Geranium incanum Pelagonium hortorum Tecoma capensis 
Gram-Negative Aqu Mth Act Aqu Mth Act Aqu Mth Act Aqu Mth Act 
A. baumannii 1940242 NA 1:16 1:16 1:128 1:128 1:128 1:64 1:128 1:128 NA NA 1:4 
UH2880 NA 1:32 1:4 1:128 1:128 1:128 1:32 1:128 1:32 NA NA 1:4 
K. pneumoniae UB4088 NA 1:16 NA NA NA NA NA NA NA NA NA NA 
E. coli 893080 NA 1:32 NA NA NA NA NA 1:128 NA NA NA NA 
892894 1:16 1:128 1:32 NA NA NA 1:32 1:32 1:64 1:4 UE UE 
891230 1:4 1:8 1:8 1:4 1:16 1:128 1:128 1:128 1:128 1:128 1:128 1:128 
892476 1:16 1:32 1:32 1:128 1:64 1:128 1:64 1:64 1:128 1:128 1:128 1:128 
893806 1:8 1:32 1:128 1:8 1:8 1:8 1:128 1:128 1:32 1:4 1:8 1:8 
P. aeruginosa ATCC27853 NA 1:32 NA 1:128 1:128 1:128 1:128 1:128 1:128 NA NA NA 
1882480 NA 1:64 NA 1:64 1:64 1:64 1:32 1:16 1:32 NA NA NA 
891975 1:8 1:128 1:64 1:32 1:16 1:64 DTD DTD DTD 1:128 1:64 1:128 
864263 1:8 1:32 1:64 1:128 1:64 1:64 DTD DTD DTD NA NA UE 
UB4094 NA 1:128 1:64 1:32 1:64 1:64 1:64 1:128 1:128 NA NA NA 
Key: Aqu: Aqueous; Mth: Methanol; Act: Acetone; ATCC: American type culture collection; NA: Not applicable  
         UE: Undiluted extract; DTD: Difficult to be detected by the microtitre reader due to high intensity colour of the extracts in the  
         first wells.        
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In the present investigation, initial concentration of the undiluted extracts of G. incanum 
used for MIC microtitre assay was 20mg/ml. The other three medicinal plants (C. 
abbreviata, P. hortorum and T. capensis) used initial concentration of 10mg/ml of the 
undiluted extracts. 
 
In Table 5.11, the aqueous extract of C. abbreviata did not inhibit any of the two A. 
baumannii strains. The lowest and highest MIC values of C. abbreviata against A. baumannii 
(UH2880) were 0.125mg/ml and 1.0mg/ml. The range of the MIC value of C. abbreviata 
plant against E. coli strains was 0.031mg/ml to 1.0mg/ml. The lowest MIC value 
(0.031mg/ml) was therefore produced by methanol extract of C. abbreviata against E. coli 
(892894) and acetone extract against another strain of E.coli (893806). 
 
The methanol extract of C. abbreviata plant is the only extract that inhibited K. pneumoniae 
strain (UB4088) at a concentration of 0.25mg/ml. Klebsiella pneumoniae were the most 
resistant strains of bacteria tested against the study plants. All the extracts of the selected 
medicinal plants failed to suppress the growth of Klebsiella pneumoniae strains except the 
methanol extract of C. abbreviata. 
 
The range of the MIC values for C. abbreviata extracts against MRSA strains was 
0.031mg/ml to 0.063mg/ml. Acetone extract of C. abbreviata failed to inhibit one strain of 
MRSA (Clinial #1) at 20mg/ml during agar dilution screening assay hence was not subjected 
to MIC analysis. All the selected strains of S. aureus were remarkably inhibited by all C. 
abbreviata extracts with the lowest MIC being 0.031mg/ml and the highest being 
0.063mg/ml. The MIC values of C. abbreviata extracts on P. aeruginosa strains ranged from 
0.031mg/ml to 0.5mg/ml. 
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Table 5.11: Mean MIC results of 23 selected bacterial strains tested with extracts of C.  
abbreviata 
Number Bacteria 
Name 
Strain Cassia abbreviata 
(mg/ml) 
Aqueous Methanol Acetone 
1 A. baumannii 1940242 - 0.25 0.25 
2 A. baumanni UH2880 - 0.125 1.0 
3 E. coli 893080 - 0.125 - 
4 E. coli 892894 0.25 0.031 0.125 
5 E. coli 891230 1.0 0.5 0.5 
6 E. coli 892476 0.25 0.125 0.125 
7 E. coli 893806 0.5 0.125 0.031 
8 K. pneumonia UB4088 - 0.25 - 
9 MRSA Clinical # 1 0.063 0.031 - 
10 MRSA 9708 0.031 0.031 0.031 
11 MRSA 1879918 0.063 0.031 0.063 
12 MRSA 1884230 0.031 0.031 0.031 
13 S. aureus ATCC43300 0.031 0.031 0.031 
14 S. aureus 891564 0.063 0.063 0.031 
15 S. aureus 891826 0.063 0.031 0.031 
16 S. aureus 867716 0.031 0.031 0.031 
17 S. aureus 867181 0.031 0.063 0.031 
18 S. aureus 864651 0.063 0.063 0.031 
19 P. aeruginosa ATCC27853 - 0.125 - 
20 P. aeruginosa 1882480 - 0.063 - 
21 P. aeruginosa 891975 0.5 0.031 0.063 
22 P. aeruginosa 864263 0.5 0.125 0.063 
23 P. aeruginosa UB4094 - 0.031 0.063 
     Key: (-): No inhibition even at highest concentration; MRSA: Methicillin-resistant S. aureus 
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Table 5.12: Mean MIC results of 23 selected bacterial strains tested with extracts of G. 
incanum 
Number Bacteria Name Strain Geranium incanum (mg/ml) 
Aqueous Methanol Acetone 
1 A. baumannii 1940242 0.063 0.063 0.063 
2 A. baumanni UH2880 0.063 0.063 0.063 
3 E. coli 893080 - - - 
4 E. coli 892894 - - - 
5 E. coli 891230 2.0 0.5 0.063 
6 E. coli 892476 0.063 0.125 0.063 
7 E. coli 893806 1.0 1.0 1.0 
8 K. pneumoniae UB4088 - - - 
9 MRSA Clinical # 1 0.063 0.063 0.063 
10 MRSA 9708 0.063 0.063 0.063 
11 MRSA 1879918 0.063 0.063 0.063 
12 MRSA 1884230 0.063 0.063 0.063 
13 S. aureus ATCC43300 0.063 0.063 0.063 
14 S. aureus 891564 0.063 0.063 0.063 
15 S. aureus 891826 0.063 0.063 0.063 
16 S. aureus 867716 0.063 0.063 0.125 
17 S. aureus 867181 0.25 0.25 0.125 
18 S. aureus 864651 0.063 0.063 0.063 
19 P. aeruginosa ATCC27853 0.063 0.063 0.063 
20 P. aeruginosa 1882480 0.125 0.125 0.125 
21 P. aeruginosa 891975 0.25 0.5 0.125 
22 P. aeruginosa 864263 0.063 0.125 0.125 
23 P. aeruginosa UB4094 0.25 0.125 0.125 
 Key: (-): No inhibition even at highest concentration; MRSA: Methicillin-resistant S. aureus 
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Table 5.13: Mean MIC results of 23 selected bacterial strains tested with extracts of P. 
hortorum 
Number Bacteria Name Strain Pelargonium hortorum (mg/ml) 
Aqueous Methanol Acetone 
1 A. baumannii 1940242 0.063 0.031 0.031 
2 A. baumanni UH2880 0.125 0.031 0.125 
3 E. coli 893080 - 0.031 - 
4 E. coli 892894 0.25 0.125 0.063 
5 E. coli 891230 0.031 0.031 0.031 
6 E. coli 892476 0.063 0.063 0.031 
7 E. coli 893806 0.031 0.031 0.125 
8 K. pneumoniae UB4088 - - - 
9 MRSA Clinical # 1 0.031 0.031 0.031 
10 MRSA 9708 0.031 0.031 0.031 
11 MRSA 1879918 0.031 0.031 0.031 
12 MRSA 1884230 0.031 0.031 0.031 
13 S. aureus ATCC43300 0.031 0.031 0.031 
14 S. aureus 891564 0.063 0.031 0.031 
15 S. aureus 891826 0.063 0.031 0.031 
16 S. aureus 867716 0.031 0.031 0.031 
17 S. aureus 867181 0.031 0.031 0.031 
18 S. aureus 864651 0.063 0.031 0.125 
19 P. aeruginosa ATCC27853 0.031 0.031 0.031 
20 P. aeruginosa 1882480 0.125 0.25 0.125 
21 P. aeruginosa 891975 DTD DTD DTD 
22 P. aeruginosa 864263 DTD DTD DTD 
23 P. aeruginosa UB4094 0.063 0.031 0.031 
     Key: (-): No inhibition even at highest concentration; MRSA: Methicillin-resistant S. aureus 
              DTD: Difficult to be detected by the microtitre reader due to high intensity colour of 
              extracts in the first wells.     
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Table 5.14: Mean MIC results of 23 selected bacterial strains tested with extracts of T. 
capensis 
Number Bacteria Name Strain Tecoma capensis (mg/ml) 
Aqueous Methanol Acetone 
1 A. baumannii 1940242 - - 1.0 
2 A. baumanni UH2880 - - 1.0 
3 E. coli 893080 - - - 
4 E. coli 892894 1.0 4.0 4.0 
5 E. coli 891230 0.031 0.031 0.031 
6 E. coli 892476 0.031 0.031 0.031 
7 E. coli 893806 1.0 0.5 0.5 
8 K. pneumoniae UB4088 - - - 
9 MRSA Clinical # 1 0.063 4.0 4.0 
10 MRSA 9708 0.031 - 0.031 
11 MRSA 1879918 0.031 - 0.031 
12 MRSA 1884230 - - 0.125 
13 S. aureus ATCC43300 0.063 - 0.063 
14 S. aureus 891564 0.5 - 4.0 
15 S. aureus 891826 0.125 - 0.063 
16 S. aureus 867716 0.031 - 0.031 
17 S. aureus 867181 0.063 - 0.031 
18 S. aureus 864651 0.5 - 4.0 
19 P. aeruginosa ATCC27853 - - - 
20 P. aeruginosa 1882480 - - - 
21 P. aeruginosa 891975 0.031 0.063 0.031 
22 P. aeruginosa 864263 - - 4.0 
23 P. aeruginosa UB4094 - - - 
 Key: (-): No inhibition even at highest concentration; MRSA: Methicillin-resistant S. aureus 
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In Table 5.12, the extracts of G. incanum displayed antibacterial activity against all the 
bacterial strains of A. baumannii, P. aeruginosa S. aureus and MRSA. Aqueous, methanol 
and acetone extracts of G. incanum had an MIC of 0.063mg/ml for all the two strains of A. 
baumannii. The lowest MIC value of G. incanum against the Gram-positive bacterial strains 
was 0.063mg/ml. This value (0.063mg/ml) was obtained in all the extracts of G. incanum 
against S. aureus and MRSA strains. The highest MIC value of G. incanum was 0.25mg/ml in 
the aqueous and methanol extracts against Gram-positive bacteria as depicted in S. aureus 
strain number 867181.  
 
For Gram-negative bacteria, the lowest MIC value (0.063mg/ml) produced by G. incanum 
extracts was detected in some strains of P. auruginosa (ATCC 27853 and 864263) and E. coli 
(892476 and 891230). The highest MIC value of G. incanum was 2.0mg/ml against Gram- 
negative bacterial strains, E. coli (891230). No Klebsiella pneumoniae strain was inhibited by 
G. incanum extracts at 20mg/ml with agar dilution method. 
 
The majority of the tested bacteria were inhibited by extracts of Pelargonium hortorum. 
The extracts of P. hortorum inhibited all A. baumannii strains (1940242 and UH2880) as 
indicated in Table 5.13. The range of MIC’s of P. hortorum on A. baumannii strains was 
0.031mg/ml to 0.125mg/ml. E. coli strain (893080) was only inhibited by the methanol 
extract of P. hortorum even at the lowest concentration of 0.031mg/ml. In E. coli strains, 
the lowest MIC value of P. hortorum extracts was 0.031mg/ml and the highest was 
0.25mg/ml in aqueous extract on strain number 892894. 
 
Aqueous, methanol and acetone extracts of P. hortorum inhibited all the selected MRSA 
strains at 0.031mg/ml. All S. aureus strains were inhibited by all extracts of P. hortorum 
with their MIC values ranging from 0.031mg/ml to 0.125mg/ml. Only three strains of P. 
aeruginosa (ATCC 27853, 1882480 and UB4094) had their MIC’s determined which ranged 
from 0.031mg/ml to 0.125mg/ml. The other two strains of P. aeruginosa (891975 and 
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864263) could not be detected by the microtitre plate reader. The reaction between the 
undiluted extracts on bacteria resulted in an intense turbidity of the extracts (extract colour 
intensified) thereby interfering with the detector of the plate reader at 550nm. The 
aqueous extract of P. hortorum exhibited slight inhibition during agar dilution screening 
assay on two strains of P. aeruginosa (ATCC 27853 and 1882480) as shown in Table 5.1. 
However, with microtitre MIC determination, the aqueous extract of P. hortorum inhibited 
the two strains of P. aeruginosa (ATCC 27853 and 1882480) at a concentration of 
0.031mg/ml and 0.125mg/ml respectively as displayed in Table 5.13. No extract of P. 
hortorum inhibited any strains of K. pneumoniae. 
 
In Table 5.14, only acetone extract of Tecoma capensis inhibited A. baumannii strains at 
1.0mg/ml. One strain of E. coli (893080) was not inhibited by any of the extracts of T. 
capensis. The lowest MIC value detected by T. capensis extracts on E. coli strains (891230 
and 892476) was 0.031mg/ml while the highest was 4.0mg/ml as displayed by methanol 
and acetone extracts on E. coli strain, 892894. T. capensis extracts did not show any 
bioactivity on K. pneumoniae strains hence no MIC’s were performed on these strains.   
 
The lowest MIC value (0.031mg/ml) of T. capensis against MRSA strains was in the aqueous 
and acetone extracts against strains (9708 and 1879918) and the highest MIC value 
(4.0mg/ml) was in the methanol and acetone extracts against one strain of MRSA (Clinical 
#1). No S. aureus strain was inhibited by methanol extract of T. capensis. The MIC value 
range produced by T. capensis aqueous and acetone extracts was 0.031mg/ml to 4.0mg/ml. 
Extracts of T. capensis showed some antibacterial activity only on two strains of P. 
aeruginosa (891975 and 864263). Only acetone extract of T. capensis inhibited P. 
aeruginosa strain (864263) at 4.0mg/ml. The lowest MIC value (0.031mg/ml) of T. capensis 
against P. aeruginosa strain number 891975 was produced by both aqueous and acetone 
extracts. Methanol extracts of T. capensis displayed less activity on bacterial strains tested 
in this study. 
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5.2.3 Anticandidal MIC determination of plants extracts 
In Table 5.1, the antimicrobial screening results of Candida albicans strains (ATCC 66027, 
1879415, 868102 and 1879083) revealed some bioactivity of the medicinal plants. Acetone 
extracts of C. abbreviata showed slight inhibition of the four C. albicans strains at 20mg/ml 
concentration. Acetone extracts of G. incanum inhibited one strain of C. albicans (1879083) 
at 20mg/ml. Three strains of C. albicans (ATCC 66027, 868102 and 1879083) were inhibited 
by methanol extracts of P. hortorum using the agar dilution method at 20mg/ml. The 
acetone extracts of P. hortorum showed slight inhibitory activity on all selected C. albicans 
strains. Basing on the screening results, three strains of C. albicans were tested for MIC 
determination using the agar dilution method and results are displayed in Table 5.15 below. 
 
      
     Table 5.15: MIC results of plant extracts on C. albicans strains 
Candida 
albicans 
 strains 
Concentration (mg/ml) 
Geranium incanum Pelargonium hortorum 
Acetone extracts Methanol extracts 
20mg/ml 10mg/ml 5mg/ml 20mg/ml 10mg/ml 5mg/ml 
ATCC 66027 - - - + - - 
868102 - - - + - - 
1879083 + - - + - - 
Key: (+): Inhibition; (-): No inhibition even at highest concentration; ATCC: American type  
 culture collection 
 
According to results displayed in Table 5.15, the lowest MIC value for C. albicans strains was 
20mg/ml. The MIC value was produced by G. incanum acetone extract on one strain 
(1879083) and P. hortorum methanol extract on three strains (ATCC 66027, 868102 and 
1879083) of C. albicans. This indicates that C. albicans strains require stronger plant 
potency hence their resistance in reduced concentrations of plant extracts. 
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5.3 THE FINDINGS OF QUALITATIVE ANALYSIS OF PHYTOCHEMICALS 
 
 Chemical tests were performed on aqueous, methanol and acetone extracts of the study 
medicinal plants for the qualitative determination of phytochemical constituents. 
Qualitative determination of phytochemical constituents was performed using various 
methods. Raaman (2006), Hossain and Nagooru (2011), Hussain et al. (2011) and Anowi et 
al. (2012) techniques were followed for the determination of alkaloids, glycosides, 
saponins, proteins and amino acids, phytosterol and phenolic compounds. Methods of  
(Odugbemi, 2008a) and Selvamohan et al. (2010) were used to determine the presence of 
anthraquinones. Flavonoids and triterpenoids were examined by adopting methods from 
Hossain and Nagooru (2011) and Kavishanka et al. (2011). The results of the phytochemical 
findings are displayed in Tables 5.16 to 5.19. 
 
     Table 5.16: Phytochemical screening of Cassia abbreviata stem bark extracts 
     Cassia abbreviata  
Active constituents Aqueous extract Methanol extract Acetone extract 
Alkaloids - - - 
Amino acids - - - 
Anthraquinones + + + 
Flavonoids + + + 
Glycosides - - - 
Phytosterol + + + 
Saponins + (5.5cm) + (3cm) - 
Tannins + + + 
Triterpenoids + + + 
     Key: (+): Present; (-): Absent 
 
Qualitative phytochemical analysis revealed the presence of anthraquinones, flavonoids, 
phytosterol, tannins and triterpenoids in all extracts of the stem bark of C. abbreviata plant. 
Saponins were present only in aqueous and methanol extracts of C. abbreviata stem bark. 
Alkaloids, amino acids and glycosides were not identified in C. abbreviata extracts. 
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     Table 5.17: Phytochemical screening of Geranium incanum leaf extracts 
Geranium incanum  
Active constituents Aqueous extract Methanol extract Acetone extract 
Alkaloids - - - 
Amino acids - - - 
Anthraquinones - - - 
Flavonoids + + + 
Glycosides - - - 
Phytosterol + + + 
Saponins + (5.5cm) - - 
Tannins + + + 
Triterpenoids - - - 
     Key: (+): Present; (-): Absent 
 
Table 5.17 exhibits the presence of flavonoids, phytosterol and tannins in all extracts of G. 
incanum leaf extracts. Saponins were present only in aqueous extract of G. incanum leaf. 
Alkaloids, amino acids, anthraquinones, glycosides and triterpernoids were absent during 
phytochemical analysis of G. incanum leaf extracts. 
 
     Table 5.18: Phytochemical screening of Pelargonium hortorum leaf extracts 
Pelargonium hortorum  
Active constituents Aqueous extract Methanol extract Acetone extract 
Alkaloids - - - 
Amino acids - - - 
Anthraquinones - - - 
Flavonoids + + + 
Glycosides - - - 
Phytosterol + + + 
Saponins + (5cm) + (2cm) - 
Tannins + + - 
Triterpenoids - - - 
     Key: (+): Present; (-): Absent 
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Table 5.18 on page 181 reveals the presence of flavonoids and phytosterol in aqueous, 
methanol and acetone leaf extracts of P. hortorum. Saponins and tannins were only present 
in aqueous and methanol leaf extracts of P. hortorum. Alkaloids, amino acids, 
anthraquinones, glycosides and triterpernoids were absent during phytochemical analysis 
of P. hortorum leaf extracts. 
 
  Table 5.19: Phytochemical screening of Tecoma capensis leaf extracts 
Tecoma capensis  
Active constituents Aqueous extract Methanol extract Acetone extract 
Alkaloids - - - 
Amino acids - - - 
Anthraquinones - - - 
Flavonoids + + + 
Glycosides - - - 
Phytosterol + + + 
Saponins + (3cm) + (2cm) - 
Tannins + + - 
Triterpenoids - - - 
     Key: (+): Present; (-): Absent 
 
Table 5.19 reveals the presence of secondary metabolites such as flavonoids, phytosterol, 
saponins and tannins that were found in leaf extracts of T. capensis. Flavonoids and 
phytosterol were present in all extracts of T. capensis. Saponins and tannins were present 
only in aqueous and methanol extracts of T. capensis. Alkaloids, amino acids, 
anthraquinones, glycosides and triterpernoids were absent during phytochemical analysis 
of T. capensis leaf extracts. 
 
Among all the tested plant extracts as demonstrated in Tables 5.17 to 5.19, the presence of 
saponins were more pronounced in aqueous extracts of both C. abbreviata and G. incanum 
with foam reaching 5.5cm high in the measuring cylinder. The least amount of saponins was 
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produced by P. hortorum and T. capensis methanol extracts with foam rising only to a 
height of 2cm in the measuring cylinder. 
 
5.4 ANALYSIS OF THIN LAYER CHROMATOGRAPHY 
 
The TLC fingerprints of different extracts were carried out by spotting the plate using a 
capillary tube with the sample from methanol and acetone extracts as a 1cm band onto a 
large TLC plate (silica gel 60 F254, 25 units, 20cm x 20cm, Merck). 
 
The plates were either developed in petroleum ether: ethyl acetate: chloroform: formic 
acid (PECF)/ (8:7:5:1) for intermediate polarity or in ethyl acetate: methanol: water (EMW)/ 
(20:2.7:2) for polar or neutral over a distance of 14cm as shown in Figure 5.21. 
 
                PECF glass jar                                                            EMW glass jar 
 
                         
 
           Figure 5.21: Extracts on TLC silica plates developing in EMW and PECF glass jars 
 
Following development of TLC plates, the plates were allowed to air dry and the separated 
compounds were visualised under ultraviolet light using BLT UV-lamp. Figure 5.22 shows 
TLC silica plates and the developed bands of methanolic extracts of selected plants when 
viewed under a BLT UV-lamp. The order of the spots on the plate were from C. abbreviata, 
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P. hortorum, T. capensis and G. incanum extracts. Table 5.20 and Table 5.21 display the Rf 
values of the tested bacteria.  
 
                         Developed bands of compounds 
 
 
           
 
           C     P    T    G       
Figure 5.22: Air dried, developed TLC silica plates as viewed under a BLT UV- lamp 
             Key: C: Cassia extract spot; P: Pelargonium extract spot; T: Tecoma extract spot 
              G: Garanium extract spot 
 
5.5 THE BIOAUTOGRAPHIC ASSAY 
 
Bioautographic results of TLC plates eluted in EMW and PECF revealed the presence of 
several various active spots (colourless spots), which are indicative of the active compounds 
against the different strains of bacteria and fungi. The bioautographic assay showed a 
number of clear white spots against a purple background. The clear zones (white spots) on 
the chromatogram indicated inhibition of bacterial growth by bioactive compounds present 
on the TLC plate surface. Inhibition zones were visible in methanol and acetone extracts of 
all the plants tested. Figure 5.23 exhibits zones of inhibition indicated by clear zones (see 
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arrows) signifying different compounds that were separated from methanol and acetone 
extracts of Cassia abbreviata, Pelargonium hortorum, Tecoma capensis and Geranium 
incanum. Table 5.20 and Table 5.21 show the Rf values of eleven selected bacteria of which 
Rf values were calculated after visualization under UV light. 
 
                              Arrows pointing to clear zones of inhibition 
 
           
                              a                                                                    b   
 
 
           
                                c                                                               d 
              Figure 5.23: Some clear zones of inhibition on TLC silica plates shown by arrows 
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TLC silica plates in a and b of Figure 5.23 are examples of the bioautographic preparations 
from methanol extracts of the selected plants while in c and d are from acetone 
preparations. 
 
Six major bands were used in reading the bioautographic results as presented in Table 5.20 
and Table 5.21. Bioautographic results depict compounds that inhibited growth of bacteria 
that were not shown during agar dilution screening method. For example, there were 
bands in methanol and acetone preparations of T. capensis that showed activity against the 
reference strain of Pseudomonas aeruginosa, ATCC 27853 (Table 5.20 and Table 5.21) 
whereas the organism was not inhibited by T. capensis during screening procedure (Table 
5.1). T. capensis methanol bioautographic assays showed some activity against A. 
baumannii strains with bands producing clear zones of inhibition on TLC silica plates. This is 
an indication that some bioactive compounds dissolve well with solvents used during TLC 
preparations. 
 
Antibacterial activity of H.influenzae strains on TLC silica plates agreed with the results 
obtained during agar dilution method. In agar dilution method, H. influenzae strains 
(8993636 and 1893772) were only inhibited by P. hortorum and G. incanum extracts (Table 
5.7). Similarly, clear zones of inhibition were created from P. hortorum and G. incanum 
extracts on TLC silica plates for H. influezae strains as depicted in Table 5.20 and Table 5.21.  
The Rf values in H. influenzae strains ranged from 0.19 to 0.78 in methanolic extracts. 
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Table 5.20: Rf values of major zones displayed in chromatograms of methanol extracts of selected medicinal plants 
Name of 
Bacterial 
Strain 
Methanol Extracts 
Band 1 Band 2 Band 3 Band 4 Band 5 Band 6 
C P T G C P T G C P T G C P T G C P T G C P T G 
S.a., ATCC 
43300 
 
0.14 
 
0.14 
 
0.14 
 
NB 
 
0.29 
 
0.29 
 
0.29 
 
0.32 
 
0.51 
 
0.51 
 
0.51 
 
0.51 
 
0.65 
 
0.65 
 
0.65 
 
0.65 
 
0.79 
 
0.79 
 
0.79 
 
0.79 
 
0.94 
 
0.94 
 
0.94 
 
0.94 
S.a., 
867716 
 
NB 
 
0.14 
 
NB 
 
0.14 
 
NB 
 
0.23 
 
0.23 
 
0.23 
 
0.47 
 
0.38 
 
0.31 
 
0.28 
 
NB 
 
0.58 
 
0.48 
 
0.48 
 
NB 
 
NB 
 
0.68 
 
NB 
 
NB 
 
0.8 
 
NB 
 
0.8 
MRSA 9708  
NB 
 
0.24 
 
0.24 
 
0.24 
 
NB 
 
0.34 
 
0.34 
 
0.34 
 
0.47 
 
0.47 
 
0.47 
 
0.47 
 
0.65 
 
0.65 
 
0.60 
 
0.65 
 
NB 
 
0.79 
 
0.79 
 
0.79 
 
0.90 
 
0.90 
 
0.90 
 
0.94 
P.s., ATCC 
27853 
 
0.09 
 
0.09 
 
0.09 
 
NB 
 
0.26 
 
0.26 
 
0.26 
 
0.26 
 
0.47 
 
NB 
 
0.47 
 
0.47 
 
0.74 
 
0.74 
 
0.74 
 
0.74 
 
0.85 
 
0.85 
 
NB 
 
0.85 
 
0.94 
 
0.94 
 
NB 
 
NB 
P.s., 891975  
NB 
 
0.14 
 
0.14 
 
0.14 
 
NB 
 
0.43 
 
0.43 
 
0.49 
 
0.51 
 
0.51 
 
0.51 
 
NB 
 
0.71 
 
0.71 
 
0.71 
 
0.71 
 
0.91 
 
0.91 
 
0.91 
 
0.91 
 
NB 
 
NB 
 
NB 
 
NB 
A.b, 
1940242 
 
0.30 
 
0.20 
 
0.30 
 
0.30 
 
0.43 
 
0.43 
 
NB 
 
0.49 
 
0.58 
 
0.58 
 
0.58 
 
NB 
 
0.71 
 
0.71 
 
0.71 
 
0.71 
 
0.81 
 
0.81 
 
0.81 
 
0.81 
 
0.94 
 
0.94 
 
0.94 
 
0.94 
A.b., 
UH2880 
 
0.21 
 
0.21 
 
0.21 
 
0.21 
 
0.36 
 
NB 
 
0.36 
 
0.36 
 
0.51 
 
0.51 
 
0.51 
 
0.51 
 
0.67 
 
0.67 
 
0.62 
 
NB 
 
0.74 
 
0.74 
 
0.74 
 
0.74 
 
0.94 
 
0.94 
 
0.94 
 
0.94 
E.c., 891230  
0.21 
 
0.21 
 
0.21 
 
0.21 
 
0.31 
 
0.31 
 
0.31 
 
0.31 
 
0.42 
 
0.42 
 
0.42 
 
0.42 
 
0.53 
 
0.61 
 
0.53 
 
0.53 
 
0.83 
 
0.83 
 
0.83 
 
0.83 
 
NB 
 
0.94 
 
0.94 
 
NB 
E.c., 892476  
NB 
 
0.20 
 
0.20 
 
0.20 
 
NB 
 
0.31 
 
NB 
 
0.31 
 
NB 
 
0.42 
 
NB 
 
0.42 
 
0.66 
 
0.66 
 
NB 
 
0.66 
 
0.76 
 
0.76 
 
0.76 
 
NB 
 
0.90 
 
0.90 
 
0.90 
 
0.90 
H.i., 
8993636 
 
NB 
 
NB 
 
NB 
 
0.19 
 
0.52 
 
NB 
 
NB 
 
NB 
 
NB 
 
0.78 
 
NB 
 
NB 
 
NB 
 
NB 
 
NB 
 
NB 
 
NB 
 
NB 
 
NB 
 
NB 
 
NB 
 
NB 
 
NB 
 
NB 
H.i., 
1893772 
 
NB 
 
NB 
 
NB 
 
0.41 
 
NB 
 
0.52 
 
NB 
 
0.52 
 
NB 
 
NB 
 
NB 
 
0.63 
 
NB 
 
NB 
 
NB 
 
0.77 
 
NB 
 
NB 
 
NB 
 
NB 
 
NB 
 
NB 
 
NB 
 
NB 
Key: C: Cassia abbreviata; P: Pelargonium hortorum; T: Tecoma capensis; G: Geranium incanum; S.a: Staphylococcus aureus;  
         P.s: Pseudomonas aeruginosa; A.b: Acinetobacter baumannii; E.c: Esherichia coli; H.i: Haemophilus influenzae;  
         NB: No band present; MRSA: Methicillin resistant-Staphylococcus aureus; ATCC: American type culture collection    
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Table 5.21: Rf values of major zones displayed in chromatogram of acetone extracts of selected medicinal plants 
Name of 
Bacterial 
Strain 
Acetone  Extracts 
Band 1 Band 2 Band 3 Band 4 Band 5 Band 6 
C P T G C P T G C P T G C P T G C P T G C P T G 
S.a., ATCC 
43300 
 
0.25 
 
0.25 
 
0.25 
 
0.25 
 
0.38 
 
0.38 
 
0.38 
 
0.38 
 
NB 
 
0.51 
 
0.51 
 
0.51 
 
0.65 
 
0.65 
 
0.65 
 
0.65 
 
0.75 
 
0.75 
 
0.75 
 
0.75 
 
0.94 
 
0.94 
 
0.94 
 
0.94 
S.a., 
867716 
 
NB 
 
0.14 
 
0.14 
 
NB 
 
NB 
 
0.23 
 
0.23 
 
0.23 
 
0.45 
 
0.45 
 
0.45 
 
0.45 
 
NB 
 
0.56 
 
0.56 
 
0.56 
 
0.70 
 
0.70 
 
0.70 
 
0.70 
 
0.87 
 
0.87 
 
0.87 
 
0.87 
MRSA 9708  
0.19 
 
0.14 
 
0.19 
 
0.19 
 
0.30 
 
0.30 
 
0.30 
 
0.30 
 
0.39 
 
0.39 
 
0.39 
 
0.39 
 
0.50 
 
0.50 
 
0.50 
 
0.50 
 
0.70 
 
0.70 
 
0.70 
 
0.70 
 
0.94 
 
0.87 
 
0.91 
 
0.87 
P.s., ATCC 
27853 
 
NB 
 
NB 
 
0.19 
 
0.19 
 
NB 
 
NB 
 
0.29 
 
0.29 
 
NB 
 
0.50 
 
0.45 
 
0.45 
 
NB 
 
0.60 
 
NB 
 
NB 
 
NB 
 
NB 
 
0.75 
 
0.75 
 
0.94 
 
0.94 
 
0.94 
 
0.94 
P.s., 891975  
0.14 
 
0.14 
 
0.14 
 
0.14 
 
0.30 
 
0.30 
 
0.30 
 
0.30 
 
0.49 
 
0.49 
 
0.49 
 
NB 
 
0.70 
 
0.70 
 
0.70 
 
0.70 
 
0.94 
 
0.94 
 
0.94 
 
0.94 
 
NB 
 
NB 
 
NB 
 
NB 
A.b, 
1940242 
 
0.24 
 
0.24 
 
0.24 
 
0.24 
 
0.32 
 
0.32 
 
0.32 
 
0.32 
 
0.54 
 
0.54 
 
NB 
 
0.54 
 
0.75 
 
NB 
 
0.75 
 
0.75 
 
0.83 
 
0.83 
 
0.83 
 
0.83 
 
0.94 
 
0.94 
 
NB 
 
0.94 
A.b., 
UH2880 
 
0.24 
 
0.24 
 
0.24 
 
0.24 
 
0.47 
 
0.44 
 
0.44 
 
0.44 
 
NB 
 
0.57 
 
0.57 
 
0.57 
 
0.70 
 
0.70 
 
0.70 
 
0.70 
 
0.94 
 
0.94 
 
0.94 
 
0.94 
 
NB 
 
NB 
 
NB 
 
NB 
E.c., 891230  
0.24 
 
0.24 
 
0.24 
 
0.24 
 
0.38 
 
0.38 
 
0.38 
 
0.38 
 
0.49 
 
0.49 
 
0.49 
 
0.49 
 
0.71 
 
0.71 
 
0.71 
 
0.71 
 
0.87 
 
0.87 
 
0.87 
 
0.87 
 
0.94 
 
0.94 
 
0.94 
 
0.94 
E.c., 892476  
NB 
 
0.19 
 
0.19 
 
0.19 
 
0.31 
 
0.31 
 
0.31 
 
0.31 
 
NB 
 
NB 
 
0.50 
 
0.50 
 
0.66 
 
0.66 
 
0.66 
 
0.66 
 
0.85 
 
0.85 
 
NB 
 
NB 
 
0.94 
 
0.94 
 
NB 
 
0.94 
H.i., 
8993636 
 
NB 
 
NB 
 
NB 
 
0.31 
 
NB 
 
NB 
 
NB 
 
0.47 
 
NB 
 
NB 
 
NB 
 
0.53 
 
NB 
 
0.75 
 
NB 
 
0.75 
 
NB 
 
NB 
 
NB 
 
0.83 
 
NB 
 
NB 
 
NB 
 
NB 
H.i., 
1893772 
 
NB 
 
0.57 
 
NB 
 
NB 
 
NB 
 
NB 
 
NB 
 
NB 
 
NB 
 
0.83 
 
NB 
 
0.83 
 
NB 
 
NB 
 
NB 
 
NB 
 
NB 
 
NB 
 
NB 
 
NB 
 
NB 
 
NB 
 
NB 
 
NB 
Key: C: Cassia abbreviata; P: Pelargonium hortorum; T: Tecoma capensis; G: Geranium incanum; S.a: Staphylococcus aureus;  
         P.s: Pseudomonas aeruginosa; A.b: Acinetobacter baumannii; E.c: Esherichia coli; H.i: Haemophilus influenzae;  
          NB: No band present; MRSA: Methicillin resistant-Staphylococcus aureus; ATCC: American type culture collection
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The Rf values in H. influenzae strains in acetone extracts was from 0.31 to 0.83. The Rf 
values for the three strains of S. aureus used in bioautographic assay (ATCC 43300, 867716 
and MRSA 9708) in both extracts (methanol and acetone) ranged from 0.14 to 0.94. In zone 
number six, both methanolic and acetone TLC preparations showed an Rf value of 0.94 for 
S. aureus, ATCC 43300. This indicates that the compound in that zone in all plants could be 
the same. The Rf values for tested P. aeruginosa strains ranged from 0.09 to 0.94 while that 
of A. baumannii ranged from 0.20 to 0.94. The tested E. coli strains had Rf value range of 
0.20 to 0.94 across both extracts. 
  
 5.6 THE AMES TEST RESULTS 
 
The Ames test is commonly used as a bacterial assay for identifying substances that can 
produce genetic damage that leads to gene mutations. The test employs a number of 
Salmonella strains with pre-existing mutations that leave the bacteria unable to synthesize 
the required amino acid, histidine, and therefore unable to grow and form colonies in its 
absence (Mortelmans & Zeiger, 2000). Extracts of C. abbreviata, G. incanum, P. hortorum  
and T. capensis were tested for the possible carcinogenicity using the Ames test.   
 
The Ames test results exhibited in Table 5.22 were read according to Organisation for 
Economic Co-operation and Development (OECD) guidelines as described by Magesh et al. 
(2008); Jin et al. (2009); Sundaram, Vijayalakshmi and Nema (2010) and Hong et al. (2011a). 
An extract was interpreted as mutagenic if the number of the revertant colonies was equal 
to or greater than two times the activity observed in a negative control (Sundaram et al., 
2010; Hong et al., 2011b; Marczewska et al., 2011). The test was repeated thrice and the 
average of the revertant colonies from the negative control plates, positive control plates 
and each plant extract were manually counted. The API 10 S (BioMerieux) test was used to 
confirm the revertant colonies of the S. typhimurim as displayed in Figure 5.24. 
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             S. typhimurium revertant colonies                   API 10 S positive test plates 
          a   b 
      Figure 5.24: Colonies of S. typhimurium on DMA agar and their verification using the API test 
 
In Figure 5.24 above, plate a contains growth of revertant colonies on a 5mg/ml C. 
abbreviata acetone plate. Plate b is an API 10 S confirmatory test for S. typhimurium 
growing on plate a. 
 
According to the criteria defined in this study, extracts of Cassia abbreviata, Geranium 
incanum, Pelargonium hortorum and Tecoma capensis could be described as possessing 
antimutagenic features. In the absence of metabolic activation, the selected plants 
displayed the absence of mutagenic induction since the mutagenic index of all the plants 
was below 2 as displayed in Table 5.22. The average range of his+ revertant colonies was 
between 5 and 40. The average mutagenic index range displayed by his+ revertant colonies 
was from 0.19 to 1.54. An average of 26 colonies was observed on negative control plates 
while average of 213 colonies were observed on positive control plates. S. typhimurium, 
TA100 exposed to different concentrations (2.5mg/ml and 5mg/ml) of study plants, did not 
show two-fold or greater increase in the mean number of revertants as compared to the 
negative control hence no extracts was considered mutagenic in this study. 
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     Table 5.22: Mutagenic index and number of revertants in S. typhimurium strain TA 100 
Plant Extract Concentration vs Number of Colonies per 
plate 
2.5mg/ml MI 5mg/ml MI 
Cassia abbreviata Aqueous 13 0.50 10 0.38 
Methanol 19 0.73 14 0.54 
Acetone 11 0.42 14 0.54 
Geranium incanum Aqueous 6 0.23 5 0.19 
Methanol 9 0.35 10 0.38 
Acetone 7 0.27 8 0.31 
Pelargonium hortorum Aqueous 15 0.58 8 0.31 
Methanol 40 1.54 12 0.46 
Acetone 27 1.04 9 0.35 
Tecoma capensis Aqueous 15 0.58 6 0.23 
Methanol 8 0.31 20 0.77 
Acetone 9 0.35 22 0.85 
4-nitroquinoline-N-oxide (positive control), 20 µg/ml      213 colonies 
Phosphate buffered water (PBS), negative control            26  colonies 
     Key: MI: Mutagenic index 
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CHAPTER 6 
DISCUSSION AND CONCLUSION 
 
Infectious diseases are still a stupendous health concern, accounting for 41% of the global 
disease burden determined in terms of Disability-Adjusted Life Years (DALYS), close to all 
non-infectious diseases (43%) and far more than injuries (Noumedem et al., 2013). 
Pneumonia and other acute lower respiratory infections (ALRI) are the third leading cause 
of death worldwide and the first in low-income countries. The vast majority of ALRI deaths 
are due to pneumonia and nearly all severe ALRI episodes occur in children under five 
years, the elderly and immuno-compromised individuals (Reid et al., 2011; Vong et al., 
2013). However, it is estimated that in children younger than five years, pneumonia is a 
leading global cause of morbidity and mortality (Kumble, 2006; Ribeiro, Ferrari & Fioretto, 
2011; Soofi, Ahmed, Fox, MacLeod, Thea, Qazi & Bhutta, 2012). Every year, there are 
approximately 156 million new cases of pneumonia and nearly two million deaths from the 
disease occur in children under five years of age (Cohen, Hyde, Verani & Watkins, 2012). 
One of the major causes of infectious diseases such as pneumonia, is the widespread 
emergence of acquired bacterial resistance to antibiotics that the world is facing today 
(Gangoue-Pieboji et al., 2009; Noumedem et al., 2013).  
 
The increase in the number of multiple-drug resistant microbial strains has been attributed 
to indiscriminate use of broad-spectrum antibiotics, immunosuppressive agents, 
intravenous catheters, organ transplantation and ongoing epidermics of human 
immunodeficiency virus (HIV) infections (Cheesbrough, 2006; Selvamohan et al., 2010; 
Bauman, 2012). This situation coupled with the undesirable side-effects of certain 
antibiotics has influenced the impetus to search for more new antimicrobial substances 
from various sources like medicinal plants hence the existence of this study. Current 
research on natural molecules and products primarily focuses on plants since they can be 
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more easily sourced and selected based on their ethno-medicinal uses (Kaur & Arora, 2009; 
Saini et al., 2011; Raj, Balachandran, Duraipandiyan, Agastian & Ignacimuthu, 2012). 
 
Medicinal plants have been used for ages in the prevention and treatment of human 
diseases (Akintobi et al., 2011; Marzouk et al., 2011; Mashele & Fuku, 2011; Saini et al., 
2011; Rahman et al., 2013). In Africa, the use of traditional herbal remedies as alternative 
medicine play a vital role since they form part of the culture and beliefs of the indigenous 
population and also feature significantly in primary healthcare (Hong et al., 2011b). Saini et 
al. (2011) deduced that the lead to search for new antimicrobial agents particularly among 
plant extracts with the goal to discover new chemical structures was necessary. This is one 
of the ways that would overcome the development of drug resistance as well as the 
appearance of undesirable side effects of certain conventional medicine (Senthilkumar, 
Kumar & Pandian, 2010). Traditional medicine may be the principal form of health care and 
may be an integrated or an alternative component of an allopathic health care system. In 
order for traditional and allopathic medicine to work in partnership, the World Health 
Organization suggests that traditional medicine must also be based on science - the 
evidence-based approach (Rai et al., 2012, p. 7). 
 
In this study, the four medicinal plants selected for investigation form part of traditional 
medicinal plants used in the Eastern Cape, as well as other parts of South Africa. The 
extracts of medicinal plants listed in Table 3.1 were studied for their antimicrobial activities 
against the standard ATCC strains and clinical isolates of Streptococcus pneumoniae, 
Haemophilus influenzae, Staphylococcus aureus, Pseudomonas aeruginosa, Acinetobacter 
baumannii, Escherichia coli and the fungus Candida albicans. Data corresponding to the 
extracts of the tested plants that showed microbial growth inhibition in the disc diffusion 
assay, agar dilution assay, broth microtitre plate assay, qualitative phytochemical 
determinations and thin-layer chromatographic assays will be discussed. In addition, data 
concerning incorporation of Ames test using Salmonella typhimuriun, TA 100 which was 
employed to assess the mutagenic activity of the study plants in the absence of metabolic 
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activation with S9 fraction will be discussed.  The mutagenicity test played a vital role in this 
study in order to determine whether the selected medicinal plants can be safely used for 
potential pharmaceutical purposes. 
 
The main aim of the study was to establish the potential antimicrobial activities of the 
selected plants (Cassia abbreviata, Geranium incanum, Pelargonium hortorum and Tecoma 
capensis) used in traditional medicine to treat acute lower respiratory infections, 
particularly pneumonia. The information concerning the presence or absence of 
antimicrobial activity may escalate the use of efficacious indigenous plant therapies. 
Ethnobotanical information revealed that all the plants selected in this study are 
traditionally used fresh for medicinal purposes (Watt & Breyer-Brandwijk, 1962; Grazzin et 
al., 1997; Kambizi & Afolayan, 2001; Van Wyk et al., 2009;  Jothi et al., 2011; Saini et al., 
2011; Saraswathi et al., 2011; Tamiljothi et al., 2011; Jothi et al., 2012a; Jothi et al., 2012b; 
Van Wyk et al., 2012).  
 
In this study water, methanol and acetone were the solvents used for extraction of the 
plant materials. Organic solvents (methanol and acetone) were incorporated in this study 
because they easily evaporate and permit an easier estimation of extract concentration 
(Assob et al., 2011). Many studies have indicated the use of respective solvents for 
redissolving their dried, individual extracts residues (Kambizi & Afolayan, 2001; Pendota et 
al., 2009; Sagar, Reethi, Akshatha & Prasad, 2012). In the present work, it was found to be 
problematic especially with the use of water. Instead, dimethylsulphoxide (DMSO) was used 
for redissolving the solvent-free dried plant extracts as illustrated by several researchers 
(Pallant & Steenkamp, 2008; Gupta & Vasudeva, 2010; Mariita, Ogol, Oguge & Okemo, 
2011; Shai, Magano, Lebelo & Mogale, 2011; Ahameethunisa & Hopper, 2012; Noumedem 
et al., 2013). Aqueous extracted the highest concentration of plant material on average for 
all the medicinal plants investigated in this study. On the other hand, acetone extraction of 
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medicinal plants produced the lowest plant extract concentration yield and as a result more 
plant material was used for acetone extraction. 
 
Two antibacterial assays were used for screening the medicinal plants, namely, agar 
dilution method and agar disc diffusion method. Table 5.1 summarises the overall inhibition 
obtained during the screening of non-fastidious bacteria and fungi. During agar dilution 
method, all examined plant extracts exhibited varying degrees of antimicrobial activity 
aganist the selected pathogens (Table 5.1). The methanol extract of Pelargonium hortorum 
leaf inhibited a greater percentage (71%) of microorganisms when compared to all extracts 
of the other three plants as shown in Figure 5.14. Interestingly, literature revealed a 
number of studies that have undertaken the investigation of pelargonium plant species. 
Most of the studies have recorded antimicrobial activities of Pelargoniums on tubers or 
roots unlike leaves  (Kolodziej,  2007; Brendler & van Wyk, 2008; Schnitzler, Schneider, 
Stintzing, Carle & Reichling, 2008; Saraswathi et al.,  2011). For instance, the root of 
Pelargoniums such as Pelargoniums sidoides and Pelargonium reniforme have been used for 
centuries as a traditional herbal remedy in South Africa. The plants (Pelargoniums) are 
highly valued by traditional healers as a remedy to treat various ailments such as coughs, 
upper respiratory tract irritations, diarrhoea, dysentery, malaria, liver complaints and 
gastrointestinal conditions (de Boer, Hagemann, Bate & Meyboom, 2007; Brown, 2009; 
Saraswathi et al., 2011; Maree & Viljoen, 2012).  
 
In the present investigation, the paramount interest was to focus on the antimicrobial 
activities of the P. hortorum leaf and not the root or tuber. The leaf of P. hortorum revealed 
to have significant antimicrobial effects in compliance with the root findings of other 
Pelaragoniums recorded in various literature. The acetone extract of P. hortorum leaf 
showed notable activity by inhibiting 60% of the organisms while aqueous extracts inhibited 
54% of the organisms tested using agar dilution method at 20mg/ml (Figure 5.14). Plants 
belonging to the genus Pelargoniums are well documented for their antimicrobial activity 
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and the inhibitory potencies demonstrated by P. hortorum leaf extracts supports this claim 
(Kolodziej, 2011; Saraswathi et al.,  2011). 
 
Methanol extracts of the stem bark of Cassia abbreviata inhibited about 66% more 
organisms than the aqueous and acetone preparations from the same plant. In Geranium 
incanum and Tecoma capensis preparations, acetone extracts exhibited more notable 
inhibition of microorganism than aqueous and methanol prepared from these plants (Figure 
5.14). Methanol extracts of T. capensis showed the least inhibition of all the extracts tested 
in this study with only 17% inhibition of the tested organisms. This contrasts the 
observation from the study conducted by Saini et al. (2011) in which the methanolic extract 
of T. capensis demonstrated much more antimicrobiral activity against both Gram-negative 
and Gram-positive bacteria including some species of fungi. The least or no antibacterial 
activity demonstrated by T. capensis extract could be due to loss of some active 
bioconstituents during extraction process and a lack of solubility of active compounds in the 
solvent. This was also observed by Kavishankar et al. (2011) in his study. 
 
The overall picture of Table 5.1 indicates that most Gram-positive bacteria were inhibited 
by the plant extracts as compared to Gram-negative ones. Similar observations have been 
reported by several researchers (Kambizi & Afolayan, 2001; Iwalewa et al., 2009; Limsuwan, 
Subhadhirasakul & Voravuthikunchai, 2009; Sharma et al., 2012). Susceptibility differences 
between Gram-positive and Gram-negative bacteria may be due to cell wall structural 
differences between the classes of bacteria (Jensen et al., 1997, p. 38-39; Singaria et al., 
2012). Gram-positive bacteria were more susceptible to the tested plant extracts than 
Gram-negative bacteria because Gram-positive bacteria cell wall is made up of 
approximately 90% peptidoglycan. The peptidoglycan component is not regulatory as 
compared to the cell membrane of the Gram-negative bacteria and therefore, it is 
incapable of performing the function of selective permeability thereby liable to allowing 
substances to sieve through it (Mills-Robertson, Tay, Duker-Eshun, Walana & Badu, 2012). 
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On the other hand, the higher resistance performed by Gram-negative organisms to plant 
extracts may be due to the thick murein layer (phospholipidic with structural 
lipopolysaccharide components) present in their outer membrane (Table 4.1) that impedes 
the entrance of inhibitor substances into the cell (Adebiyi et al., 2009; Gangoue-Pieboji et 
al., 2009; Kaur & Arora, 2009; Rai et al., 2012). Table 5.1 indicates K. pneumoniae strains as 
the bacteria that produced the greatest resistance to the selected medicinal plants. K. 
pneumoniae resisted all medicinal plant extracts except the methanolic extract of C. 
abbreviata which inhibited growth of one strain of K. pneumoniae (UB4088). This agrees 
with literature that K. pneumoniae isolates are spread worldwide in hospitals because they 
are capable of producing extended-spectrum β-lactamase (ESBL) enzymes that render them 
resistant to antibiotic treatment (Correa et al., 2013). Four strains of K. pneumoniae isolates 
used in this study resisted all beta-lactam drugs as shown in Table 5.2, probably signifying 
ESBL producing bacteria.  
 
Although resistance patterns were high in Gram-negative bacteria, the plant extracts still 
demonstrated remarkable potency on some Gram-negative bacteria under investigation at 
a concentration of 20mg/ml. In Figure 5.10, overall performance of C. abbreviata extracts 
exhibited a 100% inhibition on A. baumannii and P. aeruginosa. G. incanum extracts 
displayed a 100% inhibition on A. baumannii and 80% inhibitory activity on P. aeruginosa 
(Figure 5.11). P. hortorum extracts demonstrated a 100% inhibitory activity against both A. 
baumannii and P. aeruginosa (Figure 5.12). In Figure 5.13, T. capensis extracts exhibited 
100% inhibitory effect on A. baumannii. These were good findings as both P. aeruginosa 
and A. baumannii are known to be difficult to treat with commonly used antibiotics. For 
instance, P. aeruginosa demonstrates its resistance because of the cell wall properties. The 
organism has remakable metabolic capabilities and diverse plasmids which contribute to its 
high level of resistance to a wide range of antibiotics (Jensen et al., 1997; Prescott et al., 
2005; Omwenga & Paul, 2012). 
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The antifungal activity obtained by agar dilution method, was mainly demonstrated by the 
Geraniaceae, G. incanum and P. hortorum leaf extracts as shown in Table 5.1. The 
methanolic extract of P. hortorum showed better results by completely inhibiting the three 
strains of Candida albicans at 20mg/ml. Acetone extract of G. incanum inhibited growth of 
only one strain of C. albicans (1879083). There was no anticandidal activity demonstrated 
by T. capensis extracts while acetone extracts of C. abbreviata and P. hortorum showed 
slight inhibitory activity on all strains of C. albicans tested in this study. No C. albicans strain 
was totally inhibited at a concentration lower than 20mg/ml as such, 20mg/ml was 
considered the lowest minimum inhibitory concentration attained by the selected 
medicinal plants (Table 5.15). The results on C. albicans strains suggest that increasing the 
concentration of acetone extracts of C. abbreviata and P. hortorum would produce better 
antifungal results than testing them at 20mg/ml. 
 
The disc diffusion assay was used as a screening method to determine the presence of 
antibacterial activity against Streptococcus pneumoniae and Haemophilus influenzae. 
During agar disc diffusion screening procedure, all medicinal plants except T. capensis 
showed antimicrobial activity against S. pneumoniae and H. influenzae strains by producing 
zones of inhibition (Table 5.4). Methanol extract of C. abbreviata produced a maximum 
zone of inhibition (15mm) against the ATCC 49619 reference strain of S. pneumoniae. 
Aqueous and acetone extracts of C. abbreviata produced 13mm and 14mm zones of 
inhibition respectively against ATCC 49619. Acetone extract of C. abbreviata produced an 
inhibition zone of 18mm against S. pneumoniae strain, UF00123106. On the other hand 
acetone extract of C. abbreviata did not inhibit any strain of Haemophilus influenzae tested 
in this study. 
 
According to Table 5.4, Geranium incanum and Pelargonium hortorum also demonstrated 
notable antibacterial activity against both strains of S. pneumoniae and H. influenzae. The 
highest inhibition zone (22mm) of all extracts was produced by P. hortorum acetone extract 
199 
 
against ATCC 49619 strain of S. pneumoniae. The maximum zone of inhibition (18mm) on H. 
influenzae (8993636) strain was produced by G. incanum acetone extract.  
 
In this study, the susceptibility profile of synthetic and common antibiotics on most of the 
tested clinical and ATCC strains, showed a very high level of antibiotic resistance. Multiple-
drug resistace (MDR) in this study was defined as resistance of an isolate to at least three or 
more classes of antimicrobial agents tested (Bauman, 2011; Onanuga & Awhowho, 2012). 
In Table 5.2, all methicillin resistant Staphylococcus aureus tested in this study exhibited 
high resistance to ampicillin, penicillin, and amoxycillin. Two strains of MRSA (1879918 and 
1884230) highly resisted all classes of antibiotics tested, hence signifying as extreme 
multiple-drug resistance bacteria. Silmutaneously, strains from Klebsiella pneumoniae, 
Acinetobacter baumannii, Haemophilus influenzae, Pseudomonas aeruginosa and 
Escherichia coli also exhibited MDR pattern since they resisted at least three classes of 
antibioitics used in this study as revealed in Table 4.3 and Table 5.2.  
 
The results of MDR strains correlate with other studies reported by Ziglam et al. (2012) and 
Iwalewa et al. (2009). Data in Figure 5.16 demonstrated a high level of antibiotic resistance 
to the commonly used antibiotics such as penicillin (89%), ampicillin (81%), amoxycillin 
(73%) and cephalexin (53%). All these antibiotics belong to one class, “beta-lactams” as 
shown in Table 4.3. This implies that most organisms tested in this study resisted beta-
lactam drugs. This is in consistent with the description given by Bauman (2011) and 
Gangoue-Pieboji et al. (2009) that bacteria such as Klebsiella pneumoniae, Acinetobacter 
baumannii, Staphylococcus aureus, Escherichia coli and Haemophilus influenzae have been 
clinically proven as beta-lactam-resistant bacteria and some are ESBL producers. These 
bacteria produce enzymes known as beta-lactamases (penicillinases) which break the beta-
lactam rings of penicillin and similar molecules, rendering them inactive (Elliott et al., 2007; 
Bauman, 2012). Some resistance was also demonstrated against aminoglycosides, e.g., 
gentamicin (30%) and streptomycin (43%). Twenty four percent of the organisms resisted 
chloramphenicol while fluoroquinolones (ciprofloxacin) inhibited 89% of the tested micro-
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organisms (Figure 5.16). High resistance that was observed in the clinical isolates examined 
in this study is consistent with emerging antimicrobial resistance worldwide, particularly in 
low-income countries. Similar observations were demonstrated by a study conducted by 
Mills-Robertson et al. (2012) in Ghana. The findings in this study also agree with what Rai et 
al. (2012, p. 12) reported that “micro-organisms are becoming resistant more quickly than 
new drugs are being made available. For a number of new antibacterial drugs, resistance by 
bacteria has increased and become a global concern”. As displayed in Figure 5.16, 
resistance of micro-organisms to antibiotics is on the increase. This research may highlight 
how to overcome resistance to antimicrobials. 
 
The results obtained during agar dilution and agar disc diffusion methods indicate that the 
plant extracts showed the strongest antimicrobial activity as compared to commercially 
available antibiotics. For example, in Table 5.1 and Table 5.9, three extracts of C. 
abbreviata, and all extracts produced by G. incanum and P. hortorum inhibited all tested S. 
aureus strains (including the two most resisistant MRSA), which some notable antibiotics 
were unable to achieve as observed in this study. These observations are in agreement with 
the findings of other researches such as Adebiyi et al. (2009) and Selvamohan et al. (2010). 
Nevertheless, no correlation was observed between the antibiotic susceptibility of the 
strains and their susceptiblity to the plants, as the plants effectively inhibited antibiotic 
resistant strains whereas some antibiotic sensitive strains appeared to show resistance to 
the plants. 
 
Although the plants declared antimicrobial activity against the tested pathogens during 
screening procedures, there was need to substantiate this claim on the basis of scientific 
origin, the rate and extent of bacterial killing (kill kinetics) hence the determination of 
minimum inhibitory concentrations (MIC’s). The MIC values of aqueous, methanol and 
acetone extracts from the leaves of G. incanum , P. hortorum and T. capensis and from stem 
bark of C. abbreviata against the tested non-fastidious bacteria are shown in Tables 5.11 to 
5.14. MIC tests were performed only on the test organisms that showed inhibition during 
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the antimicrobial screening as demonstrated by Kaur and Arora (2009) and Mills-Robertson 
et al. (2012). The lowest minimum inhibitory concentration recorded on bacteria in this 
study using microtitre plate assay was 0.031mg/ml.  
 
P. hortorum produced the lowest MIC range (0.031 – 0.125mg/ml) of all the plants on A. 
baumannii. The highest MIC on A. baumannii was produced by T. capensis (acetone extract) 
recording 1.0mg/ml.  The greatest activity of plant extracts was observed on MRSA strains 
where the lowest MIC value was frequently depicted as shown in Tables 5.11 to 5.14. G. 
incanum extracts also displayed much activity against the tested MDR isolates with MIC 
values ranging from 0.063mg/ml to 2mg/ml across the organisms. The lowest MIC value to 
be achieved by G. incanum was 0.063mg/ml since its neat concentration of the crude 
extract through double fold dilutions during microtitre plate determination was 20mg/ml. 
C. abbreviata was the only plant that inhibited K. pneumoniae strain (UB4088) at a 
concentration of 0.25mg/ml. 
 
Overall observation of the results in Table 5.12 and Table 5.13, the microtitre plate assay 
was the most efficient and easiest method of determining bioactivity of medicinal plants. 
This method was quick and sensitive as compared to agar dilution technique as observed 
and also reported in literature (Eloff, 1998b; Ellof, 2000). To support this claim, methanol 
and acetone extracts of G. incanum showed antibacterial activity against E.coli (893806) 
strain with an MIC value of 1.0mg/ml in the microtitre plate assay (Table 5.12). In contrast, 
methanol and acetone extracts of G. incanum did not inhibit growth of E. coli (893806) 
during agar dilution method (Table 5.1). Aqueous and acetone extracts of P. hortorum did 
not exhibit antibacterial activity against P. aeruginosa (ATCC 27853) strain during agar 
dilution assay (Table 5.1) whereas an MIC of 0.031mg/ml was achieved on P. aeruginosa 
(ATCC 27853) strain during the microtitre plate assay. Besides, the agar dilution assay was 
more cumbersome than the microtitre plate assay since it required large volumes of the 
plant extracts to be incorporated into the melted agar for analysis. On the other hand, the 
microtitre plate assay contributed to the conservation of the plants since only small 
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amounts of the plant extracts were required to test a wide range of concentrations and 
different bacteria silmutaneously. 
 
Even though the microtitre assay was more sensitive than the agar dilution assay, it had its 
own shortfalls. Acetone and methanol extracts from T. capensis and P. hortorum produced 
dark coloured extracts due to chlorophyll interference when suspended in DMSO. The 
coloured extracts posed some problems during subsequent reading with the microtitre 
plate reader. This observation was also noted by Chinyama (2009).  
 
In Table 5.6, MIC values achieved by plants on fastidious bacteria, Streptococcus 
pnuemoniae and Haemophilus influenzae strains are displayed. In the disc diffuion method, 
the lowest minimum inhibitory concentration was achieved by the methanolic extract of C. 
abbreviata on S. pneumoniae (ATCC 49619) recording the value of 2.5mg/ml. On the other 
hand, C. abbreviata acetone extract exhibited the lowest MIC value (5mg/ml) of all extracts 
on a clinical strain of S. pneumoniae (UF00123106). P. hortorum plants recorded the lowest 
MIC value of 5mg/ml and G. incanum produced the highest MIC value of 20mg/ml on S. 
pneumoniae (ATCC 49619) strain. Silmutaneously, the activity index achieved by the plant 
extracts across S. pneumoniae strains are displayed in Table 5.8. C. abbreviata produced a 
range of 0.23mm to 0.37mm while G. incanum produced a range of 0.27mm to 0.37mm. 
The widest range of activity index across S. pneumoniae strains was produced by P. 
hortorum extracts with a range of 0.24mm to 0.73mm. 
 
The lowest MIC value produced by plant extracts on H. influenzae strains was 10mg/ml and 
was achieved by both aqueous extract of C. abbreviata and methanol extract of G. incanum. 
The activity index of C. abbreviata across H. influenzae strains was from 0.39mm to 
0.42mm. G. incanum produced 0.24mm to 0.45mm and P. hortorum displayed 0.32mm to 
0.39mm of activity index across H. influenzae strains. The shortfall of the disc diffusion 
assay was that since the extracts were added to the disc on the plate, it was observed that 
some solvents of extracts interfered with the reading of the inhibition zones. Therefore, it is 
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important to let the disc dry after adding the desired concentration of the extract in order 
to remove residual solvents which might interfere with the determination (Jindal et al., 
2012; Sharma et al., 2012). The other observation in disc diffusion assay was that the 
inhibition produced by the plant extracts against a particular organism depended on various 
extrinsic and intrinsic parameters. Due to variable diffusability in the agar medium, the 
antibacterial property may not demonstrate as a zone of inhibition commensurate to its 
efficacy (Rai et al., 2012). 
 
Besides the different plant extracts, the traditional preparations of the plants were 
examined for antimicrobial activity as these preparations are used traditionally by the 
indigenous people. Traditionally, plant extracts are prepared as teas, infusions, decoctions, 
juices and poultices (Pendota et al., 2009; Rai et al., 2012). Infusions and decoctions of the 
selected plants did not inhibit any of the organisms tested in this study as depicted in Table 
5.5. This implies that the traditional preparation using water did not extract adequate 
compounds which are responsible for activity in the acetone and methanol extracts as 
portrayed also by Kavishankar et al. (2011). 
 
The potency of plants to inhibit growth of the pathogens can be traced to the presence of 
some active ingredients in the plants. Plants are known to synthesize certain chemicals 
which are naturally toxic to bacteria, and a large body of literature has validated the 
antimicrobial activity of plant extacts (Saini et al., 2011). Some of the major bioactive 
compounds responsible for antimicrobial activities of C. abbreviata, G. incanum, P. 
hortorum and T capensis were identified using qualitative phytochemical analysis. This was 
employed in the present work bacause the use of plant extracts or phytochemicals with 
known antimicrobial properties can be of profound significance for therapeutic treatments 
(Rai et al., 2012). 
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Successful prediction of chemical compounds from plant material is largely dependent on 
the type of solvent used in the extraction procedure (Assob et al., 2011). Qualitative 
phytochemical analysis was performed using colour forming and precipitating chemical 
reagents to generate data on the constituents of the plant extracts present in this study. 
The chemical tests revealed the presence of anthraquinones, flavonoids, phytosterol, 
tannins and triterpenoids in all the extracts of C. abbreviata stem bark. Saponins were only 
present in aqueous and methanol extracts of C. abbreviata stem bark and these findings are 
tabulated in Table 5.16.  
 
Table 5.17 exhibits the pressence of flavonoids, phytosterol and tannins in all leaf extracts 
of the G. incanum. Saponins were only found in aqueous leaf extracts of the G. incanum 
plant. In Table 5.18, flavonoids and phytosterol were secondary metabolites present in all 
the leaf extracts of P. hortorum. Saponins and tannins were contained only in aqueous and 
methanol leaf extracts of P. hortorum. Table 5.19 shows the presence of flavonoids and 
phytosterol in all leaf extracts of T. capensis while saponins and tannins were only displayed 
in aqueous and methanol extracts of T. capensis. A study conducted by Saini et al. (2011), 
revealed the presence of glycosides in methanolic leaf extracts of T. capensis which was not 
detected during phytochemical testing in this study. Tamiljothi et al. (2011), also revealed 
the presence of cardiac glycosides and saponin glycosides in the leaf of T. capensis by using 
different solvents not employed in this study. This elaborates why it is difficult to compare 
the results obtained against the published findings in literature particularly when dealing 
with plant extracts. This is because several variables such as: the environment (nature of 
soil, presence or absence of other plant neighbors, etc), climatic conditions under which the 
plant grew, choice of extracts, choice of extraction method, antimicrobial test method and 
test organisms all contribute to discrepancies experienced in phytochemical analysis. 
Hence, the active ingredients of plants grown in various places and at different times may 
vary surprisingly  (Arrowsmith, 2009). 
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Another observation was that the extracting solvents played a significant role in the 
phytochemical constituents of the extracts as revealed by the variation in the 
phytochemical constituents of aqueous, methanol and acetone extracts of the same plant. 
For example, sapponins were not present in the acetone and methanol extracts of G. 
incanum but were present in the aqueous extract of the same plant, G. incanum (Table 
5.17). Similarly, saponins and tannins were absent in the acetone extract while being 
present in the aqueous and methanol extracts of the same plant, T. capensis (Table 5.19). 
This variation could be due to differences in the extraction ability of the solvents (Faparusi 
et al., 2012). A similar observation was also noted in the work done by Egharevba, Ocheme, 
Ugbabe and Abdullahi (2010). The present study showed the absence of alkaloids and 
glycosides in all the tested plant extracts (Tables 5.16, 5.17, 5.18 and 5.19).  
 
In compliance with phytochemical analysis, TLC fingerprints were employed in this study 
because it is an easy, economical and quick method of qualitatively determining the 
presence of  various secondary metabolites in herbs (Diederichs, 2006; Liu, 2011). The 
results obtained demonstrated the utility of TLC to distinguish with certainty the 
antibacterial activity of the tested plants. Bioautography combines TLC with a bioassay in 
situ and, therefore allows the reseacher to localize the active compounds within a sample. 
The developed spots shown in Figure 5.22, and the clear zones of inhibition exhibited in 
Figure 5.23 is a clear indication of the presence of some phytocompounds revealed in this 
study such as anthraquinones, flavonoids, phytosterol, saponins, tannins and triterpenoids. 
In Table 5.20 and Table 5.21, most of the developed spots across different plant extracts 
have the same Rf value implying the probable presence of the same compound in methanol 
and acetone extracts of the tested plants. The clear zones of inhibition attained by 
methanol and acetone plant extracts as shown in Figure 5.23 supports the antibacterial 
activity displayed during screening and MIC procedures undertaken in this study. 
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It was also observed that some of the organisms that were not inhibited during agar 
dilution and agar disc diffusion methods showed clear zones of inhibition during 
bioautographic assay. For example, the three strains of Staphylococcus aureus tested during 
bioautographic assay, ATCC 43300, 867716 and MRSA 9708 were not inhibited by methanol 
extracts of T. capensis during agar dilution method (Table 5.1). However, these three strains 
showed clear zones of inhibition with TLC, bioatographic assay exhibiting Rf values ranging 
from 0.14 to 0.94 (ATCC 43300), 0.14 to 0.83 (S. aureus, 867716) and 0.19 to 0.91 (MRSA 
9708) as displayed in Table 5.20. This suggests that certain compounds were released with 
the solvents employed for TLC such as chloroform and ethyl acetate. A study conducted by 
Tamiljothi et al. (2011) deduced the presence of glycosides, proteins, steroids and 
terpenoids which were not detected with methanol and acetone extracts of T. capensis 
applied in this study.  
 
Having looked at the antimicrobial activities of the study plants against selected ATCCs and 
clinical isolates known to cause pneumonia and other lower respiratory tract infections, it is 
worthy to discuss the effects of plant extracts as compared to that of standard antibiotics. 
There appeared to be no correlation between the antibiotic susceptibility patterns of 
bacteria expressed in Table 5.2 and the inhibition of the growth of bacteria by plant 
extracts shown in Table 5.1. For example, two strains with the same antibiotic susceptibility 
patterns may have totally different results with the same plant extracts, as demonstrated 
by E. coli strains (892894 and 891230). In Table 5.2, these two strains are displayed to have 
the same susceptibility pattern, whereas in Tables 5.1, it is shown that strain number 
891230 was inhibited by all the plant extracts while strain number 892894 was not inhibited 
by extracts of one plant, G. incanum. 
 
It was also noted that highly antibiotic resistant strains of bacteria (MDR) could be very 
susceptible to plant extracts. This was demonstrated by the two strains of MRSA (1879918 
and 1884230). In Table 5.2, these two strains are displayed to have the same susceptibility 
pattern as they both resisted every commercially antibiotic used in this study. On the other 
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hand, in Tables 5.1, 5.11, 5.12 and 5.13, it is observed that the two MRSA strains (1879918 
and 1884230) are completely inhibited by C. abbreviata, G. incanum and P. hortorum 
extracts with an MIC range of 0.031mg/ml to 0.063mg/ml. Similarly, an antibiotic sensitive 
strain could exhibit resistant patterns to some of the plant extracts, as displayed by E. coli 
clinical strain #9. In Table 5.2, E. coli clinical strain #9 was susceptible to GM10, C30, CIP5, 
AP10, CXF30, A10 and S10 but showed extreme resistance to all plants extracts (Table 5.1). 
 
The behaviour of MRSA strains to standard antibiotics was in compliance with the 
suggestion by Heyman et al. (2009) that approximately 60% of the staphylococcal infections 
reported in hospitals are caused by methicillin-resistant Staphylococcus aureus. In this case, 
the antibiotics required to treat the resistant strains usually have serious side effects. For 
example, vancomycin used in the treatment of MRSA infections may lead to rashes at the 
site of injection and sometimes may lead even to deafness if the level of this drug becomes 
too high in the bloodstream. Vancomycin may also cause ototoxicity, nausea and vomiting 
(Volans & Wiseman, 2009). The study plants however, showed strong antibacterial effects 
on all MRSA used in this study. This signifies that novel drugs with less or no side effects 
could be found in plants. Rai et al. (2012) supported this idea by stating that the adverse 
reactions are negligible in the case of the pure plant products as compared to the 
pharmaceuticals. 
 
There is a possibility that some of the bacteria responded well to the plant extracts because 
they had not been exposed to the plants before, and had no opportunity to develop 
resistance as compared to antibiotics which have been used over the years to treat 
infectious infections such as pneumonia. Another posibility could be that plants have 
different mechanisms of combating antagonistic microorganisms from those mechanisms 
known by standard antibiotics hence inhibition of growth of bacteria including the very 
resistant ones (Wilson, 2004; Faparusi et al., 2012). The activity of the plant extracts under 
investigation may also be due to synergistic activity of the phytochemicals that were found 
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to be present and those that were not revealed during phytochemical analysis (Omwenga & 
Paul, 2012). 
 
All medicinal plants in this study contained phenolic compounds such as flavonoids and 
tannins. Tannins are potent inhibitors of many hydrolytic enzymes such as proteolytic 
macerating enzymes used by plant pathogens (Faparusi et al., 2012). Tannins in addition 
disrupt the cell membranes of the micro-organisms by denaturing thereby inhibiting their 
growth (Omwenga & Paul, 2012). Flavonoids affect the behaviour of many cellular systems 
because they are capable of modulating the activity of enzymes hence they possess vital 
antihepatotoxic, antiallergy, anti-inflammatory, antiosteoporotic, antithrombotic and 
antitumor activities (Sunita et al., 2012). Thus, flavonoids are known to form complexes 
with bacterial cell walls which result in inhibiting bacterial growth. Flavonoids (catechins) 
also inhibit the action of DNA polymerase hence their antibacterial activity (Omwenga & 
Paul, 2012). 
 
Saponins were also present in all medicinal plants investigated in this study either in one or 
two of the extracts of each plant. Saponins are plant-based anti-inflammatory constituents 
that may lower blood cholesterol thereby preventing heart diseases as well as some 
cancers. Saponins possess other pharmacological activities such as antibiotic, antifungal, 
antiviral and anti-ulcer (Abbhi, Joseph & George, 2011; Hossain & Nagooru, 2011; Hussain 
et al., 2011). Plant sterols present in all the extracts of the study plants are best known for 
their ability to reduce cholesterol (Abbhi et al., 2011). Thus, the major factor responsible for 
bioactivity of plants is the presence of secondary metabolites. It is due to these secondary 
metabolites as described earlier on, that the plants have their medicinal properties (Rai et 
al., 2012). 
 
In Table 2.4 and Figure 2.9, the various antibiotic mechanisms are outlined. Antibiotics 
function in one of the following ways: inhibition of cell wall sysnthesis, inhibition of protein 
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synthesis, disruption of cytoplasmic membrane, inhibition of general metabolic pathway, 
inhibition of DNA or RNA synthesis and inhibition of pathogen’s attachment to, or 
recognition of host. Since extracts from a single plant contain a mixture of several bioactive 
compounds, they may inhibit micro-organisms through different mechanisms than that of 
conventional antibiotics and thus could be of clinical importance in the treatment of 
resistant pathogens (Ellof, 1998a; Faparusi et al., 2012). It is possible that the different 
bioactive compounds available within various plant extracts may function by means of 
either a combination of mechanisms illustrated by standard antibiotics or by some 
unknown ways. Thus, active compounds may have several invasive targets which could 
injure bacteria causing death (Saini et al., 2011). For example, tannins are known to form 
irrevesible complexes with proline-rich proteins resulting in the inhibition of microbial cell 
protein synthesis. According to Abbhi et al. (2011), tannins have exhibited potential 
antiviral, antibacterial and antiparasitic effects. Tannins possess anticancer activity and can 
therefore be employed in cancer prevention (Faparusi et al., 2012).  
 
In summary, phenolic compounds not only attack the organism’s cell wall and cell 
membrane thereby inducing cellular permearbility that leads to the release of intracellular 
constituents such as ribose, sodium and glutamate but also, interfere with cell membrane 
functions such as electron transport, nutrient uptake, protein and nucleic synthesis and 
enzyme activity. Furthermore, many antibacterial substances including phenolic 
compounds have the ability to induce leakage of intracellular material from bacteria such as 
E. coli and S. aureus (Saini et al., 2011; Faparusi et al., 2012). This explains why these plants 
demonstrated better effects on the micro-organisms than the synthetic drugs. This further 
explains how microbial strains that are resistant to conventional antibiotics that only inhibit 
cell wall, or disrupt cytoplasm membrane, or inhibit DNA or RNA synthesis, could be 
susceptible to a plant extract that functions by means of all these three mechanisms as well 
as additional unknown mechanisms. Thus, the study plants have demonstrated a broader 
spectrum of inhibitory activity against selective pathogens by possessing more than one 
210 
 
active principle of biological significance. It is well-known that the phytochemical 
components also offer plants protection against infection by pathogenic micro-organisms 
(Abbhi et al., 2011; Anowi et al., 2012). 
 
In many communities in South Africa and neighbouring countries, several medicinal plants 
are traditionally used in the treatment of a variety of ailments, inclunding cancer. Many of 
these herbs therefore, need to be assessed for their efficacy or safety to the tissues or 
organs of recipients. In Africa, little information is available on the toxicological properties 
of herbal preparations (Hong et al., 2011b). In this study, the Ames test was used in the 
determination of possible gene mutations caused by extracts. A positive response in any 
single bacterial strain either with or without metabolic activation is adequate to designate a 
substance as a mutagen (Mashele & Fuku, 2011). 
 
This study evaluated the in vitro mutagenic activity of the leaves of G. incanum, P. hortorum 
and T. capensis as well as the stem bark of C. abbreviata.  Although testing of probable 
carcinogenicity by using Ames test is quick and exhibits the carcinogenic potential of many 
chemicals, it is not possible to make a direct correlation between the observed activity of 
the extracts in vitro and the actual effects when tested in vivo. Results in vitro may be 
encouraging while different biochemical pathways may be activated or utilized in vivo. The 
extracts of C. abbreviata, G. incanum, P. hortorum and T. capensis tested in absence of 
metabolic activator did not show any probable carcinogenicity on the S. typhimurium TA 
100 as exhibited by the mutagenic index in Table 5.22 which was inferior than 2.00 in all the 
determinations. Since the Ames test employed did not incorporate the use of liver extracts 
(S9), the findings may not reflect the in vivo activity of the plant extracts. These results 
imply that in the absence of S9 fractions, the study plants can protect the bacterial DNA 
from attacks by mutagens. The results further suggest that it is pontentially safe to use 
these plants as medicinal plant supplements. 
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Even though the study plants did not demonstrate mutagenic effects, it is important that 
the probable carcinogenicity of these plants be further investigated. Preclinical in vivo and 
clinical trials should be conducted in order to evaluate the safety and efficacy of the 
selected plants in animals prior to use in human subjects. Thus, patients who are 
considering the use of these plants for therapy should be well informed of any side effects 
that may be incurred.  
 
6.1 CONCLUSIONS 
 
The antibacterial activity and anticandidal activity of the plants under study against 
different strains of pneumonic pathogens support validity of the plants being used 
traditionally for treating pneumonia and other respiratory tract infections. The use of 
Pelargonium hortorum leaves in traditional medicine is poorly recorded but the findings in 
this study indicate that P. hortorum leaves have a potential broad spectrum antimicrobial 
activity. The present study also shows that medicinal plants could be sources of compounds 
which might be useful for best management of infectious diseases caused by beta-lactam 
resistant bacteria and extended spectrum beta-lactamase-producing enterobactericia as 
depicted in Table 5.1. The results further suggest that ethnopharmacological research could 
play a vital role in helping fight the worldwide HIV/AIDS pandemic and its associated 
opportunistic infections such as oropharyngeal Candidiasis and tuberculosis. 
 
The phytoconstituents present in C. abbreviata, G. incanum, P. hortorum and T. capensis 
exhibited a broad spectrum of activity against both Gram-positive and Gram-negative 
bacteria and fungi. However, further investigation is required to identify more compounds 
that may be available in the study of plants. Identification of bioactive compounds alone is 
not adequate; purification and structural isolation of the compounds together with the 
determination of their respective antimicrobial potencies need to be carried out.  
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Concerning safety of the plants studied, no mutagenic effect was established during the 
Ames test. However, further toxicological evaluation with the view to formulating novel 
chemotherapeutic agents from the study plants should be investigated. This investigation 
was done in vitro without interfering with the body’s physical effects such as gastro-
intestinal motions and chemical effects such as stomach enzymes, stomach hydrochloric 
acid, mucous and many more. Based on this, the in vitro antimicrobial activity of the four 
study plants might not be sufficient to justify their potential because the response inside 
the body might be quite different and requires additional investigation of these natural 
factors (Sadeghian et al., 2012). Further work is therefore needed to evaluate the precise in 
vivo antimicrobial activity of the plant extracts.  
 
To explain further, most of the secondary metabolites as revealed in this study, directly act 
on the pathogenic micro-organisms and arrest their growth. At times, the active principles 
do not affect the pathogen, but they can stimulate the production of those elements in the 
body responsible for inhibitory action against the pathogens. This indicates that the 
mechanism of action of the drug inside the body is a complicated process. Thus, the action 
of the plant extract to some extent may vary in vivo. In addition, personal history, climatic 
conditions, and the immunity of the other symbiotic microbes may at times be responsible 
for the net effect to cure a patient (Rai et al., 2012). This provides another reason why in 
vivo antimicrobial investigation on the selective plants is recommended. 
 
Finally, the present investigation has shown that the studied plants are good potential 
sources of antimicrobial agents and would play a vital role in medicine thereby helping in 
primary health care in this part of the world. The extracts of C. abbreviata, G. incanum, P. 
hortorum and T. capensis were found to be more or less active against most of the tested 
pathogenic strains. Interestingly, the antimicrobial activities of the study plants in most 
instances were greater than that in the standard antibiotics. This demonstration of broad 
spectrum by the selected plants may help to discover new chemical classes of antibiotic 
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substances that could serve as selective agents for infectious disease chemotherapy and 
control. The plants extracts of C. abbreviata, G. incanum, P. hortorum and T. capensis have 
great potential as antimicrobial compounds against resistant micro-organisms and can 
essentially be used in the treatment of infectious diseases such as pneumonia. 
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APPENDIX A: 
Media preparation 
Medium Name Quantity 
used 
Amount of 
distilled 
water in ml 
Autoclave 
temperature 
in °C 
Autoclave 
duration 
Davis Minimal Agar (DMA) 26.6g 1000ml 121°C 15 minutes 
MacConkey Agar (MAC) 50g 1000ml 121°C 15 minutes 
Mueller-Hinton Agar (MH) 38g 1000ml 121°C 15 minutes 
Mueller-Hinton Broth (MHB) 21g 1000ml 121°C 15 minutes 
Nutrient Agar (NA) 31g 1000ml 121°C 15 minutes 
Nutrient Broth (NB) 16g 1000ml 121°C 15 minutes 
Sabouraud Dextrose 4% Agar (SAB) 60g 1000ml 121°C 15 minutes 
 
 
(i) Agar Solid Media (DMA, MAC, MH, NA, SAB) 
 Suspend powdered medium in distilled water. 
 Boil whilst stirring until completely dissolved. (For MH, prior to boiling, MH 
should be allowed to stand for 15 minutes). 
 Sterilize by autoclaving at 121°C for 15 minutes. 
 Cool medium to 45°C – 50°C. 
 Mix well and dispense into sterile plates. 
 
(ii) Broth Media (NB, MHB) 
 Dissolve powdered medium in distilled water. 
 Mix well and dispense into tubes. 
 Autoclave at 121°C for 15 minutes. 
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APPENDIX B: 
Schematic representation of the various steps taken for performing extraction and 
antimicrobial activity of the medicinal plants 
Step 1:    
Medicinal Plants 
Cassia abbreviata (stem bark) 
Geranium incanum (leaves) 
Tecoma capensis (leaves) 
Pelargonium hortorum (leaves) 
Step 2: 
Preparation of Plant Material 
Decoction        Extraction         Infusion 
 (Aqueous, Methanol, Acetone) 
Step 3: 
Antibacterial Assays 
Microtitre Plate Assay  Agar Disc Diffusion Assay  Agar Dilution Assay 
(Using microtitre plate  (Using impregnated sterile  (Using extracts prepared in 
 and INT)        6mm filter paper discs)  agar plates) 
   MIC (mg/ml)   MIC (mg/ml)  MIC (mg/ml) 
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